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Abstract 
 
Herein described are accounts of fundamentally different projects and topics. The 
content of the research to be elaborated on is divided into the following 3 chapters: The 
focus of the first chapter, under the tutelage of Dr. Daniel Clark, details the discovery and 
optimization of an unusual ruthenium complex capable of enyne metathesis. The second 
and third chapters, under the tutelage of Dr. Ivan Korendovych, relate to the design and 
discovery of short peptides that self-assemble into supramolecular structures and/or 
provide good catalytic results. The second chapter details the design of a short dipeptide 
able to self-assemble and its application in the transition-metal asymmetric transfer 
hydrogenation (ATH) reaction of converting ketones to chiral alcohols in good yields and 
high enantiomeric excess. The third chapter highlights some of the unexpected 
observations encountered from several of our peptide designs for self-assembly including 
the formation of hydrogels or metallogels.  
 
Chapter 1 
Ruthenium–catalyzed enyne metathesis is a reliable and efficient method for the 
formation of 1,3-dienes, a common structural motif in synthetic organic chemistry. The 
development of new transition-metal complexes competent to catalyze enyne metathesis 
reactions remains an important research area. This chapter describes the use of 
ruthenium (IV) dihydride complexes with the general structure RuH2Cl2(PR3)2 as new 
catalysts for enyne metathesis. These ruthenium (IV) dihydrides have been largely 
unexplored as catalysts in metathesis-based transformations. The reactivity of these 
complexes with 1,5 through 1,7-enynes was investigated. The observed reaction products 
are consistent with the metathesis activity occurring through a ruthenium vinylidene 
intermediate. 
 
Chapter 2 
Bioinspired catalysts promote a wide range of different chemical reactions with 
impressive efficiencies. Nonetheless, designing bioinspired metallopeptides to catalyze 
chemical reactions with high enantioselectivities still remains a challenge. Self-assembly 
enables formation of incredibly diverse supramolecular structures with practically 
important functions from simple and inexpensive building blocks. Here we show how a 
semi-rational approach to create emerging properties can be extended to a design of 
highly enantioselective peptide catalysts. The designed peptides comprised of as few as 
two amino acid residues spontaneously self-assemble in the presence of metal ions to 
form supramolecular, vesicle-like nanoassemblies that promote the transfer 
hydrogenation of ketones in aqueous phase with excellent conversion rates and 
enantioselectivites (90+ % ee) 
 
Chapter 3 
As an extension of the work conducted in chapter 2 of this thesis, this third chapter 
will describe the observations of a few notable peptides that directly or indirectly exhibited 
self-assembly. Various principles of ligand design were explored during our quest to find 
a robust self-assembling peptide ligand capable of enantioselective catalysis. Data 
relating to peptide self-assembly was predominantly inferred from experimental results 
obtained from the ATH reactions except in cases where irrefutable microscopy images 
could be collected. Peptide ligands that formed interesting self-assemblies or possessed 
self-assembly potential include (N-tosyl)-TFF-CONH2 which, by AFM imaging showed 
formation of fibrils, Cp*Ir(Cl)(DPLVFF-CONH2) formed a metallogel in TFE at a 125 µM 
concentration, and mixing oppositely charged peptides (DP)LDFDF and (DP)LKFKF in 
different ratios showed improved enantioselectivity over the individually tested peptide. 
Excellent ATH results were also obtained with the non-assembled peptide catalyst DPLF-
CONH2. 
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Chapter 1 Ruthenium Dihydrides as Enyne Metathesis Catalysts  
 
 
Work from this chapter has led to the following publications: 
Dolan, M. A..; Dixon, A. D. C.; Chisholm, J. D.; Clark, D. A.C. M., Ruthenium dihydride 
complexes as enyne metathesis catalysts. Tetrahedron Letters, 2018, 59 (51), 4471-
4474.  
 
Figures/Schemes/Tables from this publication were reproduced with permission from the 
Elsevier, copyright 2018.  
 
Abstract:  
Ruthenium–catalyzed enyne metathesis is a reliable and efficient method for the 
formation of 1,3-dienes, a common structural motif in synthetic organic chemistry. The 
development of new transition-metal complexes competent to catalyze enyne metathesis 
reactions remains an important research area. This chapter describes the use of 
ruthenium (IV) dihydride complexes with the general structure RuH2Cl2(PR3)2 as new 
catalysts for enyne metathesis. These ruthenium (IV) dihydrides have been largely 
unexplored as catalysts in metathesis-based transformations. The reactivity of these 
complexes with 1,5 through 1,7-enynes was investigated. The observed reaction products 
are consistent with the metathesis activity occurring through a ruthenium vinylidene 
intermediate. 
 
 
 
 
 
2 
1.1. Introduction 
 
1.1.1. Historical Background on the Development of Metathesis 
In 2005, three scientists, Yves Chauvin, Richard Schrock, and Robert Grubbs were 
co-awarded the Nobel Prize in Chemistry based on their collective works and efforts on 
the development and understanding of metal-catalyzed metathesis reactions. Metathesis, 
in the context of an organometallic reaction, is a where a metal-carbene complex 
catalyzes an addition reaction between two unactivated precursors (Scheme 1.1). The 
precursors typically represented in the reaction include alkene (C=C) or alkyne (CºC) 
functional groups. 
 
Scheme 1.1. Overview of metal-cabene metathesis reactions 
Due to the above scientists’ discoveries and pioneering works, metathesis became 
a synthetic reaction of great utility for the construction of natural products1-4, polymers, 
and other materials science.5-8 In the 1970s, Chauvin was among the first scientists to 
postulate and construct what would be considered the accepted description for how 
metathesis works. It was then Schrock who elucidated the catalytic cycle and identified 
the key metal alkylidene intermediate in the reaction pathway.9 Schrock was also notable 
for his development of the early transition metal catalysts that were metathesis active. 
Grubbs was the innovator that brought metathesis to the forefront of the scientific 
community. In the early 1990s Grubbs had developed a ruthenium metal complex that 
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was not only bench stable, but considered superior to other transition metals for its 
excellent functional group tolerance and activity. In fact, due in part to the accessibility of 
the Grubbs catalyst, a meteoric rise in metathesis related articles was seen in the 
scientific literature (Figure 1.1). Metathesis soon became the zeitgeist of the 1990s and 
early 2000s as scientists scrambled to push out articles and find newer and interesting 
catalysts and modes of activity. New developments regarding metathesis reactions 
continue to emerge into the present-day, further bolstering its utility in the scientific 
community. Furthermore, the success of these complexes was secured in part by Grubbs 
founding the company Materia® to commercialize and make accessible these 
revolutionary transition metal catalysts at an early point in the global research effort. 
 
Figure 1.1. Overview of ruthenium metathesis impact in the literature. Number of references 
produced in response to keyword queries of “ruthenium” and “metathesis” returned by SciFinder on 
December 18th, 2018. 
Undoubtedly, the introduction of these ruthenium transition metal complexes has 
made metathesis become far more impactful. As far back as 1965, two independent 
groups had found ruthenium trichloride trihydrate to be metathesis active in the ring 
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opening metathesis polymerization (ROMP) of norbornene10 and cyclobutenes11 in protic 
solvents such as ethanol or water. This was an interesting observation at the time, not 
only because ruthenium had not been reported to be metathesis active like titanium,12 but 
the display of good activity in protic solvents indicated ruthenium catalysts could possess 
a broad functional group tolerance. 
1.1.2. Background on Grubbs Catalysts 
 
Grubbs published his seminal papers in 199213 and 199314 wherein he presented 
a well-defined metathesis active ruthenium (II) complex 1 with a conjugated vinylcarbene 
ligand (Figure 1.2). Ruthenium alkylidene 1 displayed promising activity and tolerance 
towards air, water, and acids in the first test reaction with ROMP of norbornene. These 
papers were followed closely thereafter in 1995 with the publication of the more prominent 
Grubbs generation I, or commonly referred to as the “Grubbs I” complex 2.15 The Grubbs 
I complex has a basic structure that consists of two chloride ligands, two electron-
donating tricyclohexyl phosphine ligands, and a metal-carbon double bond (M=CHR) 
referred to generally as a carbene, alkylidene, benzylidene (due to phenyl group), or more 
specifically as a vinylcarbene.  
 
Figure 1.2. Overview of ruthenium catalysts commonly used in metathesis reactions 
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Through iterative advancements in the choice of electron-donating ligand and/or 
alkylidene design, Grubbs, Hoveyda as well as others,16-19 further improved upon the 
activity governed by the ruthenium complex. These complexes in Figure 1.2 are classified 
as ruthenium alkylidenes and were first prepared by Grubbs and co-workers with 
exception to Hoveyda-Grubbs complex 4, which was reported independently by 
Hoveyda20 and Blechert17 at nearly the same time. Grubbs had demonstrated early on 
that the electronics of the ligands, and to some extent the sterics of the phosphine ligand 
cone angle, could enhance the catalytic activity.14 Indeed, innovation and fine-tuning of 
the electronics involved with ligands binding to the metal center resulted in these catalysts 
possessing even greater activity. Among the myriad of developed metathesis catalysts, 
the commonly used ruthenium catalysts seen in many publications include the well-known 
Grubbs I, Grubbs II 3, Hoveyda-Grubbs II 4, and Grubbs III 5 complexes. Grubbs II is a 
close analogue of Grubbs I and is universally considered more active than Grubbs I due 
to the replacement of a single tricyclohexyl phosphine ligand with a more electron-rich N-
heterocyclic carbene (NHC) ligand. Introduction of ligands with stronger electron donation 
properties to ruthenium led to quicker initiation of the active species and permitted higher 
number of turnovers of the catalyst. The Hoveyda-Grubbs complex advanced on this 
concept by exchanging the vinylcarbene for an ortho-isoproxy benzylidene ligand. Use of 
this carbene was ingenious as it allowed for chelation of the isoproxy group to the metal 
center and avoided the need for the phosphine ligand to dissociate first in the initiation of 
the active catalytic species. Furthermore, a phosphine-free ruthenium metathesis catalyst 
meant the avoidance of phosphine degradation as a potential source of killing activity of 
the metal catalyst.21 Grubbs soon afterwards published an updated phosphine-free 
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ruthenium complex that was derived from Grubbs II by substituting the phosphine for a 
bispyridine ligand (the second pyridine is solvated and only observed in the isolated solid 
complex).22 Interestingly, kinetic analyses of the initiation rates of Grubbs III versus 
Grubbs II showed a rate constant of over one millionfold faster for the Grubbs III.  
1.1.3. Background on Olefin and Enyne Metathesis 
A majority of research concerning the field of metathesis involves the investigation 
in the scope and tolerance with alkene and alkyne functional groups in mind. As such, 
one of the first areas to be explored in this field was called olefin metathesis. Olefin 
metathesis is the descriptor used when exclusively alkene functional groups are present 
in metathesis and the metal carbene assists in doing three possibilities (Scheme 1.2); it 
allows either cracking open a cyclic alkene to then generate a polymer (ROMP), creates 
a new alkene by combining two molecules together intermolecularly via cross-metathesis 
(CM), or by fusing two fragments from the same molecule intramolecularly via ring-closing 
metathesis (RCM). There have been countless publications that have examined the study 
of olefin metathesis which can be reviewed further here,23-24 as this chapter will mainly 
discuss on the topic of enyne metathesis. 
 
Scheme 1.2. Overview of olefin metathesis transformations 
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Another facet of metathesis chemistry that arose has been called enyne 
metathesis. Enyne metathesis shares great similarity with olefin metathesis in terms of its 
reactivity being mediated by a metal carbene. This type of metathesis describes the 
reaction occurring between an alkene and an alkyne functionality to produce a 1,3-diene 
product. Some of the possible transformations used in enyne metathesis include ring-
opening metathesis (ROM), intermolecular cross-enyne metathesis (CEYM), 
intramolecular ring-closing enyne metathesis (RCEYM), and even a tandem ring-closing 
enyne metathesis reaction (Scheme 1.3). 
 
Scheme 1.3. Overview of enyne metathesis transformations 
 
It was the seminal work published by Katz and Sivavec that introduced enyne 
metathesis to the synthetic community.25 In their work, they used a tungsten-based 
Fischer carbene 23 to perform the first catalytic enyne metathesis reaction using 0.01 
equivalents (or 1 mol %) of the tungsten complex (Scheme 1.4). This observation was 
considered uncharacteristic during that time with transition metal catalysts because the 
complexes were not sophisticated enough to sustain reactivity at low catalyst loading. 
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Katz and Sivavec’s discovery with Fischer-carbenes became the template for future 
transition-metal catalysts in metathesis.26-29  
 
 
Scheme 1.4. Fisher Carbene catalyzed enyne metathesis 
1.1.4. 1,3-Dienes as a Synthetic Motif 
 
Scheme 1.5. Kinoshita and Mori’s total synthesis of (-) stemoamide 
1,3-dienes are an important synthetic motif as it can commonly be used to access 
challenging natural products1-4 and polymers.5-8 1,3-dienes are generally well-suited for 
further functionalization into cycloaddition (e.g. Diels-Alder), silylboranation,30-31 
hydroamination32-33 and other reactions.34 Remarkably, the total synthesis of (-)-
stemoamide was the first report that included an enyne metathesis reaction into a 
complex synthetic route (Scheme 1.5). The corresponding diene 27B was then utilized in 
the construction of the lactone ring. In fourteen linear steps, Kinoshita and Mori were able 
to stereoselectively form (-)-stemoamide in 9% overall yield.1 
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Scheme 1.6. Metal-catalyzed cyclization pathways with enynes 
Since the implementation of a tungsten Fischer-carbene catalyst, other transition-
metals have been found to catalyze ring-closing enyne metathesis (RCEYM) to produce 
1,3-dienes such as chromium35-40, molybdenum35, 40, gallium41, palladium42-45, and 
platinum.46-50 Typically, use of these transition metal complexes can often result in a 
mixture of regioselctive cycloisomerized products via different metal pathways (Scheme 
1.6). Palladium for example, has been extensively tested and found to access either 
pathway depending on the substrate and catalyst used.51 With simple palladium (II) 
complexes such as Pd(OAc)2, palladium carbocyclization will produce cycloisomerization 
products of type A and B. Notably however, palladium was also the first metal found to 
rearrange enynes into 1,3-diene product C with the use of palladacyclopentadienes.45, 52 
Later research with platinum (II) complexes and enynes also found it possible to catalyze 
via the rearrangement pathway to yield products C or D. Interestingly, formation of 
metathesis product D with platinum catalysts is only observed when ‘X’ in the chemical 
structure of Scheme 1.3 is a heteroatom (e.g. oxygen, nitrogen).47 One of the main 
advantages with ruthenium-type complexes is the high degree of regioselectivity from 
metathesis reactions.28 Formation of 1,3-diene C is almost usually exlcusive with Grubbs-
type metathesis catalysts.  
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1.1.5. The Importance of Atom Economy 
Before ruthenium complexes became synonymous with the field of metathesis 
however, a number of palladium-catalyzed cross coupling approaches to 1,3-dienes had 
been developed to facilitate the synthesis of these systems.53-56 In most of these cases 
the formation of the 1,3-diene is accomplished by the coupling of vinyl halides and vinyl 
metal intermediates (for an example57 see Scheme 1.7). Installation of a diene with these 
methods is accompanied by significant waste generation, with loss of stoichiometric 
amounts of both a halogen (or pseudohalogen) and metal (or metalloid) being responsible 
for the poor atom economy.58-59  
 
Scheme 1.7. Example of palladium-catalyzed cross coupling mechanism 
Many of the precursors for the vinyl starting materials are generated from alkyne 
precursors, so it is unsurprising that methods are continuously being developed to 
circumvent the need for the formation of the vinyl halide or vinyl metal intermediates; they 
instead focus on proceeding directly from an alkyne to a 1,3-diene product.60-65  The 
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advent of Grubbs-type complexes offered metathesis reactions with high activity, high 
atom economy, broad functional group compatibility, and high regioselectivity. 
1.1.6. Mechanistic Insights Into Metathesis 
Studies on enyne metathesis with Grubbs catalysts have revealed several 
limitations with the transformation. For example, it was only recently that Daesung Lee’s 
group examined endo versus exo selectivity of medium and large-sized rings upon 
RCEYM (Scheme 1.8).66-67 Their data suggested exo selectivity is exclusive for small 
and medium-sized rings with endo-selectivity favored for large macrocyclic ring 
formation (12-15-membered rings) (Scheme 1.8, equation 1). It is important to note that 
when these experiments were conducted under an atmosphere of ethylene gas, the 
predominant products observed were instead CEYM butadienes. Lee and co-workers 
further questioned and explored how selective the metal vinylcarbene intermediate was 
by conducting additional experiments looking into the cyclization preference between 
two tethered terminal olefins that were of different lengths separated from the alkyne 
(Scheme 1.8, equations 2-3). They had found not only that RCEYM occurred faster than 
RCM between the two alkenes, but smaller rings were favored when a sizeable 
difference existed between the two possible cyclized rings. 
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Scheme 1.8. Endo and exo selectivity of medium and macrocycle rings 
Mechanistic theories have been established to describe the process of olefin and 
enyne metathesis and the corresponding intermediates relevant to its reactivity utilizing 
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27, 68-70 and had proposed the process occurs via the ene-then-yne mechanism. Diver is 
among few scientists that have closely examined the kinetics involved with metathesis 
activity concerning the Grubbs complexes. An emphasis in Diver’ method was centered 
on discerning the mechanism of reactivity and the likely carbene intermediates that would 
form. Researchers had long known that initiation of the Grubbs catalysts occurred first by 
dissociation of a phosphine ligand in order to create a vacant orbital for activity to 
commence.71 Diver’s now widely accepted mechanistic theory of the ene-then-yne 
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vinylcarbene 51. Vinylcarbene 51 further reacts with an alkyne functionality to form the 
respective ruthenacyclobutene 52 intermediate. Cycloreversion of the 
ruthenacyclobutene 52 affords, after catalytic turnover, the 1,3-diene metathesis product 
47 plus a reformed ruthenium vinylcarbene. NMR studies in the literature support the 
hypothesis that enyne metathesis with ruthenium catalysts usually occurs via the ene-
then-yne pathway.72-73 It is currently believed that the vinyl ruthenium carbene species 
(i.e. 51) is the key intermediate permitting catalysis in metathesis reactions.  
 
Scheme 1.9. Accepted mechanism of ring-closing enyne metathesis 
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ruthenium dihydride 54 that had been utilized previously as a catalyst in a carbon-carbon 
bond forming reaction.79 What was interesting about this ruthenium catalyst was the 
dearth of knowledge and publications surrounding its potential for catalysis. Interestingly, 
ruthenium dihydride 54, RuH2Cl2(P(i-Pr)3)2, was only one of three reported ruthenium (IV) 
dihydrides in the literature with a general formula RuH2Cl2(PR3)2, yet only one research 
group had recognized its potential for catalysis.  
Previously, ruthenium dihydrides have been utilized as intermediates in the 
formation of other ruthenium complexes,80-83 including vinylidene type complexes which 
form upon addition of terminal alkynes or propargylic alcohols.84-86  The subject of 
ruthenium dihydrides has been reviewed87 and there are some additional publications 
documenting the synthesis of different ruthenium dihydride complexes.82, 88-94 
 
Figure 1.3. Ruthenium dihydrides synthesis and structure. (Left) General synthetic route for ruthenium 
dihydrides 54-56 and new ruthenium dihydride 57 (Right) X-ray crystal structure of ruthenium dihydride 54 
reproduced with permission from ref 86, Wiley-VCH Verlag GmbH, copyright 1998. 
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propanol or 2-butanol) followed by addition of phosphine and then reacted at 80 °C under 
a pressurized hydrogen gas atmosphere (Figure 1.3). From this general route to 
synthesize these ruthenium dihydrides, surprisingly, Werner and co-workers reported that 
only ruthenium dihydride 56 required a second synthetic to isolate the complex, as the 
mono-hydride intermediate RuHCl(H2)(P(Cy)3)2 required the addition of HCl in DCM to 
facilitate bis-hydrido ligand formation.86 Werner and co-workers had successfully 
obtained an x-ray crystal structure of ruthenium dihydride 54 depicting the spatial 
arrangement of the ligands (Figure 1.3). As a crystalline solid, both the hydrido and chloro 
ligands are cis to one another while the phosphine ligands are oriented trans from each 
other. Experimental NMR data collected by Chaudret suggests that ruthenium dihydrides 
can isomerize into two major isomers once in solution due to the low approximately 2 
kcal/mol energy difference in the isomers.96 
1.2. Results and discussion 
 
1.2.1. Discovery and Proposed Mechanism of Ring-Closing Enyne Metathesis Activity 
 
With ruthenium dihydride 54 prepared and in hand, the reactivity was tested with 1,7-
enyne 58 and was evaluated (Scheme 1.6). Our intent was to provide a new route to the 
exocyclic 1,3-diene 60, however careful consideration of the 1H and 13C NMR of the 
reaction product indicated clean conversion to the endocyclic diene 59 in moderate yield. 
Diene 59 is more commonly accessed from traditional RCEYM and to further verify 
formation of endocyclic product, the use of Grubbs-I catalyst under Mori’s conditions (3 
mol % Grubbs-I, 0.01 M DCM, 1 atm ethylene)97 was performed and provided 59 which 
was identical in all respects to the product obtained in Scheme 1.10. 
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Scheme 1.10. Accepted mechanism of ring-closing enyne metathesis 
We hypothesized that the ruthenium dihydride was forming an intermediate 
vinylcarbene similar to the Grubbs type complex, which could then catalyze the RCEYM. 
To explain the rationale of enyne metathesis occurring, we propose that the active 
ruthenium species is a ruthenium vinylidene (Scheme 1.11). The known pathways for 
ruthenium vinylidene formation from ruthenium dihydride complexes can occur either by 
coordination of an alkyne followed by a 1,2-hydrogen migration, or by oxidative addition 
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Scheme 1.11. Proposed Mechanism for Dihydride Enyne Metathesis 
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product 71 and regenerates the key intermediate alkylidene 67, allowing for catalyst 
turnover. 
1.2.2. Optimization of Ruthenium Dihydride Catalyzed Enyne Metathesis 
We set out to optimize the reaction conditions to determine if comparable yields 
could be obtained compared to the more common ruthenium alkylidenes (2-5, Figure 1.2). 
Initially a solvent screen was conducted (Table 1.1). Chlorinated solvents were first 
examined, as these were used to good effect by Mascarenas and co-workers in their 
intramolecular cycloadditions of allenes utilizing dihydride 54.79 Reaction in DCM at room 
temperature provided RCEYM product 59 in 19% yield after 24 hours (entry 1).  Increasing 
the temperature and switching to 1,2-dichloroethane (DCE) gave a similar yield of 20% in 
a shorter reaction time (5 hours) (entry 3). Other solvents were also examined, with 
toluene proving to be the most effective with catalyst 54 (entry 5). The effect of 
concentration was then explored, with a small improvement in yield (42%) being observed 
upon dilution to 0.10 M (entry 6). Other ruthenium complexes were examined to improve 
the transformation, with RuH2Cl2(P(t-Bu)2Me)2 (55) providing a 68% yield (entry 7). Given 
the better performance from complex 55, the reaction parameters were re-examined. 
Performing the transformation in toluene at room temperature (0.05 M) gave diene 58 in 
73% yield (entry 8).  Interestingly, dichloromethane under similar conditions with complex 
55 also gave a good yield of 59 (entry 9). This concentration was utilized throughout later 
experiments, as further dilution to 0.025 M did not show improvement. Decreasing the 
amount of complex 55 led to increased yield of 59 (entries 11-13), with 3 mol % loading 
being optimal. Evaluation of the previously unreported ruthenium dihydride RuH2Cl2(P(t-
Bu2)Cy)2 57 under similar reaction conditions showed no metathesis activity, presumably 
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due to the increased steric bulk of the di-tert-butylcyclohexylphosphine (entry 15). During 
the course of this work we encountered difficulty with the preparation of RuH2Cl2(P(Cy)3) 
55 and were not able to screen it in this catalysis. 
 
Table 1.1. Optimization of Reaction Conditions 
 
Entry Catalyst Catalyst Loading Solvent Temperature (°C) Concentration [M] Time (h) Yieldb 
1 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % DCM rt 0.25 24 19 
2 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % THF 66 0.25 24 27 
3 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % DCE 86 0.25 5 20 
4 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % CPME 110 0.25 2 32 
5 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % toluene 110 0.25 1.5 38 
6 RuH2Cl2(P(i-Pr)3)2 (54) 10 mol % toluene 110 0.10 4.5 42 
7 RuH2Cl2(P(t-Bu)2Me)2 (55) 10 mol % toluene 110 0.10 5 68 
8 RuH2Cl2(P(t-Bu)2Me)2 (55) 10 mol % toluene rt 0.05 1.5 73 
9 RuH2Cl2(P(t-Bu)2Me)2 (55) 10 mol % DCM rt 0.05 0.5 66 
10 RuH2Cl2(P(t-Bu)2Me)2 (55) 10 mol % toluene rt 0.025 1.5 73 
11 RuH2Cl2(P(t-Bu)2Me)2 (55) 5 mol % toluene rt 0.05 1 76 
12 RuH2Cl2(P(t-Bu)2Me)2 (55) 5 mol % DCM rt 0.05 2.5 82 
13 RuH2Cl2(P(t-Bu)2Me)2 (55) 3 mol % DCM rt 0.05 3.5 84 (72) 
14 RuH2Cl2(P(t-Bu)2Me)2 (55) 1 mol % DCM rt 0.05 24 18 
15 RuH2Cl2(P(t-Bu)2Cy)2 (57) 5 mol % DCM rt 0.05 1 0 
aTrials performed on a 0.20 mmol scale under Ar atmosphere. 
bYields were determined from 1H NMR using mesitylene as an internal standard, isolated yields are reported in parentheses. 
 
The scope of complex 54 in RCEYM reactions was also evaluated beyond the ten 
examples published in our report (Table 1.2).98 Reactions were allowed to run for 24 hours 
and were initially conducted with 5 mol% catalyst to provide a simplified way to assess 
substrate tolerance.  
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Table 1.2. Scope of the new enyne metathesis catalyst 
 
aYields were determined from 1H NMR using mesitylene as an internal standard, isolated yields are reported in parentheses. 
Reactions were run for 24 hours unless otherwise indicated. 
bThe reaction was complete in 3.5 h. 
c Reaction was complete in 6.5 h. 
74
O
Ph
O
Ph
58
O
Ph O
Ph
O Ph
76
O Ph
72
O Ph
O Ph
OPh O
O O
86
Ph
O O
88
Ph
OPh O
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
Ru-Catayst 55
5 mol %
Ru-Catayst 55
3 mol %
Ru-Catayst 55
5 mol %
Ru-Catayst 55
10 mol %
Ru-Catayst 55
5 mol %
Ru-Catayst 55
5 mol %
85%c
(72%)
84%b
(72%)
42%
61% 
(58%)
0%
0%
78
O
O
110
MeO
O
OMe
O
CH2Cl2, rt
CH2Cl2, rt
82
OMe
O
OTBS
OMe
O
TBSO
80
O
Si
Ph O
Si
Ph
CH2Cl2, rt
Ru-Catayst 55
5 mol %
Ru-Catayst 55
5 mol %
Ru-Catayst 55
10 mol %
40%
62%
31%
13%
75
59
77
73
87
89
79
111
83
81
N
Ts
103
N
Ts
H
H
N
Ts
90
N
Ts
CH2Cl2, rt
Ru-Catayst 55
N
Ts
99
N
Ts
Br
Br
101
N
Ts
N
Ts
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
expected obtained
88%
(78%)
0%
0%
13%
(7%)
5 mol %
Ru-Catayst 55
5 mol %
Ru-Catayst 55
5 mol %
Ru-Catayst 55
5 mol %
91
100
104 105
102
O
Ph
O
Ph
84
CH2Cl2, rt
Ru-Catayst 55
5 mol %
0%
85
106
PhO2S SO2Ph SO2Ph SO2Ph
107
CH2Cl2, rt
Ru-Catayst 55
10 mol % 46%
Enyne 1,3-Diene Yield Enyne 1,3-Diene Yield
CH2Cl2, rt
Ru-Catayst 55
5 mol %
O
O
O
O
N
Ts
97
N
Ts
N
Ts
94
N
Ts
N
Ts
92
N
Ts
N
Ts
95
N
Ts
Ph
Ph
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
CH2Cl2, rt
0%
83%
(56%)
78%
80%, 
2:1 (E:Z)
7.5 mol %
Ru-Catayst 55
10 mol %
98
93
93
96
Ru-Catayst 55
5 mol %
Ru-Catayst 55
Ru-Catayst 55
5 mol %
108
PhO2S SO2Ph SO2Ph SO2Ph
109
CH2Cl2, rt
Ru-Catayst 55
10 mol % 20%
N
Ts
 
21 
Metathesis was amenable to homopropargyl ether 58, as diene 59 was isolated in 
72% yield. The method was also successfully applied to propargyl ethers to afford 5- and 
6-membered rings (dienes 73-79). Dienes 73 and 75 were isolated in 58% and 72% yield, 
respectively. Diene 77 and spirocyclic diene 79 also participated in the RCEYM, providing 
yields of 42% and 40% respectively. Propargylic silyl ethers 80 and 82 were not well 
tolerated with poor to moderate yields observed. While the method was widely applicable 
to propargyl and homopropargyl terminal alkynes, metathesis was not observed with an 
internal alkyne 84 or with acrylates 86 and 88. RCEYM of sulfonamides was also 
demonstrated, accessing dihydropyrrole 91 in 78% yield. Tetrahydropyridine 93 was also 
furnished in excellent yield, accessed from one of two sulfonamides, 92 or 94. Trans-
cinnamyl diene 96 was provided in a good 80% yield in approximately a 2:1 ratio of E:Z 
isomers. Metathesis was not observed with 1,1-disubstituted alkene 97, internal alkyne 
99, or ynamide 101. To our surprise, cyclohexene 103 did not form the expected ROM 
product99 104 but instead formed alder-ene product 105 which was verified using 
Cp*Ru(COD)Cl (a known catalyst capable of alder-ene reactions100-101) and the 1H and 
13C NMR data was consistent to a previously published report.102 Metathesis with the bis-
sulfone substituted enynes 106 and 108 respectively showed RCEYM or the 
cyclopropanation/ring closing metathesis103 in moderate yields after increasing catalyst 
loading to 10 mol%. Metathesis was also demonstrably effective with the malonate 
substituted enyne 110, resulting in the synthesis of cyclopentene 111 in 62% yield. 
Overall the yields in Table 1.2 are somewhat lower than those reported by Mori 
and Nolan for the same substrates.72,97,104 This may be due to some catalyst 
decomposition (the ruthenium dihydrides are quite air-sensitive). The precatalyst also 
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requires a sacrificial alkyne in the same quantity as the catalyst loading to form the active 
vinylidene, which limits the overall yield (the reported yields are not adjusted for the loss 
of alkyne to form the vinylidene). Additionally, in many cases it was difficult to isolate the 
pure diene products due to contamination by ruthenium catalyst decomposition side 
products (difficulties in removal of metal catalyst decomposition side-products from 
metathesis reactions have been reported),105-109 which required careful chromatography 
to remove. This was especially problematic with the more polar dienes (like 91 and 93), 
and accounts for the significant differences in the NMR yields and the isolated yields. Mori 
and co-workers did have to employ an atmosphere of ethylene to achieve their higher 
yields, however, which was not required for the ruthenium dihydride based catalysts. 
Attempts to improve the yield of enyne metathesis for catalyst 55 by performing the 
reaction under an ethylene atmosphere did not result in an improved yield, however. 
 
Scheme 1.12. Mechanistic probe into ruthenium dihydride activity 
Efforts were made to provide experimental evidence to support this mechanistic 
proposal (Scheme 1.12). First, deuterated alkyne 112 was employed to verify the fate of 
the alkynyl hydrogen (equation 1). Exposing enyne 112 to the reaction conditions gave 
the expected deuterated 1,3-diene 113 in 86% yield as determined by 1H NMR (56% 
isolated yield). This material retained the deuterium label (~97% D) originally included 
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from the enyne, supporting the mechanism shown in Scheme 1.7. Additionally, the 
formation of the vinylidene intermediate from an alkyne was explored with the use of 
alkyne additives. Using diallyl dimethylmalonate 114, two reactions were conducted with 
and without the use of the alkyne additive phenylacetylene (equations 2 and 3). With no 
added phenylacetylene, ring closing metathesis was not observed. Addition of (5 mol %) 
phenylacetylene to the dihydride complex 55 afforded cyclopentene 115 in 77% yield. 
This further suggests the formation of a metathesis active vinylidene species. 
 
1.3. Conclusions 
 
We have observed and published on a new enyne metathesis catalyst system 
based on a ruthenium dihydride precursor. These ruthenium (IV) complexes 
RuH2Cl2(PR3)2 has been shown to be active in ring-closing enyne metathesis and ring-
closing olefin metathesis through use of a sacrificial alkyne. Experimental evidence 
suggests that ruthenium vinylidene intermediate is the active catalyst in this reaction. This 
hypothesis is further supported by deuterium labeling experiments and olefin metathesis 
activity in the presence of a terminal alkyne. This work demonstrates that ruthenium 
dihydrides may access a RCEYM mode of reactivity. 
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1.4. Experimental 
 
General Procedures: 
Unless otherwise indicated, all reactions were conducted in oven-(175°C) or flame-
dried glassware using distilled and degassed solvents under positive pressure of dry 
argon with standard Schlenk techniques. All air-sensitive reagents were stored in an 
MBraun Labmaster glovebox containing dry argon gas. Dry tetrahydrofuran (THF), 
toluene, acetonitrile (CH3CN), and dichloromethane (DCM) were obtained by passing 
commercially available pre-dried, oxygen-free formulations through two activated alumina 
columns using an MBraun MB-SPS solvent purification system. Stainless steel syringes 
or cannulae that had been oven-dried (175°C) and cooled under an argon atmosphere or 
in a desiccator were used to transfer air- and moisture-sensitive liquids. Yields refer to 
chromatographically and spectroscopically (1H NMR) homogeneous materials, unless 
otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) carried 
out on precoated glass plates of silica gel (0.25 mm) 60 F254 from EMD Chemicals Inc. 
using the indicated solvent system. Visualization was accomplished with ultraviolet light 
(UV 254 nm). Alternatively, plates were treated with one of the following solutions (this 
was accomplished by holding the edge of the TLC plate with forceps or tweezers and 
immersing the plate into a wide-mouth jar containing the desired staining solution) and 
carefully heating with a hot-air gun (450°C) for approximately 1-2 min (NOTE: excess 
stain was removed by resting the TLC on a paper towel prior to heating): 10% 
phosphomolybdic acid in ethanol, 1% potassium permanganate/7% potassium 
carbonate/0.5% sodium hydroxide aqueous solution, and/or anisaldehyde in ethanol with 
10% sulfuric acid. Flash column chromatography was performed using Silia Flash® P60 
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silica gel (40-63 μm) from Silicycle. All work-up and purification procedures were carried 
out with reagent grade solvents (purchased from VWR) in air.  
Instrumentation: 
Infrared (IR) spectra were recorded on a Thermo Nicolet IR-100 spectrometer, νmax 
in cm-1, and were obtained from samples prepared as thin films between KBr plates. 1H 
NMR spectra were recorded on a Bruker Avance DPX-300 (300 MHz) spectrometer and 
Bruker Avance III HD (400 MHz) spectrometer with CryoProbe Prodigy. Chemical shifts 
are reported in parts per million (ppm) and are calibrated using residual undeuterated 
solvent as an internal reference (CDCl3: δ 7.26 ppm). Data are reported as follows: 
chemical shift, multiplicity, integration, and coupling constants (Hz). The following 
abbreviations or combinations thereof were used to explain the multiplicities: s = singlet, 
d = doublet, t = triplet, q = quartet, pent = pentet, sext = sextet, sept = septet, m = multiplet, 
br = broad. 13C NMR spectra were recorded on a Bruker Avance DPX-300 (75 MHz) 
spectrometer and Bruker Avance III HD (100 MHz) spectrometer with CryoProbe Prodigy 
with complete proton decoupling. Chemical shifts are reported in ppm and are calibrated 
using residual undeuterated solvent as an internal reference (CDCl3: δ 77.23 ppm). 
Melting points (m.p.) are uncorrected and were recorded using an Electrothermal Mel-
Temp® melting point apparatus. Elemental Analyses were performed on a Costech ECS 
4010 elemental analyzer with a thermal conductivity detector and 2 meter GC column 
maintained at 65°C. 
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Ruthenium Dihydride Complexes Syntheses 
RuH2Cl2(P(i-Pr)3)2110 
  
The ruthenium dihydride was prepared according to the experimental reported by 
Werner with modifications to the apparatus used, i.e. a Fischer Porter bottle. 
[RuCl2(COD)]n was made in accordance to the protocol published by Fischer.111 The 
reaction mixture was removed from the oil bath and allowed to cool to room temperature. 
The solution was transferred by syringe to a 50 mL Schlenk tube under an argon(g) 
atmosphere. The solvent was removed in vacuo to give to an oily residue. 5 mL of 
degassed diethyl ether was added and crystallization of an orange solid was observed 
after approximately 2.5 hours at room temperature. The diethyl ether was removed by 
needle-filtration and a subsequent wash with 5 mL diethyl ether was performed. The 
original Schlenk tube was then dried in vacuo for 5 hours before transferring the orange-
colored solid into an argon-filled glovebox, yield (272 mg, 62%). The 1H NMR and 31P 
NMR data are in agreement with Werner’s data.110  
1H NMR (400 MHz, CDCl3)  δ 2.35 (m, 6H), 1.42 (dd, J = 7.3, 14.9 Hz, 36H), -12.3 (t, J = 
30.9 Hz, 2H) 
31P NMR (162 MHz, CDCl3) δ 102.5 (s). 
54
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P(iPr)3
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H
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RuH2Cl2(P(t-Bu)2Me)2 
  
The ruthenium dihydride was prepared according to the experimental reported by 
Caulton with modifications to the apparatus used, i.e. a Fischer Porter bottle. The reaction 
mixture was removed from the oil bath and allowed to cool to room temperature. The 
solution was transferred by syringe to a 50 mL Schlenk tube under an argon(g) 
atmosphere. The solvent was removed in vacuo to give a dark red residue. The residue 
was washed with degassed diethyl ether (2 x 10 mL) and the ether was removed by 
needle-filteration. The original Schlenk tube was then dried in vacuo overnight before 
transferring the burgundy-colored solid into an argon-filled glovebox, yield (688 mg, 52%). 
The 1H NMR and 31P NMR are in agreement with Caulton’s data.95 
1H NMR (400 MHz, CDCl3)  δ 1.54 (d, J = 14.7 Hz, 36H), 1.12 (d, 10.3 Hz, 6H), -11.23 (t, 
J = 30.0 Hz, 2H); 
31P NMR  (162 MHz, CDCl3)  δ 98.8 (t, J = 6.5 Hz). 
 
Ru
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H
H
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RuH2Cl2(P(t-Bu)2Cy)2 
  
To an oven-dried 100 mL Fischer-Porter bottle equipped with magnetic stir bar and 
was plugged with a 24/40 rubber septum was added [RuCl2(COD)]n (250 mg, 0.89 mmol) 
followed by two vacuum/purge cycles. Di-tertbutylcyclohexyl phosphine (0.69 mL, 2.68 
mmol) removed from an argon-filled glovebox was quickly added to the Fischer-Porter 
bottle, followed by degassed 2-butanol (22 mL). The contents were mixed for 
approximately 2 minutes and the rubber septum was quickly exchanged with the lid and 
the vessel was sealed. The vessel was then charged and vented eight times with 
hydrogen gas before finally being pressurized to ≥ 55 psi. The reaction mixture was then 
submerged into a pre-heated 80 °C oil bath and stirred for 20 hours, re-pressurizing to ≥ 
55 psi H2(g) if needed. The reaction mixture was removed from the oil bath and allowed to 
cool to room temperature. The solution was transferred by syringe to an oven-dried 50 
mL Schlenk tube and the solvent was removed in vacuo. To the resulting residue was 
added 10 mL of degassed 2-butanol. The 2-butanol was then removed by needle-filtration 
away from the brown solid. The solid in the Schlenk tube was washed with 10 mL of 
degassed diethyl ether, and removed by needle-filtration. The orange-brown solid was 
dried in vacuo for 5 hours before transferred to an argon-filled glovebox (184 mg, 33% 
yield). 
1H NMR (400 MHz, CDCl3)  δ 2.35 (d, J = 12.2 Hz, 3H), 1.76-1.70 (m, 9H), 1.35 (t, J = 
5.8 Hz, 36H), -16.9 (brs, 2H);  
31P NMR (162 MHz, CDCl3) δ = 79.9 (s) 
Ru
P(tBu)2Cy
P(tBu)2Cy
H
H
Cl
Cl
57
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13C NMR (100 MHz, CDCl3) δ 39.7 (t, J = 7.5 Hz), 37.0 (t, J = 9.0 Hz), 32.7, 32.0 (t, J = 
3.8 Hz), 28.6 (t, J = 7.8 Hz), 27.2;  
Anal. Calcd for C28H60Cl2P2Ru: C, 53.32; H, 9.59. Found: C, 53.54; H, 9.49.  
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Syntheses towards enyne substrates 
2-phenylpent-4-yn-2-ol112 
 
To a flame-dried 3-neck 500 mL round bottom flask equipped with a magnetic stir 
bar, reflux condenser, and addition funnel was added; magnesium turnings (2.92 g, 120 
mmol), HgCl2 (244 mg, 0.9 mmol), and one iodine chip. The apparatus was flame-dried 
again for activation of the magnesium metal and then purged with argon gas. Dry diethyl 
ether (70 mL) was added and the contents were stirred. To the addition funnel was added 
propargyl bromide (9.0 mL, 120 mmol) in dry diethyl ether (90 mL). Propargyl bromide 
used in the synthesis of substrates for this project was made according to a known 
protocol.113 The solution was added dropwise into the round bottom to promote self-reflux. 
When the addition was completed after ten minutes, a heating mantle was equipped 
underneath the round bottom flask and refluxed for one hour.  
The solution was allowed to cool prior to titrating the active Grignard species114 to 
a concentration of 0.625M (100 mmol). The round bottom was then cooled to -40 °C using 
a dry ice/acetone bath before the dropwise addition of acetophenone (8.01 mL, 66.7 
mmol) via syringe. After three hours of stirring at room temperature, the reaction was 
monitored by TLC and confirmed to be completed. The reaction was cooled prior to 
addition of 1M HCl(aq) (200 mL) to quench the reaction. The organics were separated and 
then the organics were extracted from the aqueous layer with diethyl ether (3 x 100 mL), 
dried with MgSO4, filtered, and finally concentrated to give a brown oil. The resulting oil 
was purified by flash column chromatography (4.0 x 12.0 cm silica) and eluted using 4% 
116
OH
Me
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EtOAc:hexanes (1 L), 5% EtOAc:hexanes (2.5 L) and concentrated to afford a pale yellow 
oil (9.70 g, 91%).  
1H-NMR (400 MHz, CDCl3)  δ 7.50-7.47 (m, 2H), 7.39-7.34 (m, 2H), 7.30-7.25 (m, 1H), 
2.77 (dd, J = 16.7, 2.6 Hz, 1H), 2.69 (dd, J = 16.6, 2.6 Hz, 1H), 2.38 (brs, 1H), 2.06 (t, J 
= 2.6 Hz, 1H), 1.65 (s, 3H) 
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4-phenylpent-1-yn-4-yl allyl ether 
 
This compound was made according to the literature with slight modifications115 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, 2-phenylpent-4-yn-2-ol 116 (3.00 g, 18.7 mmol) and dry DMF (75 mL). The 
solution was cooled to 0 °C with an ice/H2O bath and then NaH (824 mg, 20.6 mmol) was 
added in three separate portions and stirred for 30 minutes. The ice bath was removed 
and the mixture was allowed to stir at room temperature for 1 hour. The mixture was 
placed back into the ice bath and then allyl bromide (1.95 mL, 22.48 mmol) was added in 
dropwise via syringe. The ice bath was removed and the reaction was stirred for 4 hours 
at room temperature. The reaction was quenched with saturated NH4Cl(aq) (75 mL) and 
the organics were separated and then the organics were extracted from the aqueous layer 
with diethyl ether (3 x 100 mL). The combined organics were rinsed with water (2 x 250), 
followed by brine (25 mL), was dried with MgSO4, filtered, and concentrated to afford a 
yellow oil. The resulting oil was purified by flash column chromatography (2.5 x 14.0 cm 
silica) and eluted with 1% Et2O:hexanes to give clear oil (2.43 g, 65%). 
1H-NMR (400 MHz, CDCl3)  δ 7.45-7.43 (m, 2H), 7.38-7.34 (m, 2H), 7.31-7.27 (m, 1H), 
5.96-5.86 (m, 1H), 5.33-5.27 (m, 1H), 5.15-5.12 (m, 1H), 3.81-3.68 (m, 2H), 2.77-2.66 
(m, 2H), 1.97 (t, J = 2.7 Hz, 1H), 1.72 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ = 143.8, 135.5, 128.4, 127.6, 126.4, 116.2, 80.9, 78.6, 
71.0, 64.6, 33.6, 23.9 
58
O
Ph
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1-phenyl-3-buten-1-ol 
 
Conditions used in this prep were adapted from a literature procedure116 
To an oven-dried 3-neck 250 mL round bottom flask equipped with a magnetic stir 
bar and an addition funnel was added under an argon atmosphere, distilled benzaldehyde 
(2.40 mL, 24.0 mmol) and dry Et2O (37 mL). The clear solution was cooled to 0 °C using 
an ice/H2O bath. Allylmagnesium chloride (1.7M in THF) was added dropwise into the 
solution via the addition funnel. The clear gray reaction mixture was stirred at 0 °C for 1 
hour, followed by quenching with saturated NH4Cl(aq). The aqueous layer was extracted 
with diethyl ether (3 x 20 mL) and the combined organics were dried over MgSO4, filtered 
and concentrated to give a clear oil (3.42g, 96%).  
*Reaction was performed by Dr. Lauren Kaminsky 
1H-NMR (400 MHz, CDCl3)  δ 7.37-7.30 (m, 5H), 5.79 (m, 1H), 5.15-5.12 (m, 2H), 4.68 (t, 
J = 6.4 Hz, 1H), 2.89 (brs, 1H), 2.50 (t, J = 6.8 Hz, 2H) 
 
OH
117
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(1-(prop-2-ynyloxy)but-3-enyl)benzene117 
 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, 1-pheny-3-buten-1ol 117 (2.80 g, 20.9 mmol) and dry DMF (36 mL). The solution 
was cooled to 0 °C using an ice/H2O bath and then NaH (1.67 g, 41.7 mmol) was slowly 
added to the round bottom flask in one portion. The mixture was stirred for 2 hours in the 
ice bath and then propargyl bromide (2.36 mL, 31.3 mmol) was added dropwise via 
syringe. Once the addition was complete, the ice bath was removed and the mixture was 
left to stir for six hours at room temperature. The reaction was quenched with ice water 
(100 mL) and then the organics were then extracted from the aqueous layer with EtOAc 
(3 x 50 mL). The combined organics were washed with brine (25 mL), dried with MgSO4, 
and concentrated to give a dark red oil. The oil was purified by flash column 
chromatography (4.0 x 10.5 cm silica) and eluted with 2% Et2O:hexanes (1 L), 4% 
Et2O:hexanes (500 mL), and 5% Et2O:hexanes (500 mL), to afford a pale yellow oil (2.77 
g, 71%). 
1H-NMR (300 MHz, CDCl3)  δ 7.39-7.27 (m, 5H), 5.77 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 
5.10-5.00 (m, 2H), 4.55 (dd, J = 7.3, 6.2 Hz, 1H), 4.12 (dd, J = 15.7, 2.4 Hz, 1H), 3.86 
(dd, J = 15.7, 2.3 Hz, 1H), 2.68-2.58 (m, 1H), 2.50-2.42 (m, 1H), 2.40 (t, J = 2.4 Hz, 1H) 
13C-NMR (75 MHz, CDCl3) δ 140.8, 134.7, 128.7, 128.2, 127.2, 117.3, 80.6, 80.1, 74.3, 
55.8, 42.3 
72
O Ph
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(2-(allyloxy)but-3-yn-2-yl)benzene104 
 
To a flame-dried 3-neck 500 mL round bottom flask equipped with a magnetic stir 
bar was added, 2-phenylbut-3-yn-2-ol (5.50 g, 37.6 mmol) and dry DMF (150 mL). The 
solution was first cooled to 0 °C with an ice/H2O bath and then NaH (1.65 g, 41.4 mmol) 
was added in two separate portions and the mixture was stirred for one hour. The ice bath 
was then removed, stirred for one hour at room temperature, and then cooled again using 
the ice bath. Allyl bromide (3.90 mL, 45.1 mmol) was added via syringe, the ice bath was 
removed, and the reaction was stirred for four hours at room temperature. The reaction 
was quenched with saturated NH4Cl(aq) (75 mL) and the organics were separated and 
then the organics were extracted from the aqueous layer with diethyl ether (3 x 150 mL). 
The combined organics were rinsed with water (2 x 300 mL) followed by washing with 
brine (50 mL), dried with MgSO4, filtered, and concentrated to afford a yellow oil. The 
resulting oil was purified by flash column chromatography (4.0 x 12.0 cm silica) and eluted 
with 1% Et2O:hexanes to give a clear oil (1.47 g, 21%). 
1H-NMR (400 MHz, CDCl3)  δ 7.63-7.61 (m, 2H), 7.39-7.35 (m, 2H) 7.32-7.29 (m, 1H), 
5.93 (ddt, J = 17.1, 10.4, 5.6 Hz, 1H), 5.31-5.27 (m, 1H), 5.17-5.13 (m, 1H), 4.11 (ddt, J 
= 12.2. 5.6, 1.4 Hz, 1H), 3.67 (ddt, J = 12.1, 5.6, 1.4 Hz, 1H), 2.73 (s, 1H), 1.77 (s, 3H). 
13C-NMR (100 MHz, CDCl3) δ 142.8, 135.0, 128.5, 128.1, 126.1, 116.7, 84.2, 76.1, 
75.6, 66.4, 33.1 
74
O
Ph
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1-phenyl-2-propen-1-ol118 
 
To a flame-dried 3-neck 500 mL round bottom flask equipped with a magnetic stir 
bar, a dry ice/acetone reflux condenser, and an addition funnel was added; magnesium  
turnings (1.22 g, 50.0 mmol), and one iodine chip. The apparatus was flame-dried again 
for activation of the magnesium metal and then purged with argon gas. Dry THF (200 mL) 
was then added and the contents were stirred. To the addition funnel was added vinyl 
bromide (3.53 mL, 50.0 mmol), and dry THF (50 mL). The vinylbromide solution was then 
added cautiously into the round bottom flask. Note: the activated magnesium did not self-
reflux upon addition of vinyl bromide. Once the addition was completed, a heating mantle 
was applied underneath and the solution was refluxed for one hour.  
The round bottom was then cooled to 0 °C using an ice/H2O bath and then 
benzaldehyde (3.05 mL, 30.0 mmol) was added dropwise via syringe. The reaction was 
stirred for 30 minutes, the ice bath was removed, and then the reaction was stirred for 3 
hours at room temperature. The reaction was quenched with 1M HCl(aq) (100 mL). The 
organics were separated and then the organics were extracted from the aqueous layer 
with diethyl ether (3 x 100 mL), dried with MgSO4, filtered, and concentrated to afford an 
oil. The oil was purified by flash column chromatography using silica to obtain a pale-
yellow oil (2.25 g, 44%). 
1H-NMR (400 MHz, CDCl3)  δ 7.40-7.34 (m, 4H), 7.32-7.27 (m, 1H), 6.10-6.02 (m, 1H), 
5.36 (dt, J = 16.9, 1.1 Hz, 1H), 5.22-5.19 (m, 2H), 1.97 (m, 1H) 
OH
118
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(1-(prop-2-ynyloxy)prop-2-enyl)benzene119 
 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, 1-phenyl-2-propen-1-ol 118 (2.25 g, 16.8 mmol) and dry DMF (34 mL). The 
solution was stirred at 0 °C using an ice/H2O bath and then NaH (1.01 g, 25.2 mmol) was 
slowly added to the round bottom flask in one portion. The mixture was stirred for 30 
minutes in the ice bath and then propargyl bromide (2.36 mL, 31.3 mmol) was added 
dropwise via syringe. Once the addition was complete, the ice bath was removed and the 
reaction was stirred for six hours. The reaction mixture was quenched with saturated 
NH4Cl(aq) (50 mL). The organics were extracted from the aqueous layer with EtOAc (3 x 
75 mL). The combined organics were washed with brine (25 mL), dried with MgSO4, and 
concentrated to give a crude red oil. The oil was purified by flash column chromatography 
(4.0 x 11.0 cm silica) and elute with 3% Et2O:hexanes to afford a pale yellow oil (1.26 g, 
44%). 
1H-NMR (400 MHz, CDCl3)  δ 7.37-7.36 (m, 4H), 7.33-7.27 (m, 1H), 5.95 (ddd, J = 17.1, 
10.3, 6.8 Hz, 1H), 5.33 (dt, J = 17.3, 1.5 Hz, 1H), 5.26 (dt, J = 10.3, 1.1 Hz, 1H), 5.03 (d, 
J = 6.7 Hz, 1H), 4.18 (dd, J = 15.8, 2.4 Hz, 1H), 4.10 (dd, J = 15.8, 2.4 Hz, 1H), 2.43 (t, J 
= 2.4 Hz, 1H). 
13C-NMR (100 MHz, CDCl3) δ 140.2, 138.1, 128.7, 128.1, 127.3, 117.5, 81.4, 80.0, 
74.5, 55.5 
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1-ethynyl-1-cyclohexanol120 
  
To a flame-dried 3-neck 500 mL round bottom flask equipped with a magnetic stir 
bar and addition funnel was added, cyclohexanone (7.20 g, 73.3 mmol) and dry THF (25 
mL). The round bottom flask was cooled to -78 °C using an acetone/dry ice bath. A 0.5 M 
solution of ethynylmagnesium chloride in THF (220 mL, 110 mmol) was then transferred 
into the addition funnel via cannula. The ethynyl magnesium chloride was added dropwise 
into the round bottom flask from the addition funnel over a period of 45 minutes. The dry 
ice/acetone bath was removed and the mixture was stirred for 3 hours at room 
temperature. The reaction mixture was quenched with saturated NH4Cl(aq) (75 mL) and 
transferred to a separatory funnel. The organics were separated and then the organics 
were extracted from the aqueous layer using diethyl ether (3 x 150 mL), dried with MgSO4, 
filtered, and finally concentrated to give a yellow oil. The resulting oil was purified by flash 
column chromatography using 15% EtOAc:hexanes to afford a light yellow solid (4.05 g, 
45%).  
1H-NMR (400 MHz, CDCl3)  δ 2.47 (s, 1H), 1.93-1.90 (m, 3H), 1.73-1.67 (m, 2H), 1.62-
1.51 (m, 5H), 1.29-1.22 (m, 1H) 
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1-(allyloxy)-1-ethynylcyclohexane104 
  
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, 1-ethynyl-1-cylohexanol 119 (3.00 g, 24.2 mmol), dry DMF (50 mL), and dry THF 
(50 mL). The round bottom flask was cooled to 0 °C using an ice/H2O bath. To the stirred 
solution was added NaH (1.06 g, 26.6 mmol) in three portions. The mixture was stirred at 
0 °C for 30 minutes and then allyl bromide (2.30 mL, 26.6 mmol) was added dropwise to 
the round bottom flask via syringe. The ice bath was removed and the reaction was stirred 
for 3 hours at room temperature. The reaction mixture was quenched with saturated 
NH4Cl(aq) (50 mL) and transferred to a separatory funnel. The organics were separated 
and extracted from the aqueous layer using EtOAc (3 x 100 mL), dried with MgSO4, 
filtered, and finally concentrated to give a crude oil. The resulting oil was purified by flash 
column chromatography and eluted using 1% Et2O:hexanes to afford a clear oil (0.715 g, 
18%).  
1H-NMR (400 MHz, CDCl3)  δ 5.96 (ddt, J = 17.2, 10.4, 5.6, Hz, 1H), 5.29 (dq, J = 17.2, 
1.7 Hz, 1H), 5.14, (dq, J = 10.3, 1.3 Hz, 1H), 4.12, (dt, J = 5.5, 1.5 Hz, 2H), 2.46 (s, 1H), 
1.93-1.89 (m, 2H), 1.72-1.49 (m, 7H), 1.35-1.25 (m, 1H). 
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1-phenyl-2-propyn-1-ol121 
 
To a flame-dried 3-neck 1 L round bottom flask equipped with a magnetic stir bar 
and addition funnel was added, distilled benzaldehyde (8.13 mL, 80.0 mmol) and dry THF 
(35 mL). The round bottom was then cooled to -78 °C using a dry ice/acetone bath. A 
0.5M solution of ethynyl magnesium chloride in THF (240 mL, 120 mmol), was then 
transferred into the addition funnel via cannula. The ethynyl magnesium chloride was then 
added dropwise to the round bottom flask over 45 minutes. One the addition was 
complete, the dry ice/acetone bath was removed and the reaction stirred at room 
temperature. The reaction was monitored by TLC and was completed within 2 hours. The 
reaction was quenched with 1M HCl(aq) (250 mL). The organics were separated and then 
the organics were extracted from the aqueous layer with EtOAc (3 x 175 mL), dried with 
MgSO4, filtered and concentrated to give an oil. The oil was left in the freezer overnight 
to afford a solid. The resulting crude yellow solid was used without further purification 
(10.03 g, 95%).  
1H-NMR (400 MHz, CDCl3)  δ 7.58-7.55 (m, 2H), 7.42-7.33 (m, 3H), 5.48 (brs, 1H), 2.68 
(d, J = 2.2 Hz, 1H), 2.22 (br, 1H) 
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3-phenyl-1-propyn-3-yl allyldimethylsilane 
 
To a flame-dried 3 neck-500 mL round bottom flask equipped with a magnetic stir 
bar was added, imidazole (5.15 g, 75.7 mmol), 4-dimethylaminopyridine (925 mg, 7.57 
mmol), 1-phenyl-2-propyn-1-ol 120 (5.00 g, 37.8 mmol), and dry dichloromethane (250 
mL). The solution was cooled to 0 °C using an ice/H2O bath and then 
allyl(chloro)dimethylsilane (8.58 mL, 56.75 mmol) was added dropwise via syringe over a 
period of ten minutes. Once the addition was complete, the ice bath was removed and 
the reaction was left to stir for nine hours. The reaction was quenched with saturated 
NH4Cl(aq) (125 mL). The organics were separated and extracted from the aqueous layer 
with dichloromethane (2 x 175 mL). The combined organics were washed with brine (75 
mL), dried with MgSO4, and concentrated to give a dark yellow oil. The oil was purified by 
flash column chromatography (4.0 x 11.5 cm silica) and eluted with hexanes to afford a 
light-yellow oil (3.75g, 43%). 
1H-NMR (400 MHz, CDCl3)  δ 7.50 (d, J = 7.4 Hz, 2H), 7.39-7.35 (m, 2H), 7.33-7.28 (m, 
1H), 5.86-5.76 (m, 1H), 5.50 (d, J = 2.2 Hz, 1H), 4.94-4.86 (m, 2H), 2.60 (d, J = 2.2 Hz, 
1H), 1.72 (d, J = 8.0 Hz, 2H), 0.21 (s, 3H), 0.21 (s, 3H) 
13C-NMR (100 MHz, CDCl3) δ 141.1, 134.0, 128.7, 128.3, 126.5, 114.2, 84.5, 74.4, 
64.8, 25.0, -1.6, -1.7 
FT-IR: (NaCl, thin film) ν = 3301, 3076, 3031, 2960, 2881, 2117, 1630, 1255, 1067, 864, 
844, 697 cm-1. 
Anal: Calculated: C14H18OSi – C: 72.99  H: 7.88;  Found  C: 72.98 H: 7.90 
80
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RF: 0.65 (10% Et2O:hexanes) 
2-(allyloxy)-3-methoxybenzaldehyde122 
 
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added, ortho-vanillin (4.75 g, 31.2 mmol) and dry acetonitrile (25 mL).  To the stirred 
solution was added potassium carbonate, (5.18 g, 37.5 mmol) and allyl bromide (3.25 
mL, 37.5 mmol). The reaction flask was then equipped with a reflux condenser, put under 
inert atmosphere, and submerged into a pre-heated 90 °C oil bath. The mixture was 
refluxed and left to stir overnight. The reaction mixture was allowed to cool to room 
temperature followed by quenching with saturated NH4Cl(aq) (75 mL). The organics were 
extracted from the aqueous layer using DCM (3 x 100 mL). The combined organics were 
washed with brine (25 mL), dried with MgSO4, filtered and concentrated afford a gold-
yellow oil (6.00 g, 100%). The crude material did not require any purification. 
1H-NMR (400 MHz, CDCl3)  δ 10.4 (s, 1H), 7.44-7.39 (m, 1H), 7.16-7.13 (m, 2H), 6.08 
(ddt, J = 16.5, 10.4, 6.1 Hz, 1H), 5.36 (dq, J = 17.1, 1.5 Hz, 1H), 5.28-5.25 (m, 1H), 4.66 
(dt, J = 6.1, 1.1 Hz, 2H), 3.90 (s, 3H) 
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1-(2-allyloxy-3-methoxyphenyl)prop-2-yn-ol 
 
To a flame-dried 3-neck 250 mL round bottom flask equipped with a magnetic stir 
bar and addition funnel was added 2-(allyloxy)-3-methoxybenzaldehyde 121 (6.00 g, 31.0 
mmol) and dry THF (25 mL). The round bottom flask was cooled to -78 °C using an 
acetone/dry ice bath. A 0.5 M ethynylmagnesium chloride solution in THF (95 mL, 47.5 
mmol) was transferred into the addition funnel via cannula. The ethynyl magnesium 
chloride solution was then added dropwise into the round bottom flask from the addition 
funnel over a period of 30 minutes. The dry ice/acetone bath was removed and the 
mixture was stirred for 2 hours at room temperature. The reaction mixture was quenched 
with 1M HCl(aq) (150 mL) and transferred to a separatory funnel. The organics were 
separated and then the organics were extracted from the aqueous layer with Et2O (3 x 
125 mL), dried with MgSO4, filtered, and finally concentrated to give an orange oil (6.75 
g, 99%). The resulting crude oil (3.00 g) was carried through to the next step because of 
the few impurities observed. The remaining material was purified by flash column 
chromatography using silica (4.0 x 11.5 cm) and eluted with a gradient of 7% 
EtOAc/hexanes to 30% EtOAc/hexanes and the product was isolated as a clear oil (3.31 
g, 87% yield). 
1H-NMR (400 MHz, CDCl3)  δ 7.14 (dd, J = 7.7, 1.4 Hz, 1H), 7.08 (t, J = 7.8 Hz, 1H), 6.92 
(dd, J = 8.0, 1.4 Hz, 1H), 6.15 (ddt, J = 16.4, 10.4, 6.0 Hz, 1H), 5.65 (dd, J = 7.0, 2.2 Hz, 
1H), 5.40 (dq, J = 17.2, 1.5 Hz, 1H), 5.29-5.26 (m, 1H), 4.66 (dt, J = 5.9, 1.0 Hz, 2H), 3.87 
(s, 3H), 3.05 (d, J = 7.0 Hz, 1H), 2.61 (d, J = 2.2 Hz, 1H) 
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13C-NMR (100 MHz, CDCl3) δ 152.8, 145.6, 134.4, 134.2, 124.5, 119.7, 118.4, 113.1, 
84.0, 74.4, 74.3, 61.3, 56.1 
Anal: Calculated: C13H14O3 – C: 71.54  H: 6.47;  Found  C: 71.56 H: 6.43 
RF: 0.41 (30% EtOAc:hexanes) 
 
45 
tert-butyl((1-(3-methoxyl-2-(allyloxy)phenyl)prop-2-yn-1-yl) oxy)dimethylsilane 
 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, imidazole (1.87 g, 27.5 mmol), 4-dimethylamino pyridine (336 mg, 2.75 mmol), 1-
(2-allyloxy-3-methoxyphenyl)prop-2-yn-ol 122 (3.00 g, 13.75 mmol) and dry DCM (90 
mL). The contents were stirred and the mixture was cooled to 0 °C using an ice/H2O bath. 
Once cooled, tertbutyldimethyl chlorosilane (3.11 g, 20.6 mmol) was slowly added in one 
portion to the round bottom flask. The mixture was stirred for 10 minutes at 0 °C before 
the ice bath was removed and the reaction was stirred at room temperature for 6 hours. 
The reaction mixture was quenched with saturated NH4Cl(aq) (75 mL) and transferred to 
a separatory funnel. The organics were separated and then the organics were extracted 
from the aqueous layer with DCM (3 x 100 mL). The combined organics were washed 
with brine (50 mL), dried with MgSO4, filtered and concentrated to yield an oil. The 
resulting oil was subjected to flash column chromatography (2.5 x 9.5 cm silica) and 
eluted with 3% Et2O:hexanes. The fractions were concentrated to yield a clear oil (4.33 
g, 95%). 
1H-NMR (300 MHz, CDCl3)  δ 7.25 (dd, J = 7.9, 1.5 Hz, 1H), 7.08 (t, J = 8.0 Hz, 1H), 6.86 
(dd, J = 8.1, 1.4 Hz, 1H), 6.13 (ddt, J = 16.2, 10.4, 5.8 Hz, 1H), 5.84 (d, J = 2.1 Hz, 1H), 
5.40 (dq, J = 17.2, 1.4 Hz, 1H), 5.24 (dq, J = 10.4, 1.3 Hz, 1H), 4.64-4.50 (m, 2H), 3.85 
(s, 3H), 2.45 (d, J = 2.2 Hz, 1H), 0.91 (s, 9H), 0.16 (s, 3H), 0.09 (s, 3H) 
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(4-(allyloxy)pent-1-yn-1-yl)benzene  
 
To a 100 mL round bottom flask with magnetic stir bar was added 5-phenylpent-4-yn-2- 
ol (801 mg, 5 mmol) and THF (20 mL). The solution was cooled to 0 °C (ice/H2O bath) 
and sodium hydride (220 mg, 5.5 mmol) was added in one portion. After stirring at 0 °C 
for 15 minutes, allyl bromide (0.47 mL, 5.5 mmol) was added dropwise. The pale brown 
suspension stirred at room temperature for 2 hours then was quenched with sat. NH4Cl(aq) 
(20 mL). The aqueous layer was extracted with ether (3 x 50 mL) then the combined 
organics were dried over MgSO4, filtered and concentrated in vacuo to give an orange 
oil. The residue was purified via flash column chromatography (silica 2.5 x 14 cm; eluted 
with 2-4% ether/hexanes) to give alkyne 82 as a clear oil (300 mg, 30%). 
*Reaction was performed by Dr. Lauren Kaminsky. 
1H NMR (400 MHz, CDCl3)  δ 7.43-7.40 (m, 2H), 7.30-7.27 (m, 3H), 6.00-5.90 (m, 1H), 
5.32 (dq, J = 17.6, 1.6 Hz, 1H), 5.19 (dq, J = 10.4, 1.2 Hz, 1H), 4.08 (dt, J = 5.6, 1.6 Hz, 
2H), 3.76-3.69 (m, 1H), 2.72, (dd, J = 16.4, 4.8 Hz, 1H), 2.52 (dd, J = 16.8, 7.2 Hz, 1H), 
1.34 (d, J = 6.0 Hz, 3H). 
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1-phenylprop-2-yn-1-yl prop-2-enoate 
 
Conditions used in this prep were adapted from a literature procedure:115 
To a flame-dried 3 neck-500 mL round bottom flask equipped with a magnetic stir 
bar and an addition funnel was added, 1-phenyl-2-propyn-1-ol 120 (4.95 g, 37.45 mmol), 
4-dimethylaminopyridine (640 mg, 5.24 mmol), dry DCM (113 mL), and distilled 
triethylamine (10.44 mL, 74.9 mmol). The solution was then cooled to 0 °C using an 
ice/H2O bath. In a separate flask, acryloyl chloride (6.09 mL, 74.9 mmol) and dry DCM 
(175 mL) were added and the solution was transferred to the addition funnel. The acryloyl 
chloride solution was added dropwise to the cooled round bottom flask over 50 minutes. 
After the addition was complete, the ice bath was removed and the reaction was left to 
stir at room temperature for 6 hours. The reaction was quenched with saturated 
NaHCO3(aq) (300 mL). The organics were separated and then the organics were extracted 
from the aqueous layer with DCM (3 x 150 mL). The combined organics were washed 
with saturated NaHCO3(aq) (150 mL) and brine (75 mL), dried with Na2SO4, filtered, and 
then concentrated to give a crude oil. The oil was purified by flash column 
chromatography (4.0 x 14.0 cm silica) and eluted with a gradient of hexanes and 2% 
Et2O:hexanes) to afford a pale yellow oil (0.55 g, 2.6%). Note: Most fractions contained 
an impurity that co-eluted with the product. 
1H-NMR (400 MHz, CDCl3)  δ 7.57-7.55 (m, 2H), 7.43-7.37 (m, 3H), 6.54 (d, J = 2.2 Hz, 
1H), 6.48 (dd, J = 17.3, 1.1 Hz, 1H), 6.16 (dd, J = 17.3, 10.4 Hz, 1H), 5.89 (d, J = 10.4 
Hz, 1H), 2.67 (d, J = 2.3 Hz, 1H)  
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13C-NMR (100 MHz, CDCl3) δ 165.1, 136.6, 132.2, 129.3, 129.0, 128.0, 127.9, 80.3, 
75.8, 65.6 
FT-IR: (NaCl, thin film) ν =  3290, 3066, 3036, 2937, 2126, 1955, 1728, 1405, 1255, 
1173, 1037, 984, 942, 698 cm-1 
Anal: Calculated: C12H10O2 – C: 77.40  H: 5.41;  Found  C: 77.38 H: 5.41 
RF: 0.27 (10% Et2O:Hexanes) 
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1-phenyl-3-butyn-1-ol 
 
To a flame-dried 3-neck 500 mL round bottom flask equipped with a magnetic stir 
bar, a reflux condenser, and an addition funnel was added, magnesium turnings (2.16 g, 
90.0 mmol), HgCl2 (244 mg, 0.60 mmol), and one iodine chip. The apparatus was flame-
dried again for activation of the magnesium metal and then purged with an argon 
atmosphere. Dry diethyl ether (45 mL) was added and the contents were stirred. To the 
addition funnel was added propargyl bromide (6.80 mL, 90.0 mmol), and dry diethyl ether 
(75 mL). The contents of the addition funnel were added dropwise into the round bottom 
to promote self-reflux. When the addition was completed after 10 minutes, a heating 
mantle was equipped underneath the round bottom flask and refluxed for 1 hour.  
The solution was allowed to cool prior to titrating the active Grignard species114 to 
a concentration of 0.69 M. The round bottom was then cooled to -40°C using a dry 
ice/acetone bath before the dropwise addition of benzaldehyde (5.61 mL, 55.17 mmol) 
via syringe. After stirring for 2 hours at room temperature, the reaction was monitored by 
TLC and confirmed to be complete. The reaction was cooled prior to addition of 1M HCl(aq) 
(100 mL) to quench the reaction. The organics were separated and then the organics 
were extracted from the aqueous layer with diethyl ether (2 x 75 mL), treated with 
activated carbon for 15 minutes, then dried with MgSO4 and filtered over celite. The 
solution was concentrated to afford a pale-yellow oil (8.02 g, 97%).  
1H-NMR (400 MHz, CDCl3)  δ 7.42-7.35 (m, 4H), 7.33-7.29 (m, 1H), 4.88 (td, J = 6.4, 3.6 
Hz, 1H),  2.66 (d, J = 2.6 Hz, 1H), 2.64 (dd, J = 2.6, 0.8 Hz, 1H), 2.35 (d, J =  3.6 Hz, 1H), 
2.08 (t, J = 2.6 Hz, 1H) 
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 1-phenylbut-3-yn-1-yl prop-2-enoate 
 
Conditions used in this prep were adapted from a literature procedure115 
To a flame-dried 3 neck-250 mL round bottom flask equipped with a magnetic stir 
bar and an addition funnel was added, 1-phenyl-3-butyn-1-ol 123 (2.75 g, 18.8 mmol), 4-
dimethylaminopyridine (322 mg, 2.63 mmol), dry dichloromethane (50 mL), and distilled 
triethylamine (5.24 mL, 37.62 mmol). The solution was then cooled to 0 °C using an 
ice/H2O bath. In a separate flask, acryloyl chloride (3.06 mL, 74.9 mmol) and dry 
dichloromethane (175 mL) were added and the solution was transferred to the addition 
funnel.  The acryloyl chloride solution was added dropwise to the cooled round bottom 
flask over 1 hour. After the addition was completed, the reaction was left to stir overnight 
at room temperature. The reaction was quenched with a saturated NaHCO3(aq) solution 
(75 mL). The organics were separated and then the organics were extracted from the 
aqueous layer with dichloromethane (3 x 100 mL). The combined organics were washed 
with saturated NaHCO3(aq) (50 mL), brine (50 mL), dried with Na2SO4, and concentrated 
to give a crude oil. The resulting oil was purified by flash column chromatography (4.0 x 
12.0 cm silica – hexanes, 2% Et2O:hexanes) to afford a clear oil (1.25 g, 33%). 
1H-NMR (400 MHz, CDCl3)  δ 7.42-7.30 (m, 5H), 6.47 (dd, J = 17.4, 1.4 Hz, 1H), 6.18 
(dd, J = 17.4, 10.4 Hz, 1H), 5.98 (t, J = 6.4 Hz, 1H), 5.87 (dd, J = 10.4, 1.4 Hz, 1H), 2.84 
(ddd, J = 16.8, 6.8, 2.6 Hz, 1H), 2.76 (ddd, J = 16.8, 6.3, 2.7 Hz, 1H), 1.98 (t, J = 2.7 Hz, 
1H)  
13C-NMR (100 MHz, CDCl3) δ 165.3, 139.1, 131.6, 128.7, 128.6, 128.5, 126.7, 79.5, 
73.9, 71.0, 26.7 
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FT-IR: (NaCl, thin film) ν = 3293, 3066, 3035, 2942, 2916, 1722, 1406, 1295, 1267, 
1191, 1049, 985, 700 cm-1 
Anal: Calculated: C13H12O2 – C: 77.98 H: 6.04;  Found  C: 78.04 H: 6.06 
RF: 0.35 (10% Et2O:hexanes) 
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N-allyl-4-methyl-benzenesulfonamide123 
 
To a flame-dried 3-neck 1 L round bottom flask equipped with a magnetic stir bar 
was added p-toluenesulfonyl chloride, (65.0 g, 340.9 mmol), dry THF (230 mL), and 
pyridine (28.65 mL, 354.3 mmol). The round bottom flask was cooled to 0 °C using an 
ice/H2O bath and then allylamine (25.1 mL, 334.2 mmol) was added in five 5 mL portions, 
dropwise via syringe every 15 minutes. After the addition was completed, the ice/H2O 
bath was removed and the solution was left to stir for four hours. The solution was then 
treated with 2M NaOH(aq) (50 mL) and left to stir overnight. The reaction mixture was 
transferred to a separatory funnel and the organics were separated and then the organics 
were extracted from the aqueous layer with diethyl ether (2 x 125 mL). The combined 
organics were washed with brine (50 mL), dried over MgSO4, filtered through a silica plug 
(ca. 3 cm silica) with a layer of celite on top. The filter cake was then washed with diethyl 
ether (300 mL) and concentrated to give an oil. The oil was then recrystallized from 30% 
EtOAc:hexanes (225 mL) to afford an off-white solid (45.11 g). Recrystallization of the 
mother liquor using 125 mL of 30% EtOAc:hexanes yielded a light brown solid (1.95 g), 
combined yield (47.06 g, 67%). 
1H-NMR (400 MHz, CDCl3)  δ 7.76 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 5.77-5.67 
(ddt, J = 16.0, 10.2, 5.8 Hz, 1H), 5.16 (dq, J =  17.1, 1.6 Hz, 1H), 5.10 (dq, J = 10.2, 1.3, 
1H) 4.42 (br, 1H),  3.59 (tt, J = 6.3, 1.5 Hz, 2H), 2.43 (s, 3H) 
NH2
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N-allyl-N-propargyl-4-methylbenzenesulfonamide123 
 
To a flame-dried 500 mL round bottom flask with magnetic stir bar was added N-
allyl-4-methyl-benzenesulfonamide 124 (16.9 g, 80 mmol), potassium carbonate, (13.27 
g, 96 mmol), propargyl bromide (7.23 mL, 96 mmol), and reagent grade acetone (160 
mL). The reaction flask was then equipped with a reflux condenser and put under a 
positive stream of argon(g). The solution was then heated to reflux and left to react for 26 
hours and confirmed to be complete by TLC.  The reaction mixture was allowed to cool 
to room temperature followed by concentration in vacuo. The residue was diluted with 
EtOAc (150 mL) and water (75 mL) and the organics were separated and then the 
organics were extracted from the aqueous layer with EtOAc (2 x 100 mL). The combined 
organics were washed with brine (50 mL), dried with MgSO4, filtered and then 
concentrated. Recrystallization with the resulting residue using diethyl ether (1.5 mL) and 
20% ethyl acetate/hexanes (150 mL) afforded off-white/beige crystals (12.14 g). 
Recrystallization from the mother liquor using 0.5 mL diethyl ether and 75 mL of 20% 
ethyl acetate/hexanes gave beige crystals (3.13 g), combined yield (15.27 g, 76%). 
1H-NMR (400 MHz, CDCl3)  δ 7.73 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 5.78-5.68 
(m, 1H), 5.28 (dq, J = 17.1, 1.4 Hz, 1H), 5.24 (dq, J = 10.0, 1.2 Hz, 1H), 4.09 (d, J = 2.5 
Hz, 2H), 3.83 (d, J = 6.5 Hz, 2H), 2.43 (s, 3H), 2.00 (t, J = 2.5 Hz, 1H). 
MP: 56-58°C 
N
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N-[(tert-butoxy)carbonyl]-4-methylbenzenesulfonamide124 
 
To a flame-dried 3-neck 1 L round bottom flask equipped with a magnetic stir bar 
and addition funnel was added; 4-methyl-benzenesulfonamide (21.4 g, 125 mmol), dry 
DCM (165 mL), 4-dimethylaminopyridine (1.53 g, 12.5 mmol), and distilled triethylamine, 
(19.2 mL, 137.5 mmol). Separately, a solution of di-tert-butyl dicarbonate anhydride, (31.4 
g, 143.75 mmol) dissolved in dry DCM (250 mL) was transferred to the addition funnel. 
The 1 L round bottom flask was then cooled to 0 °C using an ice/H2O bath prior to 
dropwise addition of the di-tert-butyl dicarbonate solution. After the addition was 
complete, the ice bath was removed and the solution was stirred for three hours. The 
reaction mixture was concentrated under reduced pressure to afford a white residue. The 
residue was treated with EtOAc (300 mL) and 1M HCl(aq) (ca. 225 mL) and stirred for 15 
minutes. The solution was then transferred to a separatory funnel and the organics were 
extracted from the aqueous layer with EtOAc (2 x 200 mL). The combined organics were 
washed with brine (50 mL), dried with MgSO4, filtered and concentrated to afford a white 
solid (22.18 g). Recrystallization of the mother liquor was achieved using 25% 
Et2O:hexanes (250 mL) to afford colorless rods (6.88 g), combined yield (29.06 g, 86%).  
1H-NMR (400 MHz, CDCl3)  δ 7.90 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.28 
(brs, 1H), 2.45 (s, 3H), 1.38 (s, 9H) 
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N-Boc-4-methyl-N-prop-2-ynylbenzenesulfonamide125 
 
To a flame-dried 1 L round bottom flask with a magnetic stir bar was added, N-
[(tert-butoxy)carbonyl]-4-methylbenzenesulfonamide 125 (20.0 g, 73.7 mmol) and dry 
DMF (500 mL). The solution was stirred and then cooled using an ice/H2O bath. NaH 
(3.53 g, 88.5 mmol) was added slowly in one portion and the mixture was stirred for 30 
minutes. Propargyl bromide (5.55 mL, 73.7 mmol) was then added to round bottom flask 
dropwise via syringe. The mixture was stirred for an additional 15 minutes in the ice bath, 
then the reaction was left to stir over night at room temperature.  
The reaction was quenched with saturated NH4Cl(aq) (75 mL). The mixture was 
transferred to a separatory funnel and the organics were separated from the aqueous and 
then the organics were extracted from the aqueous layer using EtOAc (3 x 175 mL). The 
combined organics were washed with water (3 x 400 mL) followed by brine (75 mL), dried 
over Na2SO4, filtered and then concentrated to afford a white solid (18.8 g, 82%).  
1H-NMR (400 MHz, CDCl3)  δ 7.91 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 4.63 (d, 
J = 2.4 Hz, 2H), 2.45 (s, 3H), 2.32 (t, J = 2.4 Hz, 1H),  1.35 (s, 9H) 
 
Ts
N
Boc
126
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4-methyl-N-prop-2-ynylbenzenesulfonamide 
 
To a flame-dried 500 mL round bottom flask with magnetic stir bar was added, N-
Boc-4-methyl-N-prop-2-ynylbenzenesulfonamide 126 (18.77 g, 60.7 mmol) and TFA 
(22.5 mL, 303.4 mmol). The reaction was stirred under argon atmosphere overnight. The 
resulting oil was purified by flash column chromatography (4.0 x 13.0 cm silica) using 10% 
EtOAc:hexanes (2.5 L). The fractions were concentrated to afford a white solid (11.07 g, 
87%). 
1H-NMR (400 MHz, CDCl3)  δ 7.78 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 7.9 Hz, 2H), 4.80 (brs, 
1H), 3.82 (dd, J = 5.9, 2.4 Hz, 2H), 2.43 (s, 3H),  2.10 (t, J = 2.3 Hz, 1H) 
HN
Ts
127
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N-(but-3-en-1-yl)-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide126 
 
To a flame-dried 250 mL round bottom flask equipped with magnetic stir bar was 
added N-3-butyn-N-4-methylbenzenesulfonamide 127 (2.21 g, 10.6 mmol), dry DMSO 
(50 mL), and NaH (529 mg, 13.2 mmol) in one portion. The contents were stirred at room 
temperature for 1.75 hours and then 4-bromobutene (2.00 g, 14.8 mmol) was added in 
dropwise via syringe. The reaction was left to stir for 12 hours and then quenched with 
saturated NH4Cl(aq) (50 mL). The mixture was transferred to a separatory funnel and the 
organics were separated and then the organics were extracted from the aqueous layer 
using EtOAc (3 x 75 mL). The combined organics were washed with brine (25 mL), dried 
over MgSO4, filtered and then concentrated to give an oil. The resulting oil was subjected 
to flash column chromatography (2.5 x 12.0 cm silica) using 3% EtOAc:hexanes (2 L) and 
5% EtOAc:hexanes (500 mL) to yield a clear oil. The clear oil was left in the freezer 
overnight to afford a colorless crystalline solid (2.58 g, 92%).  
1H-NMR (300 MHz, CDCl3)  δ 7.73 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.77 (ddt, 
J = 17.1, 10.2, 6.7 Hz, 1H), 5.14-5.05 (m, 2H), 4.14 (d, J = 2.4 Hz, 2H), 3.27 (t, J = 7.2 
Hz, 2H), 2.42 (s, 3H),  2.34 (q, J = 6.9 Hz, 2H), 2.03 (t, J = 2.5 Hz, 1H) 
N
Ts
92
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N-(tert-butoxylcarbonyl)-N-but-3-ynyl-4-methylbenzenesulfonamide127 
  
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added THF (100 mL), triphenylphosphine (5.66 g, 21.6 mmol), 3-butyn-1-ol (1.48 mL, 
21.6 mmol), and N-[(tert-butoxy)carbonyl]-4-methylbenzenesulfonamide 125, (5.42 g, 
20.0 mmol). The solution was stirred and cooled to 0 °C using an ice/H2O bath. Once the 
solution was cooled, diisopropyl azadicarboxylate (4.33 mL, 21.6 mmol) was added to the 
round bottom flask via syringe, dropwise. After the addition was complete, the ice bath 
was removed and the reaction was left to stir overnight at room temperature.  
The reaction was quenched with saturated NH4Cl(aq) (50 mL), transferred to a 
separatory funnel, and the organics were extracted from the aqueous layer with DCM (3 
x 50 mL). The combined organics were washed with brine (25 mL), dried with MgSO4, 
filtered and concentrated in vacuo to afford a white solid (3.20 g, 49%).  
*Reaction was performed by Dr. Robert J. Wilson  
1H-NMR (300 MHz, CDCl3)  δ 7.80 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.1Hz, 2H), 4.03-3.98 
(m, 2H), 2.69-2.64 (m, 2H), 2.44 (s, 3H), 2.02 (t, J = 2.7 Hz, 1H), 1.35 (s, 9H) 
 
 
N
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N-(3-butyn-1-yl)-4-methylbenzenesulfonamide128 
 
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added; N-(tert-butoxylcarbonyl)-N-but-3-ynyl-4-methylbenzenesulfonamide 128 (3.20 g, 
9.89 mmol), dry DCM (20 mL) and TFA (3.80 mL, 49.5 mmol. The mixture was left to stir 
overnight. The reaction mixture was concentrated in vacuo to give a brown oil. The 
resulting oil was purified by flash column chromatography (2.5 x 10.0 cm silica) and elute 
with 15% EtOAc:hexanes (1.5 L). The fractions were concentrated to afford a clear oil. 
The oil was placed in the freezer overnight to crystallize and obtained a white solid (2.03 
g, 92%).  
1H-NMR (300 MHz, CDCl3)  δ 7.76 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 4.77 
(brs, 1H), 4.08 (s, 3H), 3.11 (q, J = 6.5 Hz), 2.43 (s, 3H), 2.34 (td, J = 6.5, 2.6 Hz, 2H), 
2.00 (t, J = 2.5 Hz, 1H) 
MP:  73-74°C 
 
HN
Ts
129
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 N-allyl-N-(3-butyn-1-yl)-4-methylbenzenesulfonamide129 
 
To a flame-dried 100 mL round bottom flask with magnetic stir bar was added, N-3-butyn-
N-4-methylbenzenesulfonamide 129 (2.03 g, 9.09 mmol), potassium carbonate (1.51 g, 
10.9 mmol), allyl bromide (0.95 mL, 10.9 mmol), and reagent grade acetone (18 mL). The 
round bottom flask was then equipped with a reflux condenser, put under an argon(g) 
atmosphere, immersed into a pre-heated 65 °C oil bath, and stirred at reflux for 24 h. The 
reaction mixture was cooled to room temperature and the solvent removed in vacuo to 
give a residue. The residue was diluted with EtOAc (150 mL) and water (75 mL) and the 
organics were separated and then the organics were extracted from the aqueous layer 
with EtOAc (2 x 100 mL). The combined organics were washed with brine (50 mL), dried 
with MgSO4, filtered and then concentrated. The resulting residue was purified by flash 
column chromatography (15% EtOAc/hexanes) to afford a clear oil (2.31 g, 96%); 1 
1H NMR (400 MHz, CDCl3)  δ 7.72 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.66 (ddt, 
J = 16.5, 10.1, 6.5 Hz, 1H), 5.19 (dd, J = 13.9, 1.4 Hz, 1H), 5.16 (dd, J = 6.8, 1.2 Hz, 1H), 
3.84 (d, J = 6.4 Hz, 2H), 3.28 (t, J = 7.5 Hz, 2H), 2.48-2.44 (m, 2H), 2.43 (s, 3H), 1.97 (t, 
J = 2.6 Hz, 1H). 
 
N
Ts
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(E)-N-cinnamyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 
 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, N-3-butyn-N-4-methylbenzenesulfonamide 127 (2.06 g, 9.56 mmol), 
triphenylphosphine (1.88 g, 9.56 mmol), and trans-cinnamyl alcohol (1.28 g, 9.56 mmol). 
The round bottom flask was put under vacuum for one minute and was then purged and 
put under a positive stream of argon gas. Dry THF (95 mL) was then transferred to the 
round bottom flask and the mixture was cooled to 0 °C using an ice/H2O bath. Diisopropyl 
azodicarboxylate (1.88 mL, 9.56 mmol) was added to the round bottom flask dropwise via 
syringe. After complete addition, the ice bath was removed and the mixture was stirred 
for 24 hours at room temperature.  
The reaction mixture was concentrated to give a viscous oil. The resulting oil was 
subjected to flash column chromatography (4.0 x 13.0 cm silica) and eluted with 4% 
EtOAc:hexanes (1 L), 5% EtOAc:hexanes (500 mL), 10% EtOAc:hexanes (500 mL), 15% 
EtOAc:hexanes (500 mL) and concentrated to afford a white solid (2.10 g, 68%).  
1H-NMR (400 MHz, CDCl3)  δ 7.77 (d, J = 8.3 Hz, 2H), 7.35-7.23 (m, 7H), 6.57 (d, J = 
15.8 Hz, 1H), 6.08 (dt, J = 15.8, 6.9 Hz, 1H), 4.13 (d, J = 2.5 Hz, 2H), 3.99 (dd, J = 6.8, 
1.0 Hz, 2H), 2.44 (s, 3H), 2.04 (t, J = 2.5 Hz, 1H) 
MP: 77-78°C 
 
N
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4-methyl-N-(2-methyl-2-propenyl)-N-(2-propynyl)benzenesulfonamide130 
  
To a flame-dried 3-neck 250 mL round bottom flask equipped with a magnetic stir 
bar and reflux condenser was added, N-3-butyn-N-4-methylbenzenesulfonamide 127 
(3.85 g, 18.4 mmol), potassium carbonate (3.18 g, 23.0 mmol), THF (50 mL), and DMF 
(50 mL). The contents were stirred at room temperature and then 3-chloro-2-
methylpropene (5.40 mL, 55.2 mmol) was added to the round bottom flask dropwise via 
syringe. The mixture was then immersed into a pre-heated 80 °C oil bath and stirred for 
24 h. The reaction mixture was cooled to room temperature and then quenched with 
saturated NH4Cl(aq) (50 mL). The solution was transferred to a separatory funnel. The 
organics were separated and then the organics were extracted from the aqueous layer 
using DCM (3 x 150 mL). The combined organics were washed with water (4 x 250 mL), 
then with brine (50 mL), dried with MgSO4, filtered, and concentrated to give a light orange 
oil that after leaving overnight formed a yellow solid. The resulting solid was subjected to 
flash column chromatography (4.0 x 10.0 cm silica) using 2% EtOAc:hexanes (1 L), 3% 
EtOAc:hexanes (1 L), and 5% EtOAc:hexanes (500 mL) to yield a white solid (3.21 g, 
66%).  
1H-NMR (400 MHz, CDCl3)  δ 7.74 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 4.97 (s, 
2H), 4.04 (d, J = 2.4 Hz, 2H), 3.73 (s, 2H), 2.42 (s, 3H),  1.95 (t, J = 2.4 Hz, 1H), 1.76 (s, 
3H) 
13C-NMR (100 MHz, CDCl3) δ 143.7, 139.3, 136.2, 129.6, 128.0, 115.8, 76.6, 73.9, 52.6, 
35.6, 21.7, 19.9 
N
Ts
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N-allyl-N-(3-bromo-2-propyn-1-yl)-4-methylbenzenesulfonamide131 
 
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added; N-allyl-N-propargyl-4-methylbenzenesulfonamide 90 (3.74 g, 15.0 mmol) and 
reagent grade acetone (25 mL). The solution was cooled to 0 °C using an ice bath and 
while the solution was stirred, N-bromosuccinimide (3.34 g, 18.75 mmol) and silver nitrate 
(408 mg, 2.40 mmol) were added sequentially. The reaction mixture was stirred for 
another 5 minutes in the ice bath, then the ice bath was removed and the round bottom 
flask wrapped in aluminum foil. The reaction continued to stir for 7 hours at room 
temperature and the reaction was confirmed to be complete by TLC. The reaction was 
quenched with water (50 mL), and the organics were separated and then the organics 
were extracted from the aqueous layer with EtOAc (3 x 50 mL). The combined organics 
were washed with brine (25 mL), and dried with MgSO4, filtered and then concentrated to 
afford a cream-colored solid. The resulting solid was purified by flash-column 
chromatography (EtOAc:hexanes = 1:3), to afford an off-white solid (3.99 g, 81%). 
1H-NMR (400 MHz, CDCl3)  δ 7.72 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.72 
(ddt, J = 16.5, 10.0, 6.5 Hz, 1H), 5.30-5.23 (m, 2H), 4.08 (s, 2H), 3.78 (d, J = 6.2 Hz), 
2.43 (s, 3H) 
13C-NMR (100 MHz, CDCl3) δ 143.9, 135.8, 132.1, 129.7, 128.0, 120.3, 73.0, 49.6, 45.1, 
37.1, 21.8  
MP:  55-56°C 
N
Ts
99Br
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N-allyl-N-formyl-4-methylbenzenesulfonamide132 
 
To a flame-dried 3-neck 250 mL round bottom flask equipped with magnetic stir 
bar and addition funnel was added; N-allyl-4-methyl-benzenesulfonamide 124 (4.79 g, 
22.65 mmol) and dry THF (55 mL) and the contents were stirred. The round bottom flask 
was then cooled to 0 °C using an ice/H2O bath. Upon the solution being cooled, n-BuLi in 
hexanes that was titrated at 2.30 M (10.8 mL, 24.9 mmol), was added dropwise to the 
round bottom via addition funnel. After stirring for 15 minutes at 0 °C, a solution of 1-
formyl-1H-benzotriazole (4.00 g, 27.2 mmol) dissolved in THF (55 mL) was transferred to 
the addition funnel and then added dropwise to the round bottom flask. 1-formyl-1H-
benzotriazole was prepared according to the publication by Hoffmann and Bueckner.18b 
The mixture was then allowed to stir overnight. 
The residue was diluted with MTBE (75 mL) and transferred to a separatory funnel. 
The solution was quenched with saturated NaHCO3 (125 mL), and the organics were 
separated and then extracted from aqueous layer with MTBE (3 x 100 mL). The combined 
organics were washed with brine (50 mL), and dried with MgSO4, filtered and 
concentrated to afford a crude solid. The solid was purified by flash column 
chromatography (4.0 x 9.0 cm silica) using 10% EtOAc:hexanes. The fractions were 
collected and concentrated down to afford white needles. (3.61g, 67%). 
1H-NMR (400 MHz, CDCl3)  δ 9.10 (s, 1H), 7.73 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.1 Hz, 
2H), 5.58 (ddt, J = 16.3, 10.3, 6.0 Hz, 1H), 5.13 (dd, J = 17.1, 1.0 Hz, 1H), 5.07 (dd, J = 
10.2 Hz, 1H), 4.10 (d, J = 6.0 Hz, 2H), 2.44 (s, 3H) 
13C-NMR (100 MHz, CDCl3) δ 161.0, 145.7, 135.4, 130.9, 130.4, 127.7, 119.2, 44.9, 21.8 
N
Ts
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N-allyl-N-(2,2-dichlorovinyl)-4-methyl-benzenesulfonamide132 
 
To a flame-dried 3-neck 250 mL round bottom flask equipped with a magnetic stir 
bar and a reflux condenser was added; N-allyl-N-formyl-4-methylbenzenesulfonamide 
130 (1.00 g, 4.18 mmol), triphenylphosphine (3.29 g, 12.5 mmol) and dry THF (50 mL). 
The contents were stirred and then the round bottom flask was then submerged into a 
preheated 60 °C oil bath. Carbon tetrachloride, (4.05 mL, 41.8 mmol), was added slowly 
to the round bottom flask over a period of 3 hours by syringe pump. The reaction 
proceeded for an additional four hours before the reaction mixture was diluted with MTBE 
(30 mL). The solution was transferred to a separatory funnel and washed with saturated 
NaHCO3(aq) (3 x 50 mL). The organics were separated and then the organics were 
extracted from the aqueous layer with MTBE (3 x 100 mL). The combined organics were 
washed with brine (25 mL), dried with MgSO4, filtered and concentrated to afford a light-
brown solid. The resulting solid was purified by flash column chromatography (2.0 x 12.0 
cm silica) using 10% EtOAc:hexanes (1 L). The fractions were collected and concentrated 
down to afford a beige solid (1.24 g, 97%). 
1H-NMR (400 MHz, CDCl3)  δ 7.70 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 6.32 (s, 
1H), 5.69 (ddt, J = 16.5, 10.1, 6.3 Hz, 1H), 5.21-5.15 (m, 2H), 4.01 (dt, J =  6.3, 1.1 Hz, 
2H), 2.44 (s, 3H) 
13C-NMR (100 MHz, CDCl3) δ 144.5, 135.8, 132.1, 130.1, 127.6, 125.0, 124.5, 119.7, 
51.9, 21.8 
N
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N-allyl-N-ethynyl-4-methyl-benzenesulfonamide132 
 
To a flame-dried 50 mL round bottom flask equipped with a magnetic stir bar and 
a thermocouple thermometer was added, N-allyl-N-(2,2-dichlorovinyl)-4-methyl-
benzenesulfonamide 131 (1.00 g, 3.27 mmol) and dry THF (16 mL). The contents were 
cooled using dry ice/acetone bath to ca. -78 °C. Once cooled, 2.5 M n-butyllithium in 
hexanes (2.90 mL, 7.18 mmol) was added to the round bottom flask dropwise via syringe. 
After addition was complete, the reaction was stirred for 3 hours and was then slowly 
warmed to -30 °C. Methanol (0.68 mL) was added to quench the reaction and the solution 
was warmed to room termperature. The reaction mixture was diluted with MTBE (25 mL). 
The solution was transferred to a separatory funnel and washed with saturated 
NaHCO3(aq) (25 mL). The organics were separated and then the organics were extracted 
from the aqueous layer with MTBE (2 x 50 mL). The combined organics were washed 
with brine (25 mL), dried with MgSO4, filtered and concentrated. The resulting material 
was purified by flash column chromatography with silica and was eluted using 7% 
EtOAc:hexanes. The fractions were collected and concentrated down to afford a pale-
yellow solid (430 mg, 56%). 
1H-NMR (400 MHz, CDCl3)  δ 7.46-7.43 (m, 2H), 7.36-7.32 (m, 2H), 4.95-4.88 (m, 1H), 
4.66-4.63 (m, 2H), 2.65-2.59 (m, 1H), 2.48 (ddt, J = 13.9, 8.6, 2.1 Hz, 1H), 2.09 (s, 1H), 
1.57 (s, 3H) 
MP: 68-70 °C 
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N-(cyclohex-2-enyl)-4-methyl-N-(prop-2-ynyl) benzenesulfonamide 
 
To a flame-dried 250 mL round bottom flask equipped with magnetic stir bar was 
added, N-3-butyn-N-4-methylbenzenesulfonamide 127 (2.47 g, 11.8 mmol), 
triphenylphosphine (3.10 g, 11.8 mmol), cyclohex-2-ene-1-ol133 (1.16 g, 11.8 mmol), and 
dry THF (120 mL). The mixture was cooled to 0 °C using an ice/H2O bath. Diisopropyl 
azadicarboxylate (2.33 mL, 11.8 mmol) was added to the round bottom flask dropwise via 
syringe. After complete addition, the ice bath was removed and the mixture was stirred 
for 24 hours at room temperature.  
The reaction mixture was concentrated to give a viscous oil. The resulting oil was 
subjected to flash column chromatography (4.0 x 13.0 cm silica) using 4% 
EtOAc:hexanes (1 L), 7% EtOAc:hexanes (700 mL), and 10% EtOAc:hexanes (1 L). The 
fractions were concentrated to afford a clear oil. The clear oil was left in the freezer 
overnight to afford a white solid (2.37 g, 69%).  
1H-NMR (400 MHz, CDCl3)  δ 7.81 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 5.90-5.86 
(m, 1H), 5.33-5.29 (m, 1H), 4.51-4.45 (m, 1H), 4.12 (dd, J = 18.4, 2.4 Hz, 1H), 3.91 (dd, 
J =  18.4, 2.5 Hz, 1H), 2.42 (s, 3H), 2.16 (t, J = 2.5 Hz, 1H), 2.01-1.95 (m, 2H), 1.87-1.69 
(m, 3H), 1.60-1.50 (m, 1H) 
103
N
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Bis(phenylthio)methane 
 
This compound was prepared according to a literature procedure with modifications:134 
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, thiophenol (7.20 mL, 70.0 mmol) and absolute ethanol (80 mL). The solution was 
stirred for 5 minutes and then NaOH (3.50 g, 87.5 mmol) was added in one portion. The 
round bottom flask was then immersed into a pre-heated 80 °C oil bath and the mixture 
was stirred for 2 hours. The round bottom was removed from the oil bath and allowed to 
cool to room temperature. At room temperature, dibromomethane (4.90 mL, 70.0 mmol) 
was added to the round bottom flask dropwise via syringe. Note: slight bubbling and a 
white precipitate around the rim of round bottom were observed upon addition of the 
dibromomethane. After the addition, the round bottom flask was re-immersed into the pre-
heated oil bath and left to stir for 3 hours. The round bottom flask was removed once 
more from the oil bath and cooled to room temperature. The reaction mixture was 
concentrated under reduced pressure and quenched with water (50 mL). The mixture was 
diluted with EtOAc (50 mL) and transferred to a separatory funnel. The organics were 
separated and then the organics were extracted from the aqueous layer using EtOAc (3 
x 100 mL). The combined organics were washed with brine (25 mL), dried with Na2SO4, 
filtered, and then concentrated to afford a gold-yellow oil, (8.53 g, 100%.). The oil was 
carried through onto the next step with few impurities.  
1H-NMR (400 MHz, CDCl3)  δ 7.36-7.33 (m, 4H), 7.26-7.22 (m, 4H), 7.19-7.15 (m, 2H), 
4.27 (s, 2H) 
S S
Ph Ph
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Bis(phenylsulfonyl)methane 
 
This compound was prepared according to a literature procedure with modifications 135 
To a flame-dried 1 L round bottom flask equipped with a magnetic stir bar was 
added, bis(phenylthio)methane 133 (8.53 g, 36.7 mmol) and dry DCM (750 mL). The 
solution was stirred and the round bottom flask was then cooled to 0 °C with an ice/H2O 
bath. To the stirred solution was added m-CPBA (37.25 g, 183.5 mmol) in three portions. 
The reaction was stirred in the ice bath for 2 hours, then the reaction was removed from 
the ice bath and left to stir at room temperature for 20 hours. The mixture was 
concentrated under reduced pressure to give a solid. The resulting solid was subjected 
to flash column chromatography (4.0 x 13.5 cm silica) and eluted with 30% 
EtOAc:hexanes (1 L) and 70% EtOAc:hexanes (1 L). The fractions were concentrated to 
afford a white solid (9.12 g, 84%).  
1H-NMR (300 MHz, CDCl3)  δ 7.99-7.96 (m, 4H), 7.75-7.70 (m, 2H), 7.63-7.58 (m, 4H), 
4.73 (s, 2H)  
S S
Ph Ph
O O O O
134
 
70 
1,1-bisbenzenesulfonyl-3-butene136 
  
To a flame-dried 250 mL round bottom flask equipped with a magnetic stir bar was 
added, bis(phenylsulfonyl)methane 134 (3.00 g, 10.1 mmol), dry DMF (35 mL) and NaH 
(425 mg, 10.6 mmol) in three portions. Evolution of H2(g) gas was observed upon addition 
of NaH to the solution. The round bottom flask was then immersed into a pre-heated 70 
°C oil bath and stirred for 20 minutes. The round bottom flask was removed from the oil 
bath and allowed to cool to room temperature. Next, allyl bromide (0.990 mL, 11.5 mmol) 
was added dropwise via syringe. Once the addition was complete, the round bottom flask 
was re-immersed into the pre-heated oil bath and stirred for 3 hours. The round bottom 
flask was removed once more from the oil bath and cooled to room temperature. The 
reaction mixture was quenched with saturated NH4Cl(aq) (50 mL). The mixture was diluted 
with DCM (50 mL) and transferred to a separatory funnel. The organics were separated 
and then the organics were extracted from the aqueous layer using DCM (3 x 100 mL). 
The combined organics were washed with water (3 x 300 mL), brine (50 mL), dried with 
MgSO4, filtered, and then concentrated. The resulting solid was recrystallized from 
absolute ethanol (75 mL), filtered, and washed with cold hexanes to yield white needles 
(2.00 g). Recrystallization of the mother liquor was achieved using absolute ethanol (30 
mL) and gave pale yellow needles (0.678 g), combined yield (2.678 g, 79%). 
1H-NMR (400 MHz, CDCl3)  δ 7.98-7.95 (m, 4H), 7.73-7.69 (m, 2H), 7.61-7.56 (m, 4H), 
5.81 (ddt, J = 16.9, 10.1, 6.8 Hz, 1H), 5.09-5.02 (m, 2H), 4.47 (t, J = 6.0 Hz, 1H), 2.95-
2.91 (m, 2H), 2.36-2.32 ( m, 2H), 2.24-19 (m, 2H) 2.00 (t, J = 2.8 Hz, 1H) 
MP: 115-116 °C 
PhO2S SO2Ph
135
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4,4-bis(phenylsulfonyl)hept-1-en-6-yne 
  
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added, 1,1-bisbenzenesulfonyl-3-butene 135 (1.00 g, 2.97 mmol), potassium carbonate 
(616 mg, 4.46 mmol), and dry DMF (10 mL). The solution was stirred for 15 minutes and 
propargyl bromide (0.246 mL, 3.27 mmol) was added to the mixture dropwise via syringe. 
The reaction mixture was then left to stir at room temperature for 24 hours. The reaction 
mixture was quenched with saturated NH4Cl(aq) (25 mL). The mixture was diluted with 
DCM (25 mL) and transferred to a separatory funnel. The organics were separated and 
then the organics were extracted from the aqueous layer using DCM (2 x 50 mL). The 
combined organics were washed with water (2 x 100 mL), brine (25 mL), dried with 
MgSO4, filtered, and then concentrated to afford a pale-yellow solid. The resulting solid 
was subjected to a silica plug over a coarse fritted funnel (ca. 2.5 cm silica) and eluted 
with 30% EtOAc (500mL) to afford an off-white solid (1.00 g, 90%). 
1H-NMR (400 MHz, CDCl3)  δ 8.14-8.11 (m, 4H), 7.75-7.70 (m, 2H), 7.61-7.57 (m, 4H), 
6.13-6.03 (m, 1H), 5.33-5.31 (m, 1H), 5.29 (brs, 1H), 3.28 (d, J = 2.7 Hz, 2H), 3.11 (dt, J 
= 6.9, 1.3 Hz, 2H), 2.09 (t, J = 2.8 Hz, 1H) 
13C-NMR (100 MHz, CDCl3) δ 136.7, 135.0, 131.8, 129.7, 128.8, 121.4, 89.0, 76.0, 
74.6, 33.5, 21.0 
MP: 141-142 °C 
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1,1-bis(phenylsulfonyl)-3-butyne137 
     
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added, bis(phenylsulfonyl)methane 134 (3.50 g, 11.8 mmol) and dry DMF (20 mL). The 
solution was stirred and NaH (520 mg, 13.0 mmol) was added in one portion. The solution 
was stirred at room temperature for 5 minutes then immersed into a pre-heated 70 °C oil 
bath and stirred for 10 minutes. The round bottom flask was removed from the oil bath 
and allowed to cool to room temperature. Propargyl bromide (0.94 mL, 12.5 mmol) was 
added to the mixture dropwise via syringe, and then the round bottom flask was re-
immersed into the pre-heated oil bath and left to stir for 20 minutes. The reaction mixture 
was quenched with saturated NH4Cl(aq) (25 mL). The mixture was diluted with EtOAc (50 
mL) and transferred to a separatory funnel. The organics were separated and then the 
organics were extracted from the aqueous layer using EtOAc (3 x 100 mL). The combined 
organics were washed with water (2 x 200 mL), brine (50 mL), dried with MgSO4, filtered, 
and then concentrated to afford a solid. Note: the crude solid by proton-NMR suggested 
a significant amount of over alkylation (ca. 80%). The resulting solid was subjected to 
flash column chromatography (2.0 x 12.0 cm silica) and eluted with 10% EtOAc:hexanes 
to afford fractions containing either a mixture of mono and di-alkylated products or starting 
material mixed with the mono-alkylated product. The mixed fractions containing mono-
alkylated product were collected, concentrated, and then recrystallization from absolute 
ethanol (50 mL) yielded a white solid after rinsing with cold hexanes (473 mg, 12%). 
1H-NMR (400 MHz, CDCl3)  δ 8.02-8.00 (m, 4H), 7.75-7.71 (m, 2H), 7.62-7.58 (m, 4H),  
4.59 (t, J = 6.1 Hz, 1H), 3.14-3.12 (m, 2H), 1.93 (t, J = 2.8 Hz, 1H) 
PhO2S SO2Ph
136
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2-methylidenehex-5-en-1-ol138 
   
To a flame-dried 3-neck 500 mL round bottom flask equipped with magnetic stir 
bar, addition funnel, and internal thermocoupled detector was added, distilled TMEDA (30 
mL, 200 mmol) and 2.5 M n-BuLi in hexanes (80 mL, 200 mmol). The flask was then 
cooled to -78 °C using an acetone/dry ice bath. A solution of ß-methylallyl alcohol (8.40 
mL, 100 mmol) in dry Et2O (150 mL) that was cooled to 0 °C, was then transferred to the 
addition funnel. The ß-methallyl alcohol solution was then added dropwise into the 
solution over a period of 1.5 hours while maintaining temperature of the round bottom 
flask below -70 °C. The dry ice/acetone bath was removed upon complete addition of the 
solution and the mixture was allowed to stir at room temperature for 24 hours. The round 
bottom flask was then cooled again to -78 °C using an acetone/dry ice bath, with dropwise 
addition of allyl bromide (6.50 mL, 75 mmol) via syringe. The mixture was stirred for 2 
hours at -78 °C and the ice bath was removed and the reaction was left to stir overnight 
at room temperature. The reaction mixture was quenched with saturated NH4Cl(aq) (25 
mL) and the mixture was transferred to a separatory funnel. The organics were separated 
and then the organics were extracted from the aqueous layer using Et2O (3 x 50 mL). The 
combined organics were washed with water (2 x 100 mL), saturated CuSO4(aq) (3 x 50 
mL), brine (50 mL), dried with MgSO4, filtered, and then concentrated to give a yellow oil, 
(7.64 g, 68%). The crude alcohol was used without further purification. 
1H-NMR (400 MHz, CDCl3)  δ 5.82 (ddt, J = 16.4, 10.1, 6.1 Hz, 1H), 5.06-4.95 (m, 3H), 
4.89 (q, J = 1.1 Hz, 1H), 4.08 (s, 2H), 2.26-2.20 (m, 2H), 2.18-2.15 (m, 2H), 1.51 (brs, 
1H) 
OH
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2-methylidenehex-5-ene-1-ethylcarbonate 
  
This compound was prepared according to a literature procedure with modification to 
the chloroformate used in the reaction138 
To a flame-dried 50 mL round bottom flask equipped with a magnetic stir bar was 
added, crude 2-methylidenehex-5-en-1-ol 137 (1.00 g, 8.92 mmol), dry DCM (10 mL), 4-
dimethylaminopyridine (5 mg, 0.0410 mmol), and distilled pyridine (3.61 mL, 44.6 mmol). 
The solution was cooled to 0 °C using an ice/H2O bath. Once cooled, ethyl chloroformate 
(4.26 mL, 44.6 mmol) was added and the reaction was stirred for 10 minutes at 0 °C and 
then stirred for 4 hours at room temperature. The reaction mixture was diluted with DCM 
(25 mL) and transferred to a separatory funnel. The organics were separated and then 
the organics were extracted from the aqueous layer using DCM (3 x 50 mL). The 
combined organics were washed with water (75 mL), saturated CuSO4(aq) (75 mL), brine 
(25 mL), dried with MgSO4, filtered, and then concentrated to afford a pale-yellow oil 
(crude 1.47 g, 90%). The crude compound was used in the subsequent reaction. 
1H-NMR (400 MHz, CDCl3)  δ 5.81 (ddt, J = 16.1, 10.2, 5.7 Hz, 1H), 5.09 (brs, 1H), 
5.06-5.02 (m, 1H), 4.98-4.96 (m, 2H), 4.57 (br, 2H), 4.21 (q, J = 7.2 Hz, 2H), 2.26-2.17 
(m, 4H), 1.31 (t, J = 7.1 Hz, 3H) 
O
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4,4-bis(phenylsulfonyl)hept-1-en-6-yne138 
   
To an oven-dried 50 mL Schlenk tube equipped with a magnetic stir bar was added 
1,1-bis(benzenesulfonyl)-3-butyne 136 (390 mg, 1.17 mmol), 2-methylidenehex-5-ene-1-
ethylcarbonate 138 (234 mg, 1.27 mmol), triphenylphosphine (47.4 mg, 4.46 mmol), and 
dry THF (1.5 mL). To the solution was added Pd2(dba)2·CHCl3 which was synthesized 
according to procedure.48 The Schlenk tube was then quickly evacuated and then purged 
and put under an argon(g) atmosphere. The Schlenk tube was immersed into a pre-heated 
55 °C oil bath and then stirred for 15 hours. Note: A foam was observed upon the yellow 
reaction mixture being heated. 
The Schlenk tube was removed from heat, concentrated in vacuo, and the resulting 
solid was subjected to flash column chromatography (1.0 x 9.5 cm silica) and eluted with 
20% Et2O:hexanes (400 mL) and 40% Et2O:hexanes (200 mL). The fractions were 
concentrated to afford a pale-yellow solid (438 mg, 85%).  
1H-NMR (400 MHz, CDCl3)  δ 8.06-8.04 (m, 4H), 7.70 (t, J = 7.5 Hz, 2H), 7.55 (t, J = 7.9 
Hz, 4H), 5.80 (ddt, J = 16.8, 10.2, 6.4 Hz, 1H), 5.27 (s, 1H), 5.11 (s, 1H), 5.01 (dd, J = 
17.1, 1.6 Hz, 1H), 4.97-4.93 (m, 1H), 3.39 (d, J = 2.7 Hz, 2H), 3.12 (s, 2H), 2.34 (t, J = 
6.8 Hz, 2H), 2.22 (t, J = 7.2 Hz, 2H), 2.00 (t, J = 2.8 Hz, 1H)  
MP: 116-118 °C 
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2-allyl-malonic acid dimethyl ester139 
 
To a flame-dried 250 mL round bottom flask equipped with magnetic stir bar was 
added dimethyl malonate (3.43 mL, 30.0 mmol), allyl bromide (2.60 mL, 30.0 mmol), 
potassium carbonate, (12.44 g, 90.0 mmol), and reagent grade acetone (100 mL). The 
reaction flask was then stirred for 24 hours at room temperature. The reaction mixture 
was quenched with saturated NH4Cl(aq) (75 mL) and transferred to a separatory funnel. 
The organics were extracted from the aqueous layer with EtOAc (2 x 100 mL). The 
combined organics were washed with brine (50 mL), dried with MgSO4, filtered and 
concentrated to give a light-yellow oil. The resulting oil was subjected to flash column 
chromatography (4.0 x 8.0 cm silica) and eluted with 15% EtOAc:hexanes (750 mL). The 
fractions were concentrated to afford a clear oil (3.00 g, 58%). 
1H-NMR (400 MHz, CDCl3)  δ 5.76 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H), 5.12 (dp, J = 17.0, 
1.5 Hz, 1H), 5.07-5.05 (m, 1H), 3.73 (d, J = 1.7 Hz, 6H),  3.46 (td, J = 7.6, 1.4  Hz, 1H), 
2.67-2.63 (m, 2H)  
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2-allyl-2-(prop-2-ynyl)-malonic acid dimethyl ester139 
 
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added, 2-allyl-malonic acid dimethyl ester 139 (1.48 g, 8.60 mmol) and dry THF (28 mL). 
The solution was stirred and cooled to 0 °C using an ice/H2O bath. Once cooled, NaH 
(378 mg, 9.45 mmol) was added in two portions. Evolution of gas was observed upon 
addition of NaH and the mixture was stirred at 0 °C for 30 minutes. Propargyl bromide 
(0.712 mL, 9.45 mmol) was added directly to the mixture dropwise via syringe. Once 
added, the ice bath was removed and the reaction was stirred for 5 hours. The reaction 
mixture was quenched with saturated NH4Cl(aq) (50 mL) and transferred to a separatory 
funnel. The organics were extracted from the aqueous layer with EtOAc (3 x 75 mL). The 
combined organics were washed with brine (25 mL), dried with MgSO4, filtered and 
concentrated to give an oil. The resulting oil was subjected to flash column 
chromatography (1.0 x 9.0 cm silica) and eluted with 2% Et2O:hexanes (500 mL), 10% 
Et2O:hexanes (500 mL). The fractions were concentrated to afford a clear oil (1.43 g, 
79%). 
1H-NMR (400 MHz, CDCl3)  δ 5.62 (ddt, J = 17.4, 10.1, 7.5 Hz, 1H), 5.18 (dq, J =18.3, 
1.3 Hz, 1H), 5.14-5.11 (m, 1H), 3.74 (s, 6H), 2.82 (br, 1H), 2.82-2.79 (m, 4H), 2.02 (t, J = 
2.7 Hz, 1H). 
13C-NMR (100 MHz, CDCl3) δ 170.3, 131.8, 120.2, 78.9, 71.7, 57.1, 53.0, 36.7, 22.9 
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N-allyl-N-([3-2H2]-2-propyne-4-methylbenzenesulfonamide 
 
Compound 112 was synthesized using the method of Bew et al.140 
To a flame-dried 100 mL round bottom flask equipped with a magnetic stir bar was 
added; N-allyl-N-propargyl-4-methylbenzenesulfonamide 90 (499 mg, 2.00 mmol), 
potassium carbonate (415 mg, 3.00 mmol), and dry acetonitrile (7.20 mL). The reagents 
were allowed to stir together at room temperature for thirty minutes. Deuterium oxide 
(1.80 mL, 100 mmol) was added to the reaction mixture and left to stir for 2 hours. The 
reaction was diluted with methylene chloride (10 mL), transferred to a separatory funnel, 
and the organics were separated and the aqueous layer was extracted with 
dichloromethane (2 x 15 mL). The combined organics were dried over MgSO4, filtered 
and concentrated to afford an off-white solid (0.457 g, 91%, >96% Deuterium-
incorporation).  
1H-NMR (400 MHz, CDCl3)  δ 7.73 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.72 (ddt, 
J = 16.6, 10.0, 6.5 Hz, 1H), 5.25 (dd, J = 22.8, 17.2 Hz, 2H), 4.09 (s, 2H), 3.82 (d, J = 
6.4Hz, 2H), 2.42 (s, 3H) 
13C-NMR (100 MHz, CDCl3) δ 143.8, 136.2, 132.1, 129.7, 128.0, 120.2, 76.3 (t, J = 7.4 
Hz), 73.6 (t, J = 38.2 Hz), 49.2, 35.9, 21.7   
FT-IR: (KBr pellet) ν = 3269, 3086, 2922, 2859, 2577, 1974, 1599, 1341, 1326, 1162, 
1122, 1091, 1064, 930, 890, 754, 665 cm-1 
Anal: Calculated: C13H14DNO2S – C: 62.37  H: 6.44  N: 5.60;  Found  C: 62.51 H: 6.46  
N: 5.58 
N
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RF: 0.41 (20% EtOAc:hexanes) 
MP: 55-57°C 
 
 
 
 
Diallyl-dimethyl malonate141 
  
To a flame-dried 50 mL round bottom flask equipped with magnetic stir bar was 
added THF (10 mL) and NaH (600 mg, 15.0 mmol). The suspension was then cooled to 
0 °C using an ice/H2O bath and stirred for 20 minutes. Dimethyl malonate (0.570 mL, 5 
mmol) was then added and the mixture was stirred for an additional 30 minutes. Allyl 
bromide (1.30 mL, 15.0 mmol) was added dropwise via syringe at 0 °C. The round bottom 
flask was removed from the ice bath and left to stir at room temperature for 3 hours. 
The reaction mixture was quenched with saturated NH4Cl(aq) (25 mL) and 
transferred to a separatory funnel. The organics were separated and then the organics 
were extracted from the aqueous layer with EtOAc (3 x 25 mL). The combined organics 
were washed with brine (25 mL), dried with MgSO4, filtered and concentrated to afford a 
pale-yellow oil. (1.07 g, 100% yield). 
1H NMR (400 MHz, CDCl3) δ 5.69-5.59 (m, 2H), 5.13-5.11 (m, 2H), 5.09-5.08 (m, 2H), 
3.71 (s, 6H), 2.64 (dt, J = 7.4, 1.2 Hz, 4H). 
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General Method for 1,3-Diene Synthesis 
To an oven-dried 50 mL Schlenk tube with magnetic stir bar was added in an argon(g)-
filled glovebox, RuH2Cl2(P(t-Bu)2Me)2 (4.9 mg, 0.010 mmol; 5 mol %), 2 mL of 
dichloromethane, and enyne (0.20 mmol) dissolved in 2 mL of dichloromethane (4 mL). 
The sealed tube was then removed from the glovebox and placed under a positive stream 
of argon(g) and the solution stirred for 24 hours. The reaction mixture was then filtered 
through a pipette plugged with ca. 3.0 cm of celite, and the Schlenk tube was rinsed with 
either Et2O (tetrahydropyran and dihydrofuran substrates) or EtOAc (2 x 2 mL) and 
washed through the celite plug. The solution was concentrated down and the resulting 
yield was determined by 1H NMR based on the terminal diene signal as compared to the 
internal mesitylene standard. The solutions were then purified by flash column 
chromatography with silica gel using the listed solvent systems. 
 
2-methyl-2-phenyl-4-vinyl-3,6-dihydro-2H-pyran. Purified by silica gel chromatography 
(1% Et2O/hexanes); Clear oil (28.7 mg, 72%); Rf: 0.58 (10% Et2O/hexanes); FT-IR: 
(NaCl, thin film) ν = 3087, 3026, 2974, 2926, 2828, 1652, 1607, 1445, 1275, 1120, 899, 
765, 700 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.40-7.27 (m, 4H), 7.25-7.23 (m, 1H), 6.40 
(dd, J = 10.8, 6.8 Hz, 1H), 5.60 (d, J = 2.3 Hz, 1H), 5.28 (d, J = 17.2 Hz, 1H), 5.05 (d, J = 
10.8 Hz, 1H), 4.25 (d, J = 17.6 Hz, 1H), 3.98 (dd, J = 15.7, 2.5 Hz, 1H), 2.85 (d, J = 16.9 
Hz, 1H), 2.42 (dq, J = 16.8, 2.3 Hz, 1H), 1.54 (s, 3H);13C NMR (100 MHz, CDCl3) δ 144.9, 
138.4, 132.9, 128.4, 127.2, 126.5, 125.8, 111.1, 74.3, 62.2, 32.9, 30.2; Anal. Calcd for 
C14H16O2: C, 83.96; H, 8.05. Found: C, 84.05; H, 8.03. 
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2-phenyl-5-vinyl-3,6-dihydro-2H-pyran.142 Oil (21.3 mg, 58%); 1H NMR (400 MHz, 
CDCl3) δ 7.42-7.35 (m, 4H), 7.29 (tt, J = 14.0, 6.1, 1.7 Hz, 1H), 6.33 (dd, J = 17.9, 11.1 
Hz, 1H), 5.94 (bs, 1H), 5.02 (s, 1H), 4.98 (d, J = 6.6 Hz, 1H), 4.61 (d, J = 15.5 Hz, 1H), 
4.55 (dd, J = 9.9, 3.9 Hz, 1H), 4.49 (dq, J = 15.5, 2.9 Hz, 1H), 2.52-2.36 (m, 2H). 
 
2-methyl-2-phenyl-3-vinyl-dihydrofuran.143 Purified by silica gel chromatography (2-
5% Et2O/hexanes); Clear oil (26.7 mg, 72%); 1H NMR (400 MHz, CDCl3) δ 7.37-7.34 (m, 
2H), 7.27-7.23 (m, 2H) 7.17 (tt, J = 14.6, 6.4, 1.3 Hz, 1H), 6.14 (ddd, J = 17.8, 11.2, 0.8 
Hz, 1H), 5.91 (s, 1H), 5.00 (d, J = 17.9 Hz, 1H), 4.95 (d, J = 11.2 Hz, 1H), 4.69 (s, 2H), 
1.72 (s, 3H). 
 
2-methyl-2-phenyl-3-vinyl-dihydrofuran).142 Oil (42% 1H NMR yield); 1H NMR (400 
MHz, CDCl3) δ 7.39-7.27 (m, 5H), 6.57 (dd, J = 17.6, 10.8 Hz, 1H), 5.95 (m, 1H), 5.33 (dt, 
J = 17.3, 1.5 Hz, 1H), 5.26 (dt, J =10.3, 1.1 Hz, 1H), 5.03 (d, J = 6.7 Hz, 1H), 4.15 (qd, J 
= 15.8, 2.4 Hz, 2H). 
 
1-(allyloxy)-1-ethynylcyclohexane.143 Oil (40% 1H NMR yield); 1H NMR (400 MHz, 
CDCl3) δ 6.18 (dd, J = 17.8, 11.2 Hz, 1H), 5.83 (s, 1H), 5.46 (d, J = 17.8 Hz, 1 H), 5.13 
(d, J = 11.2 Hz, 1H), 4.59 (s, 2H), 1.73-1.64 (m, 10 H). 
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2,2-dimethyl-5-vinyl-6-phenyl-3,6-dihydro-2H-[1,2]-oxasiline. Oil (11% 1H NMR 
yield); diene signals apparent. 1H NMR (300 MHz, CDCl3) δ 6.34 (dd, J = 17.8, 11.2 Hz, 
1H), 6.24 (dd, J = 8.0, 3.9 Hz, 1H) 
 
10-methoxy-[5-(tert-butyldimethylsiloxy)]-5-vinyl-2,5-dihydrobenzoxepin. Oil (31% 
1H NMR yield); 1H NMR (400 MHz, CDCl3) δ 7.16 (dd, J = 8.0, 1.2 Hz, 1H), 6.88 (t, J = 
7.9 Hz, 1H), 6.81-6.78 (m, 1H), 6.36 (dd, J = 17.4, 10.8 Hz, 1H), 5.62 (s, 1H), 5.50 (t, J = 
4.3 Hz, 1 H), 5.26 (d, J = 17.5 Hz, 1H), 4.96 (d, J = 11.0 Hz, 1H), 4.88 (dd, J = 16.3, 4.3 
Hz, 1H), 4.60 (dd, J = 16.3, 3.9 Hz, 1H), 3.76 (s, 3H), 0.79 (s, 9H), -0.01 (s, 3H), -0.12 (s, 
3H) 
 
2,5-dihydro-1-(p-toluenesulfonyl)-3-vinyl-1H-pyrrole.143 Purified by silica gel 
chromatography (eluted with 10% EtOAc/ hexanes); off-white solid (30.7 mg, 77%); 1H 
NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.3 Hz, 2H), 7.31 (dd, J =17.7, 10.8 Hz, 2H), 5.58 
(brs, 1H), 5.14 (d, J = 10.8 Hz, 1H), 5.00 (d, J = 17.6 Hz, 1H) 4.20-4.15 (m, 4H), 2.41 (s, 
3H), 2.00 (t, J = 2.5 Hz, 1H). 
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N-p-toluenesulfonyl-3-vinyl-1,2,5,6-tetrahydropyridine.142 Purified by silica gel 
chromatography (7% EtOAc/hexanes); Clear oil (29.7 mg, 56%); 1H NMR (400 MHz, 
CDCl3) δ 7.69 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.24 (dd, J = 17.8 11.0, Hz, 
1H), 5.75 (bs, 1H), 5.01 (d, J = 17.8 Hz, 1H), 4.96 (d, J = 11.0 Hz, 1H), 3.72 (d, J = 2.0 
Hz, 2H), 3.17 (t, J = 5.8 Hz, 2H), 2.42 (s, 3H), 2.31-2.26 (m, 2H). 
 
1-[(4-methylphenyl)sulfonyl]-3-[2-phenylvinyl]-2,5-dihydro-1H-pyrrole.144 Solid 
(80% 1H NMR yield); 1H NMR (400 MHz, CDCl3) (E)-isomer δ 7.76 (d, J = 8.2 Hz, 2H), 
7.37-7.22 (m, 7H), 6.76 (d, J = 16.8 Hz, 1H), 6.32 (d, J = 16.3 Hz, 1H), 5.68 (s, 1H), 4.33 
(br, 2H), 4.22 (br, 2H), 2.40 (s, 3H); (Z)-isomer δ 7.76 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 
Hz, 2H), 7.37-7.22 (m, 4H), 7.10-7.08 (m, 1H), 6.56 (d, J = 11.7 Hz, 1H), 6.10 (d, J = 12.0 
Hz, 1H), 5.60 (s, 1H), 4.06 (br, 2H), 3.74 (br, 2H), 2.43 (s, 3H) 
 
1-(4'-methylphenylsulphonyl)-1-aza-3-methylidine bicyclo[4.3.0]nona-5-ene.102  
purified by silica gel chromatography (15% EtOAC:hexanes); off-white solid (4.3 mg, 7% 
isolated yield) data in agreement with reported literature; 1H NMR (400 MHz, CDCl3) δ 
7.73 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.81-5.77 (m, 1H), 5.66-5.61 (m, 1H), 
4.85 (q, J = 1.9 Hz, 1H), 4.84 (q, J = 2.3, 1H), 3.97 (tq, J =  27.0, 14.1, 1.7 Hz, 2H), 
3.91-3.86 (m, 1H), 2.74 (brs, 1H), 2.42 (s, 3H), 2.16-1.99 (m, 2H), 1.94 (dq, J = 12.8, 4.2 
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Hz, 1H), 1.63-1.53 (m, 1H);  13C-NMR (100 MHz, CDCl3) δ 147.5, 143.6, 135.5, 130.0, 
128.9, 127.6, 124.1, 108.1, 59.1, 51.8, 43.0, 26.7, 23.7, 21.7 
 
1,1-bis(phenylsulfonyl)-3-(vinyl)-3-cyclopentene.47 (38% 1H NMR yield); 1H NMR (400 
MHz, CDCl3) δ 8.06-7.98 (m, 4H), 7.72-7.65 (m, 2H), 7.59-7.52 (m, 4H), 6.14 (dd, J = 
17.4, 10.7 Hz, 1H), 5.20 (s, 1H), 5.03 (dd, J = 15.7, 10.8 Hz, 2H), 3.45 (s, 2H), 3.39 (s, 
2H)  
 
[3,3-bis(phenylsulfonyl)]-tricyclo[4.3.1.0]-dec-2-ene.103 (20% 1H NMR yield); 1H NMR 
(400 MHz, CDCl3) δ 8.02-7.94 (m, 4H), 7.66-7.60 (m, 2H), 7.58-7.48 (m, 4H), 5.86 (dd, J 
= 9.9, 2.7 Hz, 1H), 5.25 (ddd, J = 9.4, 7.1, 2.1 Hz, 1 H), 2.97 (d, J = 16.1 Hz, 1H), 2.83 (t, 
J = 16.6 Hz, 2H), 2.69 (d, J = 16.1 Hz, 1H), 1.83-1.76 (m, 2H), 1.59-1.51 (m, 1H), 1.10-
1.02 (m, 1H), 0.98 (d, J = 4.8 Hz, 1H), 0.94 (d, J = 4.8 Hz, 1H), 
 
2-allyl-2-(prop-2-ynyl)-malonic acid dimethyl ester.145 Oil (62% 1H NMR yield); 1H 
NMR (400 MHz, CDCl3) δ 5.62 (ddt, J = 17.5, 10.0, 7.5 Hz, 1H), 5.19 (dq, J =17.0, 1.3 
Hz, 1H), 5.13 (dq, J = 10.0, 0.9 Hz, 1H), 3.74 (s, 6H), 2.82-2.80 (m, 4H), 2.02 (t, J = 2.7 
Hz, 1H). 
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3-[(1-2H)ethenyl]-1-(4-methylbenzenesulfonyl)-2,5-dihydro-1H-pyrrole. Purified by 
silica gel chromatography (5-10% EtOAc/ hexanes); off-white solid (26.0 mg, 52%); 1H 
NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 5.58 (s, 1H), 
5.15 (s, 1H), 5.00 (bs, 1H), 4.21-4.17 (m, 4H), 2.42 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 143.7, 137.7, 134.3, 130.0, 127.6, 123.5, 116.8, 55.3, 53.6, 21.7. 
 
Dimethyl-3-cyclopentene-1,1-dicarboxylate.146 oil (28 mg, 77%); 1H NMR (400 MHz, 
CDCl3) δ 5.60 (br, 2H), 3.73 (s, 6H), 3.02 (brs, 4H).  
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Chapter 2 Design of a Self-Assembling Peptide Catalyst for 
Asymmetric Transfer Hydrogenation 
 
 
 
 
Work from this chapter has led to the following manuscript: 
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Korendovych, I. V., Catalytic Nanoassemblies Formed by Short Peptides Promote Highly 
Enantioselective Transfer Hydrogenation., Submitted 
 
 
 
Abstract.  
 
Bioinspired catalysts promote a wide range of different chemical reactions with impressive 
efficiencies. Nonetheless, designing bioinspired metallopeptides to catalyze chemical 
reactions with high enantioselectivities still remains a challenge. Self-assembly enables 
formation of incredibly diverse supramolecular structures with practically important 
functions from simple and inexpensive building blocks. Here we show how a semi-
rational, bottom-up approach to create emerging properties can be extended to a design 
of highly enantioselective peptide catalysts. The designed peptides comprised of as few 
as two amino acid residues spontaneously self-assemble in the presence of metal ions 
to form supramolecular, vesicle-like nanoassemblies that promote the transfer 
hydrogenation of ketones in aqueous phase with excellent conversion rates and 
enantioselectivites (90+ % ee) 
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2.1. Introduction 
 
2.1.1. Overview of self-assembling catalytic peptides 
 
Both peptides and proteins are biologically relevant molecules that serve to 
catalyze reactions at an accelerated rate in complex organisms to sustain homeostasis 
of life. These biological molecules often utilize metal ions as co-factors to assist with 
enzymatic function. Enzymes are unique and complex molecules, with their structural 
composition usually determined by its amino acid sequence which can be composed of 
by any twenty natural encoding chiral L-amino acids. This complexity is further 
compounded when enzymes also arrange and fold themselves into different stable 
secondary structures (e.g. alpha-helix and ß-sheet) and often form well-defined three-
dimensional structures. One could imagine then that for complex enzymes to exist as they 
do today, proteins must have evolved over time from simpler molecules. Discussions on 
the origins of life usually describe a ‘‘primordial soup’’ of many key ingredients, including 
amino acids, which can be produced from inorganic compounds.1-2 These basic building 
blocks have been hypothesized to condense into larger peptides3-6 potentially proceeding 
via an ‘‘amyloid world’’ theory.7-9 The amyloid world theory suggests the possibility of 
various chemical reactions facilitated by short self-assembled peptides. While many gaps 
and fundamental questions certainly remain in our understanding of prebiotic chemistry 
and the origins of life, it remains entirely plausible that the assembly of small building 
blocks into larger more complex structures has played a significant role in the 
development on early Earth. 
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Scheme 2.1. Various chemical transformation known to be catalyzed by self-assembled peptide 
catalysts. Reproduced from ref 10 with permission from The Royal Society of Chemistry, 
copyright 2018. 
Peptides can already catalyze quite a variety of chemical transformations10 such 
as aldol,11-13 Michael addition,14 Mannich reaction,15-16 and ester hydrolysis17-19 (Scheme 
2.1). It is quite often found that a subsequent improvement in the peptide design by 
amino acid substitutions can yield more efficient enzymes.20-21 While the permissive 
opportunities of peptide chemistry are vast, most modern-day chemical transformations 
objectively are done with small molecular catalysts and metal complexes that have been 
heavily refined and carefully considered. Consequently, the bigger issues faced today 
with peptide chemistry are: one, the limitations of possible chemical transformations that 
are either interesting or impactful to field of science; two, making peptides outperform 
most of the already developed small molecular catalysts; and three, identifying a good 
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approach or design to produce effective enzymes. To some, self-assembly may be a 
possible solution to address the disparity between peptides and highly optimized 
unnatural small molecules. Therefore, self-assembly of short peptides sequences may 
provide new functionality to small molecules to create heterogeneous and reusable 
catalysts with no resulting loss of activity. 
Peptides are particularly well suited to form diverse and functional supramolecular 
structures as they provide easy access to various modes of hydrogen bonding, 
electrostatic, and stacking interactions (e.g. π–π stacking). As a result, peptides can form 
various supramolecular structures such as coil-coiled bundles,22-25 amphiphilic amyloid 
peptides,26-28 hydrogels29-31 as well as other motifs32-34 in a controlled manner. Moreover, 
they can bind transition metal co-factors providing additional opportunities for promoting 
chemical reactions and in some cases self-assembly.35-37 Despite the appeal of creating 
catalysts through self-assembly, the nature of small molecular modifications of peptides 
can often be detrimental to their rapid development. The issue lies in establishing any 
true meaningful structure–activity relationships as it can be difficult to rationally predict 
which modifications will work and how a self-assembled peptide will behave in the 
absence of accurate modeling tools or standard predictive methods.38 Furthermore, the 
incredible diversity of possible tertiary and quaternary structures can be difficult to 
characterize using traditional ‘‘small molecule’’ instrumentation. Thus currently, the 
interface of the fields of catalysis, self-assembly and peptides appears to be quite limited 
(Figure. 2.1).39 
. 
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Figure 2.1. Representative overview of catalytic peptide self-assemblies in the literature. 
Number of references produced in response to keyword queries of ‘‘peptides’’, ‘‘self-assembly’’, 
and ‘‘catalysis’’ as well as their overlaps returned by SciFinder on March 5th, 2018. Reproduced 
from ref 10 with permission from The Royal Society of Chemistry, copyright 2018. 
2.1.2. Literature examples of self-assembling peptide catalysts 
 
One research group which has reported extensively in the area of self-assembling 
peptide catalysis is that of Beatriu Escuder. Escuder’s group is interested in the 
development of functional organogelators, namely, molecules that contain either binding, 
catalytic or reactive groups with the ability to form supramolecular gels. In one of their 
earliest reports,40-41 Escuder and co-workers prepared two low-molecular weight gelators 
containing terminal pyridine groups (Scheme 2.2). Interestingly, the ability of both peptide 
1 and 2 to form a hydrogel in organic solvents was particularly good in dichloromethane, 
acetone, dimethyl ether, dioxane, acetonitrile, ethyl acetate, and toluene. By adding a 
solution of palladium (II) acetate to the formed hydrogel in toluene, palladium 
incorporation into the hydrogel network was observed by TEM. Using the gel 
functionalized with Pd(II), a simple oxidation reaction of benzyl alcohol to benzaldehyde 
was performed with a maximum yield of 50% obtained after 48 hours. 
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Scheme 2.2. Escuder and co-workers palladium catalyzed oxidation with pyridine peptides. Cryo-
SEM image of peptide 2 hydrogel with proposed assembly of palladium complex performing 
aerobic oxidation. Reproduced from ref 40 with permission from The Royal Society of Chemistry, 
copyright 2005. 
Another relevant paper from Escuder and co-workers was their study on the L-
proline-based supramolecular hydrogel and the effect of hydrophobicity on the catalytic 
aldol reaction.42 To explore and monitor the hydrophobicity effect, the heterogeneous 
organocatalyst 3 was used in the direct aldol reaction between 4-nitrobenzaldehyde and 
linear alkyl ketones of varying alkyl chain lengths (Scheme 2.3). Hydrogels were prepared 
at a minimum gel concentration of 2 mM in water and stabilized for 24 hours prior to the 
addition of the reagents. Their results showed a correlation between longer alkyl chain 
length and improved yields in the reaction with little variable change in the measured 
enantiomeric excess (ee). Therefore, the steric demands of the reaction site were similar 
for each substrate and this furthermore supports the hydrophobic effect as the main 
driving force for both self-assembly of the catalyst and the approach of the substrates to 
the catalytic center. Despite the fact that the aldol reaction is widely studied, the authors 
reported the main advantage of this hydrogel is that it can be easily recycled and 
recovered as a solid-like heterogeneous phase.43 Moreover, due to the dynamic 
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reversible nature of the reported catalyst, it can be disassembled in response to slight 
environmental changes like temperature or pH, allowing on–off switching of catalytic 
activity. 
 
Scheme 2.3. (Top) Escuder and co-workers direct aldol with proline-valine dipeptide with c-
terminal alkyl tail. (Bottom) Proposed model for hydrogel assembly and reactive site. Reproduced 
from ref 42 with permission from The Royal Society of Chemistry, copyright 2013. 
The work of Parquette and co-workers also found utility in a proline-lysine 
dipeptide attached with a 1,4,5,8-naphthalene-tetracarboxylic acid diimide (NDI) 
chromophore (Scheme 2.4).44 The side-chain of the lysine residue was synthetically 
modified and resulted in the molecule able to assemble into a catalytic nanotube with a 
bilayer assembly. The catalytic proline residues were found positioned along both the 
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inner and outer surface of the assembly. The nanotubes, which were found to be water 
soluble, show moderate to good yields, good diastereoselectivity, and good 
enantioselectivity in the aldol reaction of cyclohexanone with various nitroaldehydes. 
Importantly, these catalytic assemblies are reusable following a cycle of 
ultracentrifugation–resuspension, with subsequent reactions of recycled catalysts 
experiencing only a marginal drop in yield, diastereoselectivity, and enantioselectivity. 
 
Scheme 2.4. Parquette and co-workers catalytic nanotubes for aldol reaction along with TEM 
image of assemblies formed in reaction mixture of 4-nitrobenzaldehyde with cyclohexanone in 
water (500 µM). Reproduced from ref 44 with permission from The Royal Society of Chemistry, 
copyright 2015. 
Our research group has previously demonstrated that short heptameric peptides 
can self-assemble in the presence of zinc ions to form a robust heterogenous amyloid ß 
structure (Scheme 2.5).45 The self-assembly of the lead peptide from that work (Ac-
IHIHIQI-CONH2)  had an improved catalytic efficiency of p-nitrophenyl acetate hydrolysis 
as comparable to other well-established de novo enzymes.45-46 As an extension to that 
impactful work, other chemical transformations were pursued utilizing this fibril system 
(Scheme 2.5).46-47 One such example that we published on, is the catalytic redox C-C 
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coupling of 2,6-dimethoxyphenol (DMP) in the presence of copper ions and oxygen to 
produce a dimer.47 The scintillating reception of these short catalytic peptide fibrils called 
into question what other opportunities may exist within the realm of self-assembled 
peptides. 
 
Scheme 2.5. Self-assembled fibrils can perform catalytic reactions. 
We hypothesized that peptides capable of productive binding of transition metal 
ions upon self-assembly can adopt ordered chiral structures, which in turn will promote 
highly enantioselective catalysis. In a test case of the approach we focused on transition 
metal-assisted enantioselective reduction of ketones.  
2.1.3. Asymmetric hydrogenation background 
Asymmetric or enantioselective hydrogenation is an essential key step in the 
synthesis of many optically active and enantiopure compounds. Hydrogenation is one of 
the most fundamental transformations in organic synthesis and this simple reaction is still 
of great significance in academia and pharmaceutical industries alike. In fact, some small 
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molecule drugs approved by the FDA in recent years are reported to use asymmetric 
hydrogenation in large-scale manufacturing of the drugs (Figure 2.2).48-51 
 
Figure 2.2. Examples of commercial drugs with asymmetric hydrogenation included in its 
manufactured synthesis. Bonds shown in red are the stereocenters generated by 
enantioselective hydrogenation. 
Hydrogenation can be performed through direct hydrogenation with H2 gas or by 
transfer hydrogenation, a process involving the transfer of a hydrogen atom to a molecule 
from a non-H2 hydrogen source. In a series of pioneering studies, Ikariya and Noyori have 
shown that complexes of Ru, Rh and Ir with ligands based on the monotosyl-
ethylenediamine motif (TsDPEN) promote transfer hydrogenation, a process that utilizes 
formic acid or sodium formate as hydrogen sources without the inconvenience and hazard 
of using hydrogen gas at high pressure.52 This reaction is of high practical significance, 
thus it has been extensively studied providing mechanistic knowledge and benchmarks.53-
54 Currently, the use of water as a reaction solvent in transition metal-catalyzed transfer 
hydrogen is highly desirable as water is a low-cost and environmentally green solvent. 
The major disadvantages of water as a reaction solvent is due to a several reasons. 
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Namely there are few water-soluble hydrogen sources, few water-soluble ligands, a 
limited number of developed water-soluble catalysts, and reactions tend to be bi-phasic 
due to poor water solubility of most organic compounds.55  
Notably, iridium complexes catalyze this reaction under aerobic and near-ambient 
conditions in water.56 Hilvert and co-workers found that the simple H2N-Gly-Gly-Phe-
CO2H (GGF) tripeptide was particularly adept in the reduction of various ketones, imines 
and aldehydes. A turnover frequency (TOF) of 200 h-1 with GGF and iridium was reported 
for the reduction of model substrate acetophenone, whereas ruthenium and rhodium had 
marginal activity of 2 h-1 and 1 h-1 respectively.  
2.2. Results and Discussion 
 
2.2.1. Design and Application of a Self-Assembling Peptide Catalyst 
 
Fundamentally, the coordination environment of tosyl-ethylenediamine is chemically 
similar to that of the N-terminus of polypeptides: two donor nitrogen atoms, one in an 
amino group and the other, separated by a short linker, in the sulfonamide moiety (shown 
in blue in Scheme 2.6). The chirality of the ligand provided by substituents in the short 
linker determines the enantiomeric selectivity. Moreover, the stability of the iridium 
complexes with the tosyl-ethylenediamine ligand makes them ideal test cases for studies 
of emergence of enantioselectivity through self-assembly in peptide assemblies. 
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Scheme 2.6. Design of self-assembling peptide catalysts. A) Representation of iridium TsDPEN-
based catalyst and corresponding step-wise design process to create self-assembling peptides, 
the ethylenediamine core is shown in blue; B) Assembly of peptide catalyst leads to micelle and 
vesicle-type structures. 
The first question we set out to explore was whether the coordination of iridium 
can be functionally replicated in a short peptide. It takes at least two peptide residues to 
provide the minimum necessary coordination environment for the metal ion as well as for 
arranging side chains in a pseudo-C2 symmetrical fashion (Scheme 2.6). Given that 
proline has been extensively used in enantioselective catalysis,57 we prepared a library 
of twenty HN-Pro-X-CONH2 dipeptides, where X represents all genetically encoded 
amino acids. Next, we investigated the ability of the dipeptides to bind the Ir-Cp* moiety 
and to promote reduction of acetophenone by sodium formate. The results of screening 
the dipeptides as ligands in Ir-promoted transfer hydrogenation are shown in Figure 2.3. 
Excitingly, nearly all dipeptide ligands promoted some degree of enantioselective 
reduction of ketones. Dipeptides containing His, Cys, Met (residues that are likely to form 
a strong bond with the transition metal ion) showed low yield and enantioselectivity. On 
the other hand, Ala, Thr, Leu and Trp -containing dipeptides show moderate ee values in 
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agreement with previous work on protein- and peptide-like small molecule-assisted 
transfer hydrogenation.57-59 HN-Pro-Leu-CONH2 showed the best combination of yield 
and selectivity, with ee values as high as 50% in Ir-promoted transfer hydrogenation of 
acetophenone.  
 
 
Figure 2.3. Performance of peptide catalysts in transfer hydrogenation. Yield (%, red) and 
enantiomeric excess (%, blue) of dipeptides of the general formula HN-Pro-X-CONH2 (where X 
includes all 20 genetically encoded amino acids) in transfer hydrogenation of acetophenone (5 
mol % of catalyst). A 3.125 M solution of sodium formate was used (5 equivalents of formate 
relative to substrate). 
While the initial screen focused on the naturally occurring L-amino acids to 
establish the best combination of the substituents, in order to exert maximum 
enantioselectivity the substituents that determine chirality (R and R’, Scheme 2.6) need 
to be on the opposite sides of the plane defined by the iridium and the two nitrogen donor 
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atoms in a pseudo-C2 fashion. Peptides with mixed stereochemistry i.e. HN-Pro-DLeu-
CONH2 or its enantiomer HN-DPro-Leu-CONH2 show significant improvement in 
enantioselectivity, reaching 80% ee in reduction of acetophenone (Figure 2.3, Figure 2.4). 
 
 
Figure 2.4. Performance of peptide catalysts in transfer hydrogenation. a) Enantiomeric excess 
shown by peptides of the general formula HN-DPro-Leu-CONH-Cn, with aliphatic tails of various 
lengths (n), in transfer hydrogenation of representative ketones (2.5 mol % of catalyst). b) 
Acetophenone conversion rates in transfer hydrogenation catalyzed by Cp*Ir(DPL-C16) (red) and 
Cp*Ir(TsDPEN) (blue) under identical experimental conditions (2.5 mol % of catalyst). A 3.125 M 
solution of sodium formate was used (5 equivalents of formate relative to substrate). 
Encouraged by the remarkable ability of simple dipeptides to promote asymmetric 
hydrogenation we explored the degree to which stereoselectivity of HN-DPro-Leu-CONH2 
can be further improved by assembling it into supramolecular structures. Several 
examples of fusing hydrophobic moieties to short peptides that lead to self-assembly into 
functional nanosized materials have been already reported.60-63 Therefore, we 
investigated the effect of attaching saturated hydrocarbon chains to the C-terminus of the 
dipeptides to preserve the optimized metal-binding properties of the ligand while 
simultaneously inducing self-assembly to further create a chiral nano-assembly. 
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Introduction of C-terminal hydrocarbon tails into HN-Pro-Leu-CONH2 leads to 
further 3-fold improvement (from 9:1 to 27:1 ratio of the S to R enantiomers) of 
enantioselectivity in transfer hydrogenation for all substrates. The ligands containing 
chains of 10 or more carbons show particularly good results, with maximum selectivity 
observed for palmitoyl (C16) chains (Figure 2.4a). The resulting Cp*Ir(HN-DPro-Leu-
CONH-C16) complex is stable under the reaction conditions and shows turnover number 
of at least 3,500. Comparing performance of self-assembled catalysts to that of 
Cp*Ir(TsDPEN), the most commonly used complex for iridium-catalyzed transfer 
hydrogenation, provides independent benchmarks. Remarkably, HN-DPro-Leu-CONH-
C16 (referred to as DPL-C16) shows higher enantioselectivity and similar reaction rates in 
reduction of acetophenone (93 % ee) than Cp*Ir(TsDPEN), under identical experimental 
conditions (Figure 2.4b, Table 2.1). We have explored the substrate scope of DPL-C16 for 
various substrates and found excellent enantioselectivity in all cases with exception to the 
challenging 2-heptanone alkyl ketone (Table 2.1). DPL-C16 performed particularly well in 
reducing difficult heteroaromatic and ortho-substituted substrates. The broad substrate 
scope of the self-assembled peptide catalysts can be very useful for synthetic schemes 
that require late stage diversification. 
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Table 2.1. Transfer hydrogenation of ketones catalyzed by Cp*Ir(DPL-C16) and Cp*Ir(TsDPEN)  
 
 
Yields (as determined by NMR) and enantiomeric excesses (as determined by HPLC or GC) in transfer 
hydrogenation of ketones were catalyzed Cp*Ir(DPL-C16) and Cp*Ir(TsDPEN) at 2.5 mol % of catalyst. A 
3.125 M solution of sodium formate was used (5 equivalents of formate relative to substrate). aReduction 
of ketone was done for 24 hours. bEnantiomeric configuration of the alcohol was determined to be (R). 
 
1) MD-3-123, MD-5-059, PB-3-122, PB-4-120; 2) MD-3-131, MD-5-060, PB-4-049, PB-4-120; 3) MD-3-130, MD-5-063, PB-3-119, 
PB-4-120; 4) MD-4-034, MD-5-090, PB-3-124, PB-4-121; 5) MD-4-035, MD-5-089, PB-3-124, PB-4-121; 6) MD-5-044, MD-5-061, 
PB-4-104, PB-4-121; 7) MD-4-004, MD-5-084, PB-3-119, PB-4-120; 8) MD-4-036, MD-5-087, PB-4-036, PB-4-121; 9) MD-3-132, 
MD-5-062, PB-3-130, PB-4-120; 10) MD-5-039, MD-5-083, PB-4-112, PB-4-120; 11) MD-3-133, MD-5-080, PB-3-126, PB-4-120; 
12) MD-5-042, MD-5-091, PB-4-137, PB-4-121; 13) MD-4-003, MD-5-081, PB-3-119, PB-4-120; 14) MD-4-002, MD-5-082, PB-3-
119, PB-4-120; 15) MD-5-043, MD-5-092, PB-4-112, PB-4-121; 16) MD-4-005, MD-5-064, PB-3-122, PB-4-121; 17) MD-4-038, MD-
5-085, PB-3-124, PB-4-121; 18) MD-4-037, MD-5-086, PB-3-124, PB-4-121; 19) MD-5-041, MD-5-093, PB-4-104, PB-4-121 20) 
MD-6-019, MD-6-019 
 
Many transition metal-based catalysts, including Cp*Ir(TsDPEN), can be 
incorporated into proteins using covalent and/or non-covalent interactions.64 Following 
subsequent directed evolution, these unnatural metalloproteins can show high 
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efficiencies and enantioselectivities for various substrates. Given the complexity of 
proteins, directed evolution has to be performed independently for enzymes to obtain 
different enantiomers and typically only one enantiomer can be produced with high ee 
values. The simplicity of the peptide sequence of DPL-C16 allows for easy stereochemistry 
reversal not practically feasible for large proteins. Indeed, Cp*Ir(PDL-C16) catalyzes 
reduction of ketones to produce the opposite enantiomers with the same ee. 
 
Figure 2.5. (A) DFT model of Cp*Ir(DPL-C16). (B) DFT model of Cp*Ir(H)(DPL-C16). (C) A fragment 
of crystal packing for DPF-C12.  
DFT models of both pre-catalyst Cp*Ir(DPL-C16) as well as the corresponding 
active species Cp*Ir(H)(DPL-C16) (Figure 2.5) shows bidentate coordination of iridium to 
the peptide backbone via the N-terminus and the deprotonated amide nitrogen of the 
leucine residue. Interestingly, the Ir-N (2.122 Å, 2.114 Å for Ir-NPro and Ir-NLeu, 
respectively) and Ir-H bond (1.600 Å) lengths, obtained from the model are very close to 
those calculated for Cp*Ir(H)(TsDPEN) (2.137 Å, 2.095 Å and 1.578 Å, respectively, for 
the corresponding distances).65 The coordination of the metal to deprotonated backbone 
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amide is further supported by mass-spectrometric data (Figure 2.6). Differences in the 
expected molecular weight of the positively charged metal species [Cp*Ir(DPL-C16)]+ was 
more in agreement with amide N-H backbone metal-binding as opposed to amide C=O 
coordination.  
 
Figure 2.6. ESI-MS data for the of Cp*Ir(Cl)(DPL-C16) complex (calculated isotopic pattern is 
shown in red). 
While our efforts to crystallize Cp*Ir(DPL-C16) so far have not been successful, we 
were able to obtain a crystal structure of DPF-C12, a close analog of DPL-C16. In the crystal 
DPF-C12 stacks in a bilayer-like form driven by the van der Waals packing of hydrophobic 
tails (Figure 2.5c) that is likely to drive the self-assembly in both metal-free and metal-
bound forms. This crystal structure also helps explain why slightly better stereoselectivity 
is observed at a 2:1 or higher metal:peptide ratios (Figure 2.7) as larger spacing between 
bulky Cp*Ir moieties are found under these conditions. 
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Figure 2.7. Enantiomeric selectivity in transfer hydrogenation promoted by DPL-C16 at various 
metal:peptide ratios (ligand concentration was kept constant at 0.025 mM). 
Dynamic light scattering (DLS) studies of the solution containing DPL-C16 shows 
aggregates of the average size of approximately 200 nm and the size of the aggregates 
does not change much upon formation of the catalyst (Figure 2.8). Additional DLS studies 
were conducted on the catalytic peptide species Cp*Ir(H)(DPL-C16) in an effort to 
determine the critical micelle concentration (CMC) (Figure 2.9). The obtained 
experimental data suggests the CMC of the peptide catalyst occurs at a concentration 
lower than 50 µM. Indubitably, a catalyst concentration below 50 µM would not be 
applicable in providing good conversion for catalytic ATH reactions. 
 
Sodium formate–H2O (0.8 mL)
40 °C, 3 h
5 mol % DPL-C16
(2.5, 1.25, or 0.625 mol %) [IrCp*Cl2]2
TFE (0.2 mL), 40 °C, 0.5 h
OHO
R R
R = H, Br, OMe
R1 = H, Me, OMe
R1 R1
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Figure 2.8. (Left) Dynamic light scattering data for DPL-C16 (0.02 mM solution (Right), and 
Cp*Ir(H)(DPL-C16) (0.02 mM solution) 
 
Figure 2.9.Dynamic light scattering data for Cp*Ir(H)(DPL-C16) in EtOH/Water. a)  (50 µM 
solution) b)  (75 µM solution) c)  (100 µM solution)  
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In agreement with the DLS data, transmission electron microscopy (TEM) of the 
complex shows structures of similar size. Interestingly, both micelle-like and vesicle-like 
structures can be observed on the grid (Figure 2.10). Micelles under TEM typically have 
a defined cylindrical rod or spherical composition with a corresponding ring or “corona” 
surrounding a dark colored core, whereas vesicles often appear as closed bilayers that 
encapsulates some aqueous solvent.66 Elucidating the difference between micelle and 
vesicles by TEM can often be difficult due to the similarity in appearances of those 
assemblies to those found from staining agents or electron beam damage.67 Additionally, 
there is no other microscopy method that could provide a clear visual distinction of our 
peptide assemblies due to the smaller size of these nano-assemblies. Thus, the 
information discerned from TEM details the type of discrete assemblies that are inherently 
formed under our reaction conditions. 
 
Figure 2.10. TEM images showing self-assembled micelle structures formed by Cp*Ir(H)(DPL-
C16). (Left) Micelle-like assemblies (Right) vesicle-like assemblies. 
We hypothesize that interconversion between different morphologies can promote 
substrate sequestration into the hydrophobic catalyst assembly. No self-assembled 
structures are found for HN-DPro-Leu-CONH2, or DPL-C4 as well as their corresponding 
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complexes consistent with the notion that self-assembly leads to high enantioselectivity. 
The vesicle-like morphology of the DPL-C16-based catalyst is consistent with the 
observations of vesicles for HN-Pro-Trp-CONH-C12, a molecule closely resembling DPL-
C16.68  
2.3. Conclusions 
In conclusion, we have shown that a semi-rational approach that utilizes self-
assembly of short peptides allows for development of highly efficient nanosized catalysts 
for enantioselective hydrogenation of a wide variety of substrates under mild, aerobic 
conditions in aqueous solution. The resulting catalyst combines a high degree of the metal 
coordination sphere control characteristic of homogeneous catalyst with an ease of 
catalyst separation commonly observed in heterogeneous catalysis. DPL-C16, to our 
knowledge, is the first example of self-assembling peptide that can catalyze an industrially 
important chemical reaction with excellent efficiency, enantioselectivity and substrate 
scope. The catalyst, produced in a two-step synthesis from simple and inexpensive amino 
acid building blocks, can be manufactured in large quantities at a fraction of the cost of 
presently utilized ligands for transfer hydrogenation. Most importantly, this work 
demonstrates that the bottom-up self-assembly paradigm to create enantioselective 
catalysts presents an excellent alternative to the traditional approach where bulky 
substituents are combinatorially introduced into ligands to create increasingly rigid 
complex structures. Utilizing peptides with non-natural amino acids can offer incredible 
opportunities for tuning the properties of the metal ions and is likely to improve the 
functional properties of the assemblies even further. Additionally, the biocompatibility of 
the simple dipeptide catalytic moiety allows for potential incorporation of metal-binding 
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fragments into proteins to allow for additional improvement using directed evolution. 
Given the ease with which we were able to create self-assembling catalysts for transfer 
hydrogenation from a very limited set of peptides we expect our approach to be generally 
applicable to a wide range of different metallopeptide-promoted transformations. 
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2.4. Experimental 
General Procedures and Instrumentation 
1H and 13C NMR. All spectra were recorded on a Bruker Avance DPX-300 (300 MHz) 
spectrometer, a Bruker Avance DPX-400 (400 MHz) spectrometer, or a Bruker Avance 
III HD (800 MHz) spectrometer. Chemical shifts are reported in parts per million (ppm) 
and are calibrated using residual undeuterated solvent as an internal reference (CDCl3: 
7.26 ppm; DMSO-d6: 2.50 ppm). Data are reported as follows: chemical shift, multiplicity, 
coupling constants (Hz), and integration. The following abbreviations or combinations 
thereof were used to note signal multiplicities: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sext = sextet, m = multiplet, dd = doublet of doublets, ddd =doublet of 
doublet of doublets, br = broad. 13C NMR spectra were recorded on a Bruker Avance 
DPX-300 (75 MHz) spectrometer or a Bruker Avance DPX-400 (100 MHz) spectrometer 
with complete proton decoupling. Chemical shifts are reported in ppm and are calibrated 
using residual undeuterated solvent as an internal reference (CDCl3: δ 77.23 ppm; 
DMSO-d6: 39.52 ppm).  
 
HPLC. Enantiomeric excess was determined by chiral HPLC using a (250 x 4.6 mm) 
Phenomenex Lux-Cellulose 1 on a Shimadzu Prominence UFLC instrument. The 
enantiomeric selectivity was estimated by integration of signals at 254 nm. All solvents 
used in our normal-phase system contained 0.1% TFA.  The conditions for separation of 
alcohol enantiomers can be found in the compound characterization of transfer 
hydrogenation products.  
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GC. Enantiomeric excess was also determined by chiral GC using a (30 m x 0.25 mm x 
0.25 µm) Agilent J&W Cyclodex-B column on an Agilent 7820A instrument. The 
conditions for separation of alcohol enantiomers can be found in the compound 
characterization of transfer hydrogenation products. 
 
IR spectra. Infrared (IR) spectra were recorded on a Thermo Fischer Scientific Nicolet 
IR-100 or Nicolet iS5 spectrometer, νmax in cm-1, and were obtained from samples 
prepared as pellets in KBr, oils with NaCl plates, or neat.  
 
Melting point. Melting points (m.p.) are uncorrected and were recorded using an 
Electrothermal Mel-Temp melting point apparatus.  
 
MALDI-TOF. A Bruker Autoflex III Smartbeam MALDI-TOF mass spectrometer was used 
for identification of the peptides.  
 
Electrospray ionization (ESI). ESI mass spectrometry analyses were carried out on 
Shimadzu LCMS-8100.  
 
DFT Modeling. All simulations were carried out with the Gaussian 16 Rev. B.01 software 
package.69The geometries of the structures were optimized with density functional theory 
(DFT) employing the parameter-free Perdew-Burke-Ernzerhof (PBE0) hybrid functional70 
and the valence triple-zeta polarization basis set (def2-TZVP) for all atoms.71 
Convergence cutoffs on forces and step sizes were tightened using the keyword, 
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opt=tight, and the integration grid was set to 99 radial shells and 590 angular points per 
shell with the keyword, integral (grid=ultrafine). DFT modelling was done in collaboration 
with Dr. Korter at Syracuse University.  
 
Transmission Electron Microscopy (TEM). TEM measurements were performed on a 
JEOL 2000EX instrument operated at 120 kV with a tungsten filament at N.C. Brown 
Center for Ultrastructure studies at SUNY-ESF. The particle size was analyzed manually 
by modeling each self-assembled structure as sphere. The statistical analysis of the 
structures was performed using the ImageJ software on populations of at least 100 
counts.  
 
Dynamic Light Scattering (DLS). DLS measurements were performed on a Malvern 
Zetasizer Nano ZS instrument utilizing a 173° backscattering detector. The hydrodynamic 
diameter (Dh) and Z-average (Zave) were calculated using CONTIN analysis.  
 
Single crystal X-ray diffraction. Single crystal structural analysis was carried out using 
a Bruker KAPPA APEX DUO diffractometer equipped with APEX II CCD and LT-II low 
temperature device. The diffraction data were collected at 100 K using Cu-Kα radiation 
using the omega scan technique. The unit cell and space group were determined using 
the SAINT+ program. The structure was solved using SHELXL-2014/719. All non-
hydrogen atoms were refined anisotropically. Hydrogen atoms were positioned based on 
electron density within the refined solved structure. The structure has been deposited into 
CCDC (1884477). 
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Ligand synthesis 
Unless otherwise indicated, all reactions were conducted in oven- (140°C) or flame-dried 
glassware. Yields refer to chromatographically and spectroscopically (1H NMR) 
homogeneous materials, unless otherwise stated. Flash column chromatography was 
performed using Silia Flash® P60 silica gel (40-63 μm) from Silicycle, Brockmann Grade 
I neutral alumina (50-200 µm) from Acros Organics, or Brockmann Grade I basic alumina 
(58 Å) from Alfa Aesar. All work-up and purification procedures were carried out with 
reagent grade solvents (purchased from VWR or Pharmaco-Aaper). The identities of the 
purified peptides were confirmed either by 1H NMR, Bruker Autoflex III Smartbeam 
MALDI-TOF mass spectrometer, or by mass spectrometry. The purity of the peptides 
were determined by NMR.  
 
Solid-Phase Peptide Synthesis 
Dipeptides were synthesized by manual fluorenylmethyloxycarbonyl (Fmoc) solid phase 
peptide synthesis strategy as described before.72 Deprotection of the side chains and 
cleavage of the peptides from the rink-amide MBHA resin was achieved by subjecting the 
peptides to a mixture of TFA/H2O/TIS (95:2.5:2.5, v/v), or TFA/H2O/TIS/EDT 
(93:2.5:2.5:2, v/v for oxidation sensitive functionalities) for 2 hours at room temperature. 
The solution was then filtered through a pipette plugged with glass wool and the solution 
concentrated to remove excess TFA using a stream of nitrogen. Purification of short 
dipeptides with C-terminal amides can easily be done by dissolving it in a minimum 
amount of TFA and transferring the solution into dry-ice cooled diethyl ether to facilitate 
precipitation. The precipitated peptide was then spun down using a centrifuge, the ether 
 
 215 
discarded, and then dried under a vacuum pump. If the peptides were not easily crashed 
out with diethyl ether, the concentrated solution was diluted with water or alternatively a 
mixture of solvent A (99.9:0.1 H2O/TFA) and solvent B (90:9.9:0.1 MeCN:H2O:TFA) to ca. 
5 mL total volume. The homogeneous solutions were then subjected to lyophilization. 
This cycle was repeated until lyophilization afforded peptide trifluoroacetates as white fluff 
solids.   
 
Liquid Phase Peptide Synthesis 
Short peptides with C-terminal alkyl tails were synthesized by solution-phase synthesis 
utilizing the tertbutyloxycarbonyl (Boc) peptide synthesis strategy using DMF as the 
reaction solvent. A slight excess of the activator HBTU (N,N,N′,N′-tetramethyl-O-(1H-
benzotriazol-1-yl)uronium hexafluorophosphate, or its analog HCTU 2-(6-chloro-1-H-
benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate), were used in our 
peptide syntheses. In general, the alkyl amine was also added in a similar molar ratio to 
activator, with 2 equivalents of base N,N’-diisopropylethyl amine (DIPEA) added. 
 
All racemic alcohols were synthesized from their corresponding ketones using sodium 
borohydride. Standard reaction conditions involved substrate (1 mmol) dissolved in 2 mL 
EtOH with addition of NaBH4 (1.5 mmol) and was reacted for 2-3 hours. The reaction 
mixture was quenched with water (5 mL), transferred to a separatory funnel. The organics 
were extracted with EtOAc (2 x 25 mL), washed with sat. brine, dried over MgSO4, filtered, 
and concentrated to the corresponding oil or solid. 
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Asymmetric Transfer Hydrogenation (ATH) Reactions 
 
Scheme SI 2.1. Standard ATH Conditions 
 
ATH Method 1:  Single Reaction 
To an oven-dried tapered glass microtube DPL-C16 (11.3 mg, 25 µmol), [IrCp*Cl2]2 (5.0 
mg, 6.25 µmol), and 0.2 mL trifluoroethanol (TFE) were added. The tube was sealed with 
a 14/20 rubber septum and a short needle was then inserted through the rubber septum 
into the head space. The microtube was agitated (1000-1200 rpm) for 30 minutes at 40 
°C in a Thermo-Mixer shaker (Fisher Scientific). After formation of the pre-
catalyst/peptide-metal complex, 0.8 mL of a prepared 3.125 M sodium formate stock 
solution in water was added followed by addition of substrate (0.5 mmol). The tube is 
resealed with the rubber septum and needle, and is placed back in the Thermo-Mixer and 
is agitated (1000 – 1200 rpm) for 3 hours at 40 °C.  
 
ATH Method 2: Multiple Reaction Setup 
Note: This method allows for scalability and a pre-calculated stock solution can be 
created for multiple ATH reactions to be run in parallel. Due to some observed minimal 
evaporation of TFE after heating, an additional 5% amount of reagents and solvent are 
included into the calculated values to compensate for the small loss of TFE.  
(DP)L-C16
N
H
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In a typical reaction, DPL-C16 (11.3 mg, 25.0 µmol x (# of reactions +5% excess), 
[IrCp*Cl2]2 (5.0 mg, 6.25 µmol x (# of reactions +5% excess), and 0.2 mL TFE x (# of 
reactions +5% excess) were added to a 15 mL screw-capped tube equipped with a 
magnetic stir bar. The tube was then sealed and immersed into a pre-heated 40 °C oil 
bath and the pre-catalyst solution was stirred for 30 minutes. The tube was then removed 
from the oil bath and allowed to cool to room temperature. Aliquots of the solution (0.2 
mL) are then transferred to separate glass-tapered microtubes followed by addition of a 
prepared 3.125 M sodium formate solution in water (0.8 mL), and substrate (0.5 mmol). 
The microtubes were then sealed with a 14/20 rubber septum and a short needle was 
inserted through the rubber septum into the head space to vent CO2 formation and limit 
reaction mixture evaporation. The microtube(s) were agitated (1000-1200 rpm) for 3 
hours at 40 °C in a Thermo-Mixer shaker.  
 
Work Up Method 1: Extraction 
The crude reaction mixture was transferred to a separatory funnel, the reaction tube was 
rinsed with either dichloromethane (DCM), methyl-tert-butyl ether (MTBE), or diethyl ether 
(Et2O), and washes were combined with the reaction mixture. The organics were 
extracted from the aqueous layer with either DCM, MTBE, or Et2O (2 x 5 mL). The 
combined organics were washed with saturated brine (5 mL), dried over Na2SO4 or 
MgSO4, filtered through a fritted funnel, and the solvent removed under reduced pressure 
on a rotavap to afford the crude alcohol product. 
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Work Up Method 2: Silica Plug Purification 
For quick analysis of results, the crude reaction mixture is directly purified through a short 
silica plug (ca. 2.0 cm height) by eluting with MTBE and collecting 50–100 mL of solvent. 
Note 1: Due to the amount of water in the reaction mixture, some silica has been observed 
to accumulate in the collection flask. Note 2: This method was not applied with pyridine 
substrates. 
Yields were determined by 1H NMR with the addition of mesitylene as an internal 
standard (~6.8 ppm, 1H and ~2.3 ppm, 3H) in CDCl3.  
 
 
 
Enantiomeric excess was then determined either by HPLC or GC. Knowing the 
approximate yields by 1H NMR first provided us useful information on how much to dilute 
the products. For HPLC, the products are dissolved in 10:90 EtOH:Hexanes, the volume 
of which is closely based on the 1H NMR yields (e.g. 0.7 mL of the EtOH:Hexanes will be 
added to a ~72% yield reaction). This initial solution is then diluted 10-fold by taking an 
aliquot of 100 µL and transferring to a glass culture tube and then adding 900 µL of 
hexanes. Approximately 200 µL of diluted solution are transferred to an eppendorf tube 
equipped with a 0.44 micron filter and spun down in a VWR® C1213 Galaxy Mini 
Centrifuge for at least 15 seconds. The filtered solution is transferred to an HPLC vial 
fitted with a glass insert and analyzed using chiral HPLC as described above. For GC, 
the products were instead dissolved with DCM (e.g. 4 mL will be added to a ~44% yield 
0.5 mmol (substrate)
3 (symmetrical signal intensity)
X
120.19 g
mol
1 mL
0.869 g
X 23.1 µL=
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reaction) and ca. 2 µL of the diluted solution was then manually injected into a chiral 
capillary GC column under isothermal conditions. 
All racemic alcohols were synthesized from their corresponding ketones using 
sodium borohydride. Standard reaction conditions involved substrate (1 mmol) dissolved 
in 2 mL EtOH with addition of NaBH4 (1.5 mmol) and was reacted for 2-3 hours. The 
reaction mixture was quenched with water (5 mL) transferred to a separatory funnel, and 
the organics were extracted with EtOAc (2 x 25 mL), washed with saturated brine, dried 
over MgSO4, filtered, and concentrated to give the corresponding oil or solid. 
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Synthesis of Dipeptides From Solid Phase 
Note: All dipeptides used in the screen were isolated as TFA salts 
  
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.75 (brs, 1H), 7.64 (brs, 1H), 7.09 (brs, 
1H), 4.47 (br, 1H), 4.02 (qd, J = 17.2, 6.3 Hz, 2H), 3.45 (br, 2H), 2.54-2.44 (m, 1H), 2.18-
2.02 (m, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 173.6, 170.3, 162.9 (q, J = 35.1 Hz), 116.3 
(q, J = 290.1 Hz), 59.9, 46.6, 42.2, 29.5, 23.8 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.71 (d, J = 4.0 Hz, 1H), 7.69 (brs, 1H), 
7.08 (brs, 1H), 4.42 (br, 1H), 4.39-4.32 (m, 1H), 3.44 (br, 2H), 2.53-2.45 (m, 1H), 2.17-
2.02 (m, 3H), 1.44 (d, J = 7.2 Hz) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 177.4, 169.6, 162.9 (q, J = 35.4 Hz), 116.3 
(q, J = 290.0 Hz), 59.7, 49.9, 46.6, 29.7, 23.7, 16.6 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.77 (d, J = 6.2 Hz, 1H), 7.72 (brs, 1H), 
7.20 (brs, 1H), 4.53-4.46 (m, 2H), 3.92 (m, 2H), 3.45 (br, 2H), 2.56-2.47 (m, 1H), 2.19-
2.02 (m, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O)δ = δ = 173.8, 170.0, 162.8 (q, J = 35.2 Hz), 
116.3 (q, J = 289.8 Hz), 61.2, 59.8, 55.8, 46.7, 29.7, 23.8 
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1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.65 (d, J = 7.2 Hz, 1H), 7.73 (brs, 1H), 
7.20 (brs, 1H), 4.51 (br, 1H), 4.36 (dd, J = 7.7, 4.8 Hz, 1H), 4.26-4.20 (m, 1H), 3.45 (br, 
2H), 2.56-2.48 (m, 1H), 2.18-2.02 (m, 3H), 1.26 (d, J = 6.3 Hz, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 174.1, 170.1, 162.9 (J = 35.4 Hz), 116.3 (J 
= 290.1 Hz), 67.1, 59.8, 59.5, 46.7, 29.8, 23.7, 18.9 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.82 (d, J = 6.4 Hz, 1H), 7.76 (brs, 1H), 
7.24 (brs, 1H), 4.54 (q, J = 7.2, 1H) 4.47 (br, 1H), 3.44 (br, 2H), 3.05-2.91 (m, 2H), 2.56-
2.45 (m, 1H), 2.18-2.02 (m, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 174.0, 169.9, 162.9 (q, J = 35.3 Hz), 116.3 
(q, J = 290.0 Hz), 59.8, 55.9, 46.7, 29.7, 25.3, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.42 (d, J = 6.7 Hz, 1H), 7.60 (brs, 1H), 
7.00 (brs, 1H), 4.29 (brs, 1H), 3.96 (t, J =7.2 Hz, 1H), 3.27 (br, 2H), 2.38-2.26 (m, 1H), 
1.96-1.84 (m, 4H), 1.01 (d, J = 6.8 Hz, 6H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 175.8, 169.9, 162.9 (q, J = 35.2 Hz), 116.3 
(q, J = 290.1 Hz), 60.0, 59.6, 46.7, 29.9, 29.7, 23.7, 18.3, 17.7 
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1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.67 (d, J = 6.2 Hz, 1H), 7.73 (brs, 1H), 
7.11 (brs, 1H), 4.42 (brt, J = 7.0 Hz, 1H), 4.32 (dt, J = 9.4, 5.3 Hz, 1H), 3.50-3.37 (m, 2H), 
2.52-2.42 (m, 1H), 2.14-1.99 (m, 3H), 1.73-1.57 (m, 3H), 0.96 (d, J = 6.1 Hz, 3H) 0.92 (d, 
J = 6.2 Hz, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 177.1, 169.8, 162.9 (q, J = 35.1 Hz), 116.3 
(q, J = 290.1 Hz), 59.6, 52.8, 46.7, 39.8, 29.8, 24.3, 23.7, 22.1, 20.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.58 (d, J = 6.7 Hz, 1H), 7.76 (brs, 1H), 
7.16 (brs, 1H), 4.44 (brs, 1H), 4.19-4.15 (m, 1H), 3.43 (br, 2H), 2.52-2.42 (m, 1H), 2.12-
1.99 (m, 3H), 1.90-1.80 (m, 1H), 1.58-1.48 (m, 1H), 1.29-1.18 (m, 1H), 0.97 (d, J = 6.8 
Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 175.9, 169.8, 162.9 (q, J = 35.1 Hz), 116.3 
(q, J = 290.1 Hz), 59.6, 58.9, 46.7, 35.8, 29.8, 24.6, 23.7, 14.7, 10.2 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.79 (d, J = 6.4 Hz, 1H), 7.74 (brs, 1H), 
7.17 (brs, 1H), 4.51-4.42 (m, 2H) 3.50-3.37 (m, 2H), 2.69-2.56 (m, 2H), 2.53-2.42 (m, 1H), 
2.17-2.01 (m, 8H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 175.8, 169.8, 162.9 (q, J = 35.2 Hz), 116.3 
(q, J = 290.2 Hz), 59.7, 53.1, 46.7, 30.3 29.7, 23.7, 14.1 
N
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1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 7.75 (brs, 1H), 7.08 (brs, 1H), 4.46 (dd, J 
= 8.3, 6.4 Hz, 1H), 3.75-3.70 (m, 1H), 3.65-3.58 (m, 1H), 3.44 (br, 2H), 2.63-2.51 (m, 1H) 
2.39-2.33 (m, 1H), 2.13-1.92 (m, 6H)  
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 176.4, 168.2, 162.9 (q, J = 35.4 Hz), 116.3 
(q, J = 290.1 Hz), 60.5, 59.2, 47.7, 46.8, 29.6, 28.3, 24.6, 23.9 
 
1H-NMR   (400 MHz, DMSO-d6)   δ = 9.17 (brs, 1H), 8.70 (d, J = 8.3 Hz, 1H), 8.43 (brs, 
1H), 7.61 (s, 1H), 7.30-7.18 (m, 5H), 7.15 (s, 1H), 4.49 (td, J = 9.2, 4.6 Hz, 1H), 4.10 (p, 
J = 6.1 Hz, 1H), 3.25-3.10 (m, 2H), 3.04 (dd, J = 13.8, 4.6 Hz, 1H), 2.80 (dd, J = 13.8, 9.7 
Hz, 1H), 2.34-2.23 (m, 1H), 1.90-1.78 (m, 3H) 
13C-NMR (100 MHz, DMSO-d6) δ = 172.2, 167.9, 158.0 (q, J = 32.8 Hz), 137.7, 129.1, 
128.1, 126.4, 57.8, 54.3, 45.7, 37.6, 29.5, 23.4 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.67 (d, J = 7.0 Hz, 1H), 7.62 (brs, 1H), 
7.20 (dt, J = 9.3, 2.7 Hz, 2H), 7.09 (brs, 1H), 6.89 (dt, J = 9.4, 2.8 Hz, 2H), 4.57 (dt, J = 
14.1, 7.0, Hz, 1H), 4.34 (br, 1H), 3.48-3.34 (m, 2H), 3.10 (dd, J = 14.1, 7.0 Hz, 1H), 3.00 
(dd, J = 14.0, 8.6 Hz, 1H), 2.50-2.38 (m, 1H), 2.11-1.98 (m, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 175.5, 169.5, 162.9 (q, J = 35.1 Hz), 154.6, 
130.5, 128.0, 116.3 (q, J = 289.9 Hz), 115.5, 59.6, 55.5, 46.7, 36.1, 29.7, 23.7 
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1H-NMR   (400 MHz, 10% D2O, 90% H2O)  δ = 8.61 (d, J = 6.7 Hz, 1H), 7.69 (d, J = 8.0 
Hz, 1H), 7.54 (brs, 1H), 7.52 (d, J = 8.2 Hz, 1H), 7.28 (s, 1H), 7.27 (dt, J = 8.1, 0.9 Hz, 
1H), 7.19 (dt, J = 7.8, 0.6 Hz, 1H), 7.04 (brs, 1H), 4.29 (br, 1H), 3.37 (br, 2H), 3.29 (qd, J 
= 14.7, 7.1 Hz, 2H), 2.45-2.36 (m, 1H), 2.07-1.94 (m, 3H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 175.8, 169.5, 162.9 (q, J = 35.2 Hz), 136.2, 
126.8, 124.7, 122.0, 119.3, 118.3, 116.3 (q, J = 290.0 Hz), 112.0, 109.0, 59.6, 54.8, 46.7, 
29.7, 27.1, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.89 (d, J = 6.7 Hz, 1H), 7.66 (brs, 1H), 
7.18 (brs, 1H), 4.41 (t, J = 6.7 Hz, 1H), 3.50-3.37 (m, 2H), 2.93 (dd, J = 16.8, 5.2 Hz, 1H), 
2.82 (dd, J = 16.8, 8.4 Hz, 1H), 2.52-2.42 (m, 1H), 2.15-2.03 (m, 3H)  
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 174.8, 174.7, 169.7, 162.9 (q, J = 35.2 Hz), 
116.3 (q, J = 290.1 Hz), 59.8, 50.7, 46.6, 36.2, 29.6, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.76 (d, J = 6.5 Hz, 1H), 7.75 (brs, 1H), 
7.15 (brs, 1H), 4.44-4.35 (m, 2H), 3.49-3.36 (m, 2H), 2.59-2.43 (m, 3H), 2.19-1.98 (m, 
6H)  
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13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 177.0, 175.6, 169.8, 162.9 (q, J = 35.1 Hz), 
116.3 (q, J = 290.1 Hz), 59.7, 53.3, 46.7, 30.0, 29.7, 26.2, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.88 (d, J = 6.4 Hz, 1H), 7.67 (brs, 2H), 
7.18 (brs, 1H), 6.98 (brs, 1H), 4.41 (brt, J = 6.9 Hz, 1H), 3.49-3.37 (m, 2H), 2.87 (dd, J = 
15.6, 5.5 Hz, 1H), 2.77 (dd, J = 15.7, 8.8 Hz, 1H), 2.52-2.42 (m, 1H), 2.14-2.03 (m, 3H)  
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 174.7, 174.4, 170.0, 162.9 (q, J = 35.1 Hz), 
116.3 (q, J = 290.0 Hz), 59.8, 50.7, 46.6, 36.4, 29.6, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.79 (d, J = 6.2 Hz, 1H), 7.77 (s, 1H), 
7.58 (brs, 1H), 7.18 (s, 1H), 6.89 (brs, 1H), 4.43 (brt, J = 7.0 Hz, 1H), 4.36 (dt, J = 8.5, 6.2 
Hz, 1H), 3.49-3.37 (m, 2H), 2.53-2.44 (m, 1H), 2.41 (t, J = 7.5 Hz, 1H), 2.18-1.99 (m, 5H)  
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 177.9, 175.6, 169.8, 162.9 (q, J = 35.2 Hz), 
116.3 (q, J = 290.1 Hz), 59.7, 53.4, 46.7, 31.1, 29.7, 26.9, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.93 (d, J = 6.7 Hz, 1H), 8.61 (d, J = 1.2 
Hz, 1H), 7.72 (brs, 1H), 7.35 (s, 1H), 7.24 (brs, 1H) 4.39 (dd, J = 8.2, 6.2 Hz, 1H), 3.48-
3.15 (m, 5H), 2.51-2.38 (m, 1H), 2.10-2.01 (m, 3H)  
N
H
N
H
O
O
NH2
O
NH2
PN
N
H
N
H
O
NH2
O
PQ
NH2O
N
H
O
N
H
NH2
O
PH
N
HN
 
 226 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 173.8, 169.7, 162.9 (q, J = 35.2 Hz), 133.8, 
128.2, 117.4, 116.3 (q, J = 290.0 Hz), 59.7, 53.0, 46.6, 29.7, 26.4, 23.7 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.72 (d, J = 5.4 Hz, 1H), 7.74 (s, 1H), 
7.54 (brs, 2H), 7.16 (s, 1H), 4.43 (brs, 1H), 4.30 (q, J = 6.8 Hz, 1H), 3.43 (br, 2H), 3.00 
(br, 2H) 2.52-2.43 (m, 1H), 2.14-2.01 (m, 3H), 1.90-1.76 (m, 2H), 1.71 (p, J = 7.4 Hz, 2H), 
1.55-1.41 (m, 2H)  
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 176.2, 169.8, 162.9 (q, J = 35.2 Hz), 116.3 
(q, J = 290.1 Hz), 59.7, 54.1, 46.7, 39.4, 30.4, 29.8, 26.5, 23.8, 22.0 
 
1H-NMR   (400 MHz, 10% D2O, 90% H2O)   δ = 8.79 (d, J = 6.1 Hz, 1H), 7.76, (s, 1H), 
7.24 (brt, J = 4.8 Hz, 1H), 7.17 (s, 1H), 6.67 (brs, 2H), 4.45 (brt, J = 7.0 Hz, 1H), 4.32 (q, 
J = 6.3 Hz, 1H), 3.43 (br, 2H), 3.24 (q, J = 6.7 Hz, 2H), 2.53-2.42 (m, 1H), 2.14-2.01 (m, 
3H), 1.92-1.77 (m, 2H), 1.75-1.62 (m, 2H) 
13C-NMR (100 MHz, 10% D2O, 90% H2O) δ = 176.1, 169.9, 162.9 (q, J = 35.6 Hz), 157.0, 
116.3 (q, J = 289.8 Hz), 59.7, 53.9, 46.7, 40.6, 29.8, 28.1, 24.4, 23.7 
 
1H-NMR   (400 MHz, DMSO-d6)   δ = 9.41 (brs, 1H), 8.68  (d, J = 8.4 Hz, 1H), 8.51 (brs, 
1H), 7.53 (s, 1H), 7.09 (s, 1H), 4.28 (dq, J = 8.5, 5.6 Hz, 1H), 4.21 (br, 1H), 3.22 (br, 2H), 
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2.36-2.27 (m, 1H), 1.92-1.82 (m, 2H), 2.52-2.42 (m, 1H), 1.80-1.71 (m, 1H), 1.61-1.44 (m, 
3H), 0.89 (d, J = 6.2 Hz, 3H), 0.84 (d, J = 6.2 Hz, 3H) 
13C-NMR (100 MHz, DMSO-d6) δ = 173.6, 168.1, 158.5 (q, J = 31.7 Hz), 117.0 (q, J = 
296.5 Hz), 59.1, 51.1, 45.7, 40.8, 30.0, 24.5, 23.6, 23.1, 21.2  
FT-IR: (KBr pellet) ν = 3437, 3284, 2960, 1673, 1561, 1431, 1203, 1134, 838, 799, 723 
cm-1 
MP: 142-145 °C 
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Synthesis of Tailed Dipeptides  
 
Scheme SI 2.2. Synthesis of DPL-Cn peptides  
 
General Protocol A: H2N-Leu-Cn (n = 8-18)  
To the flask containing Boc-L-Leucine (575 mg, 2.5 mmol) was added alkylamines (2.0-
2.2 mmol), and HCTU (1.24 g, 3.0 mmol). The solids were dissolved in 25 mL of DMF. 
Next, DIPEA (0.52 mL, 3.0 mmol) was then added and the contents were stirred at room 
temperature for one hour. The solution was then transferred to a separatory funnel. The 
round bottom flask was rinsed three times with EtOAc (50 mL total) and then added to 
the separatory funnel. The organics were extracted from the aqueous layer using EtOAc 
(2 x 75 mL). The combined organics (200 mL in total) were washed with water (100 mL), 
saturated brine (3 x 100 mL), dried over MgSO4, filtered over a fritted funnel and 
concentrated to afford a crude Boc protected intermediate. Next, to the flask containing 
crude Boc-Leu-Cn was added magnetic stirring bar and trifluoroacetic acid (ca. 15 mL). 
The solution was then stirred for 15 minutes. The TFA was removed by blowing air over 
it until a viscous oil remained. The excess TFA was then neutralized with a saturated 
NaHCO3 solution (100 mL, pH = 7). The solution was then transferred to a separatory 
funnel. The organics were extracted from the aqueous layer using EtOAc (2 x 75 mL). 
The combined organics (200 mL in total) were washed with saturated brine (3 x 100 mL) 
and dried over MgSO4, filtered over a fritted funnel and concentrated to afford crude 
material. Silica gel column chromatography was then performed. A 1:1 EtOAc:hexanes 
2) TFA (> 50 equiv.), RT, 0.25 h
3) NaHCO3 (aq) pH = 7
H2N N
H
O
nHN OH
O
O
O
HBTU or HCTU (1.1 equiv.)
DIPEA (2 equiv.)
alkylamine (1.1 equiv.)
DMF, RT, 1 h
1)
H
N N
H
O
n
O
N
H
2) TFA (> 50 equiv.), RT, 0.25 h
3) NaHCO3 (aq) pH = 7-8
HBTU or HCTU (1.2 equiv.)
DIPEA (2 equiv.)
Boc-D-Pro-OH (1.2 equiv.)
DMF, RT, 1 h
1)
n = 7, 9, 11, 13, 15, 17 n = 7, 9, 11, 13, 15, 17Boc-L-Leu-OH
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eluent is used to remove impurities, then the solvent is switched to DCM, and the product 
band was eluted using 5% methanol in DCM mixture. Upon solvent evaporation, colorless 
oils to white semisolids were obtained.  
 
General Protocol B: DPL-Cn (n=8-18) Peptides 
To the flask containing Boc-DPro-COOH (0.43 g, 2.00 mmol), was added Leu-Cn (1.78 
mmol), HCTU (0.83 g, 2.0 mmol), DIPEA (0.52 mL, 3.0 mmol) and 25 mL of DMF. The 
contents were stirred at room temperature for one hour. The solution was then transferred 
to a separatory funnel. The solution was diluted with saturated brine solution and the 
organics were extracted using EtOAc (150 mL total). The organics were separated, and 
the combined organics portions were washed with water (100 mL), saturated brine (3 x 
100 mL), dried over MgSO4, filtered over a fritted funnel and concentrated to afford crude 
solid. To the flask containing crude Boc-DPro-Leu-Cn was added a magnetic stirring bar 
and trifluoroacetic acid (ca. 10 mL). The solution was then stirred for 15 minutes at room 
temperature. TFA was then removed by blowing air over it until a viscous oil remained. 
The excess TFA was then neutralized with a saturated NaHCO3 solution (100 mL, pH = 
7-8). The solution was then transferred to a separatory funnel. The round bottom flask 
was then rinsed with EtOAc (50 mL total) and the solution was added to the separatory 
funnel. The organics were separated, and then the organics were extracted from the 
aqueous layer using EtOAc (2 x 75 mL). The combined organics (200 mL in total) were 
washed with saturated brine, dried over MgSO4, filtered over a fritted funnel and solvents 
were removed under reduced pressure.  Alumina (basic or neutral) column 
chromatography was then performed. A 1:1 EtOAc:hexanes eluent is used to remove 
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impurities, then the solvent is switched to DCM, and the product band was eluted using 
5% methanol in DCM mixture. Upon solvents evaporation, colorless to white solids were 
obtained. 
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Scheme SI 2.3. Synthetic scheme for preparation of DPL-C4. 
 
DPL-C4 
To a round bottom flask equipped with a magnetic stirring bar 
was added, Boc-DPro-COOH (1.07 g, 5 mmol), L-Leu-methyl 
ester (1.09 g, 6 mmol), HCTU (2.48 g, 6 mmol) and 25 mL DMF followed by addition of 
DIPEA (1.9 ml, 10 mmol). The contents were stirred at room temperature for one hour 
and then the solution was transferred to a separatory funnel. The solution was diluted 
with saturated brine and the organics were extracted several times with EtOAc (100 mL 
total). The organics were separated, and the combined organics portions were dried over 
MgSO4, filtered over a fritted funnel and concentrated to afford crude solid. Purification of 
the intermediate following protocol B using basic alumina afforded a white crystalline solid 
(0.56 g, 33% yield) that was carried over to the next step of the syntheses.  
To the flask containing Boc-DPro-LLeu-OMe (1.0 g, 3.0 mmol), excess butylamine 
(5.0 mL, 50.6 mmol) was added and heated at 80 °C for 6 hours in double-walled sealed 
glass tube. The tube was allowed to cool to room temperature and then the glass tube 
was rinsed thoroughly using DCM (15 mL). Solvents were removed in vacuo to yield a 
white solid. TFA (ca. 5 mL) was added and the solution was then stirred for 0.5 hours 
under ambient conditions in air. TFA was then removed by blowing air over it until a 
viscous oil remained. The residual TFA was then neutralized with saturated NaHCO3 (pH 
= 8). The solution was then transferred to a separatory funnel and extracted several times 
DMF, 1 h
HCTU (1.1 equiv.)
DIPEA (2 equiv.)
2) TFA, RT, 0.5 h
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with EtOAc (100 mL total). The combined organics were washed with saturated brine, 
dried over MgSO4, filtered over a fritted funnel and concentrated to afford a colorless solid 
(0.31 g, 38% yield). 
1H-NMR (300 MHz, d6-DMSO) δ = 7.99-7.92 (m, 2H), 4.30-4.22 (m, 1H), 3.53 (dd, J = 
8.4, 4.8 Hz, 1H), 3.12-2.95 (m, 2H), 2.88-2.71 (m, 2H), 1.98-1.87 (m, 1H), 1.64-1.19 (m, 
11H), 0.88-0.83 (m, 9H) 
13C-NMR (100 MHz, d6-DMSO) δ = 173.8, 171.6, 60.1, 50.5, 46.6, 41.9, 38.0, 31.1, 30.4, 
25.7, 24.3, 22.9, 21.9, 19.4, 13.6. 
FT-IR: (neat) ν = 3275 (m), 3091 (w), 2955 (m), 2933 (m), 2863 (w), 1636 (s), 1541 (s), 
1227 (m), 706 (m) cm-1 
LC-MS (ESI): expected m/z: [M + H]+, 284.23 and observed 284.20 
 
H2N-Leu-C8 
Following general protocol A, Boc-L-Leucine (1.15 g, 5.0 mmol), 1-
octylamine (0.51 g, 4.0 mmol), HCTU (2.06 g, 5.0 mmol) were dissolved 
in 25 mL of DMF followed by addition of DIPEA (1.04 mL, 6.0 mmol). Purification afforded 
a colorless oil (0.72 g, 74% overall yield). 
1H-NMR   (400 MHz, CDCl3) δ = 7.20 (br, 1H), 3.42-3.39 (m, 1H), 3.20 (q, J = 7.3 Hz, 2H), 
2.20 (br, 2H), 1.75-1.63 (m, 2H), 1.48 (p, J = 7.0 Hz, 2H), 1.37-1.25 (br, 11H), 0.94 (d, J 
= 6.3 Hz, 3H), 0.91 (d, J = 6.2 Hz, 3H), 0.87 (t, J = 6.7 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.1, 53.5, 44.0, 39.2, 31.8, 29.6, 29.3 (2C), 27.0, 24.9, 
23.3, 22.7, 21.6, 14.1 
FT-IR (NaCl): 3298, 2955, 2926, 2855, 1649, 1538, 1467, 1368, 846 cm-1 
H2N N
H
O
7
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LC-MS (ESI):  expected m/z: [M + H]+, 243.42 and observed 243.20 
 
 DPL-C8 
This peptide was synthesized following general protocol B and 
purification with achieved using neutral alumina to yield a colorless 
solid (0.31 g, 54% overall yield).  
1H-NMR   (400 MHz, CDCl3) δ = 7.91 (d, J = 8.0 Hz, 1H), 6.37 (br, 1H), 4.30 (q, J = 8.6 
Hz, 1H), 3.77 (dd, J = 8.4, 5.4 Hz, 1H), 3.28-3.12 (m, 2H), 3.05-2.99 (m, 1H), 2.96-2.91 
(m, 1H), 2.29 (br, 1H), 2.19-2.10 (m, 1H), 1.86 (sext, J = 6.6 Hz, 1H), 1.77-1.52 (m, 5H), 
1.45 (p, J = 6.6 Hz, 2H), 1.26 (br, 10H), 0.93 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.3 Hz, 3H), 
0.87 (t, J = 6.9 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.4, 172.1, 60.5, 51.6, 47.4, 40.3, 39.6, 32.0, 31.0, 
29.7, 29.4 (2C), 27.1, 26.2, 25.1, 23.1, 22.8, 22.3, 14.3 
FT-IR: (KBr pellet) ν = 3290 (s), 3094 (w), 2957 (m), 2923 (m), 2853 (m), 1641 (s), 1543 
(m), 1468 (m), 1230 (m), 845 (s), 721 (m), 703 (m) cm-1 
MP: 72 – 74 °C 
MALDI:  expected m/z: [M + Na]+, 362.28 and observed 362.30 
 
H2N-Leu-C10 
This intermediate was synthesized following protocol A to yield a 
colorless oil (0.43 g, 81% overall yield). 
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1H-NMR   (400 MHz, CDCl3) δ = 7.59 (br, 1H), 4.88 (brs, 2H), 3.77 (br, 1H), 3.33-3.24 (m, 
1H), 3.19-3.11 (m, 1H), 1.72 (br, 2H), 1.57-1.49 (m, 3H), 1.31-1.25 (m, 14H), 0.97 (d, J = 
6.1 Hz, 3H), 0.95 (d, J = 6.0 Hz, 3H), 0.88 (t, J = 6.6 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.0, 53.5, 43.9, 39.2, 31.9, 29.6 (2C, large peak), 29.4, 
27.0, 24.9, 23.3, 22.7, 21.6, 14.1 
LC-MS (ESI): expected m/z: [M + H]+, 271.47 and observed 271.20 
 
DPL-C10  
This peptide was synthesized following protocol B to yield a glassy 
solid (0.43 g, 66% overall yield).   
1H-NMR   (400 MHz, CDCl3) δ = 7.88 (d, J = 8.3 Hz, 1H), 6.35 (br, 1H), 4.30 (td, J = 8.7, 
6.2 Hz, 1H), 3.74 (dd, J = 9.2, 5.2 Hz, 1H), 3.28-3.12 (m, 2H), 3.03-2.97 (m, 1H), 2.93-
2.87 (m, 1H), 2.17-2.08 (m, 1H), 1.96 (br, 1H), 1.86 (sext, J = 6.7 Hz, 1H), 1.78-1.52 (m, 
5H), 1.45 (p, J = 6.7 Hz, 2H), 1.25 (br, 14H), 0.93 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.4 Hz, 
3H), 0.87 (t, J = 7.0 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.9, 172.0, 60.6, 51.4, 47.4, 40.2, 39.6, 32.1, 31.0, 
29.7 (large peak), 29.5 (2C), 27.0, 26.3, 25.0, 23.1, 22.9, 22.3, 14.3 
FT-IR: (KBr pellet) ν = 3281 (m), 3071 (w), 2956 (m), 2924 (s), 2853 (m), 1642 (s), 1552 
(m), 1468 (m), 1253 (m), 847 (s), 711 (w) cm-1 
MP: 61 – 63 °C 
MALDI:  expected m/z: [M + Na]+, 390.31 and observed 390.24 
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 H2N-Leu-C12 
This intermediate was synthesized following protocol A to yield a 
colorless solid (0.44 g, 75% overall yield).  
1H-NMR   (400 MHz, CDCl3) δ = 7.67 (t, J = 5.3 Hz, 1H), 5.45 (br, 2H), 3.40 (br, 1H), 3.27-
3.19 (m, 1H), 3.14-3.06 (m, 1H), 1.72-1.63 (m, 2H), 1.51-1.43 (m, 3H), 1.24 (br, 18H), 
0.92 (d, J = 6.2 Hz, 3H), 0.90 (d, J = 6.2 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.2, 53.7, 44.2, 39.3, 32.1, 29.9, 29.8 (4C), 29.5 (2C), 
27.2, 25.1, 23.6, 22.9, 21.6, 14.3 
FT-IR: (KBr pellet) ν = 3345 (m), 3309 (m), 3075 (w), 2956 (m), 2924 (s), 2853 (m), 1649 
(m), 1533 (m), 1468 (m), 1379 (m), 845 (w), 721 (w) cm-1 
MP: 30-33 °C 
LC-MS (ESI): expected m/z: [M + H]+, 299.31 and observed 299.25 
 
 DPL-C12  
This peptide was synthesized following general protocol B, and 
purification with achieved using neutral alumina to yield a colorless 
solid (0.33 g, 47% overall yield).  
1H-NMR   (400 MHz, CDCl3) δ = 7.88 (d, J = 8.4 Hz, 1H), 6.35 (br, 1H), 4.30 (td, J = 8.7, 
6.2 Hz, 1H), 3.75 (dd, J = 9.2, 5.2 Hz, 1H), 3.28-3.12 (m, 2H), 3.03-2.97 (m, 1H), 2.93-
2.87 (m, 1H), 2.17-2.08 (m, 1H), 1.93-1.80 (m, 3H), 1.78-1.52 (m, 5H), 1.45 (p, J = 6.7 
Hz, 2H), 1.24 (br, 18H), 0.93 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.4 Hz, 3H), 0.87 (t, J = 7.0 
Hz, 3H) 
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13C-NMR (100 MHz, CDCl3) δ = 175.9, 172.0, 60.6, 51.4, 47.4, 40.3, 39.6, 32.1, 31.0, 
29.8 (3C), 29.7 (2C), 29.5 (2C), 27.0, 26.3, 25.0, 23.1, 22.9, 22.3, 14.3   
FT-IR: (KBr pellet) ν = 3288 (s), 3096 (w), 2957 (m), 2921 (s), 2851 (s), 1641 (s), 1559 
(m), 1542 (m), 1468 (m), 1386 (m), 1230 (m), 721 (m), 700 (m) cm-1 
MP: 72-74 °C 
MALDI: expected m/z: [M + Na]+, 418.34 and observed 418.62 
 
H2N-Leu-C14 
This intermediate was synthesized following protocol A to yield a 
colorless viscous oil (0.64 g, 98% overall yield). 
1H-NMR (300 MHz, CDCl3) δ = 7.42 (br, 1H), 3.58 (br, 3H), 3.28-3.09 (m, 2H), 1.72-1.63 
(m, 2H), 1.49-1.39 (m, 3H), 1.25 (br, 22H), 0.93 (d, J = 7.1 Hz, 3H), 0.91 (d, J = 6.6 Hz, 
3H), 0.87 (t, J = 6.9 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 173.1, 53.2, 42.8, 39.6, 32.1, 29.9 (large peak), 29.8 
(3C), 29.7, 29.5 (2C), 27.1, 24.8, 23.0, 22.8, 22.0, 14.3 
FT-IR: (KBr pellet) ν = 3349 (m), 3296 (m), 3080 (m), 2956 (s), 2922 (s), 2851 (s), 1667 
(s), 1624 (s), 1526 (s), 1469 (s), 1202 (s), 1180 (m), 1140 (m), 837 (w), 801 (m), 721 (m) 
cm-1 
MP: 35-37 °C 
LC-MS (ESI): expected m/z: [M + H]+, 327.34 and observed 327.25 
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 DPL-C14  
This peptide was synthesized following protocol B to yield a 
colorless solid (0.38 g, 50% overall yield). 
1H-NMR   (400 MHz, CDCl3) δ = 8.07 (d, J = 8.4 Hz, 1H), 6.63 (br, 1H), 4.34 (td, J = 8.4, 
5.9 Hz, 1H), 3.90 (dd, J = 8.3, 5.6 Hz, 1H), 3.41 (br, 1H), 3.23-3.14 (m, 2H), 3.12-2.97 (m, 
2H), 2.19 (sext, J = 7.6 Hz, 1H) 1.88 (sext, J = 6.7 Hz, 1H), 1.78-1.69 (m, 3H), 1.66-1.52 
(m, 2H), 1.46 (p, J = 6.7 Hz, 2H), 1.24 (br, 22H), 0.93 (d, J = 6.2 Hz, 3H), 0.90 (d, J = 6.4 
Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H)  
13C-NMR (100 MHz, CDCl3) δ = 174.6, 172.1, 60.5, 51.8, 47.3, 40.5, 39.7, 32.1, 30.9, 
29.9 (3C, large peak), 29.8 (2C), 29.7, 29.5 (2C), 27.1, 26.0, 25.1, 23.1, 22.9, 22.3, 14.3 
FT-IR: (KBr pellet) ν = 3289 (s), 3096 (w), 2957 (m), 2921 (s), 2850 (s), 1641 (s), 1560 
(m), 1542 (m), 1467 (m), 1229 (w), 840 (w), 721 (w), 699 (w) cm-1 
MP: 73 – 75 °C 
LC-MS (ESI): expected m/z: [M + H]+ 424.39 and observed 424.30 
 
Boc-Leu-C16 
To a flame-dried 100 mL round bottom flask equipped with 
magnetic stir bar was added Boc-L-Leu-OH (2.27 g, 9.1 mmol), 
HBTU (4.14 g, 10.9 mmol), and DMF (40 mL). To the stirred solution was added DIPEA 
(3.2 mL, 18.2 mmol) via syringe and after complete addition was stirred for ca. 5 mins. 
Hexadecylamine (2.64 g, 10.9 mmol) was then added slowly in one portion to the round 
bottom flask. The mixture was then allowed to stir at room temperature for one hour. The 
reaction was stopped and then transferred to a separatory funnel. The round bottom flask 
was rinsed several times with ethyl acetate and transferred to the separatory funnel (~300 
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mL total). The organics were washed with saturated NaHCO3 (2 x 50 mL), then with water 
(4 x 150 mL), and finally with saturated brine (~50 mL). The organic layer was dried over 
MgSO4, filtered over a fritted funnel and concentrated to produce a pale yellow solid. The 
solid was recrystallized from 1:3 EtOAc:hexanes, filtered over a frit and rinsed with cold 
hexanes to yield a white powder (1.35 g, 33%). Note 1: Purification by silica gel 
chromatography and eluting with EtOAc:hexanes (1:9 – 2:1) will provide higher isolated 
yields. Note 2: The Boc intermediate and impurities are typically carried through the 
syntheses until purification of the deprotected dipeptide. Note 3: All Boc protected amino 
acids and Boc-peptide intermediates examined by 1H NMR showed rotamers under 
ambient temperatures. 
 
1H-NMR   (400 MHz, CDCl3) δ = 6.03 (br, 1H), 5.74 (rotamer), 4.83 (br, 1H), 4.03 (br, 1H), 
3.23 (q, J = 6.6 Hz, 2H), 3.00 (br, 1H), 1.71-1.60 (m, 2H) 1.50-1.44 (m, 11H), 1.25 (br, 
26H), 0.94 (d, J = 4.2 Hz, 3H), 0.93 (d, J = 2.8 Hz, 3H), 0.88 (t, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 172.6, 161.8, 156.0, 80.1, 53.4, 45.8, 41.5, 40.0, 39.7, 
32.1, 31.1, 30.0, 29.9 (large peak), 29.8 (2C) 29.7 (2C), 29.5 (2C), 29.3, 28.5, 27.0, 26.9, 
24.9, 23.1, 22.9, 22.3, 14.3 
FT-IR: (KBr pellet) ν = 3330 (m), 3289 (m), 2956 (m), 2918 (s), 2850 (m), 1688 (m), 1657 
(s), 1542 (m), 1169 (m), 1048 (w), 1028 (w), 839 (w) cm-1 
MP: 58–60 °C 
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H2N-Leu-C16   
This intermediate was synthesized following general protocol A, Boc-
Leu-C16 (617 mg, 1.35 mmol) and 5 mL of TFA. Purification afforded an 
off-white solid (460 mg, 96% yield).  
1H-NMR   (400 MHz, CDCl3) δ = 7.25 (br, 1H), 3.38 (dd, J = 10.0, 3.5 Hz, 1H), 3.22 (q, J 
= 6.8 Hz) 1.90 (br, 2H), 1.75-1.66 (m, 2H), 1.49 (p, J = 7.1 Hz, 2H), 1.36-1.24 (m, 28H), 
0.95 (d, J = 6.2 Hz, 3H), 0.92 (d, J = 6.1 Hz, 3H), 0.8& (t, J = 7.0 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.4, 53.7, 44.3, 39.3, 32.1, 29.9 (2C, large peak), 29.8 
(3C), 29.6, 29.5, 27.1, 25.1, 23.6, 22.9, 21.6, 14.3 
FT-IR: (KBr pellet) ν = 3406 (m), 3351 (m), 2958 (m), 2919 (s), 2849 (s), 1624 (s), 1526 
(m), 1470 (m), 1143 (w), 720 (w) cm-1 
MP:  53–56 °C 
LC-MS (ESI): expected m/z: [M + H]+, 355.37 and observed 355.30 
 
Boc-DPL-C16  
To a flame-dried 50 mL round bottom flask equipped with 
magnetic stir bar H2N-Leu-C16 (709.2 mg, 2.0 mmol), Boc-D-Pro-
OH (478.3 mg, 2.2 mmol), HBTU (842.7 mg, 2.2 mmol), and DMF (10 mL) were added. 
To the stirred solution DIPEA (0.70 mL, 4.0 mmol) was added dropwise via syringe. After 
the addition was complete the mixture was allowed to stir at room temperature for one 
hour and then transferred to a separatory funnel. The round bottom flask was rinsed 
several times with EtOAc and transferred to the separatory funnel (200 mL total). The 
organics were washed with saturated NaHCO3 (2 x 50 mL) then water (4 x 100 mL), and 
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finally with saturated brine (50 mL). The organics were dried over MgSO4, filtered over a 
fritted funnel and concentrated to afford a yellow solid. Purification by silica gel 
chromatography and eluting with 1:9 to 2:1 gradient of EtOAc:Hexanes results in isolation 
of a white solid (1.10 g, 83%). 
1H-NMR   (400 MHz, CDCl3) δ = 6.82, 6.21 (br, 1H), 6.47 (brs, 1H), 4.39 (td, J = 9.0, 4.9 
Hz, 1H), 4.15 (br, 1H), 3.46, 3.37 (m, 2H), 3.19 (br, 2H), 2.18-1.91 (m, 3H) 1.84 (br, 2H), 
1.63 (sept, J = 6.7 Hz, 1H), 1.54-1.43 (m, 12H), 1.23 (br, 26 H), 0.90 (t, J = 6.2 Hz, 6H), 
0.86 (t, J = 7.0 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 172.7, 171.8, 155.6, 80.7, 61.4, 60.8, 51.9, 47.4, 41.3, 
40.6, 39.8, 32.1, 29.9 (large peak), 29.8 (2C), 29.7, 29.5 (2C), 28.5, 27.1, 25.0, 23.2, 22.9, 
21.9, 14.3 
FT-IR: (KBr pellet) ν = 3335 (m), 3261 (m), 3050 (w), 2957 (m), 2924 (m), 2853 (m), 1685 
(s), 1639 (s), 1553 (m), 1419 (m), 1164 (m), 772 (w), 685 (w) cm-1 
MP:  58–60 °C 
 
DPL-C16 
To the flask containing Boc-DPro-Leu-C16 (6.18 g, 11.2 mmol) was 
added a magnetic stirring bar and trifluoroacetic acid (ca. 20 mL). The solution was then 
stirred for one hour under ambient conditions in air. TFA was then removed by blowing 
air over it until a viscous oil remained. The excess TFA was then neutralized with 
saturated NaHCO3 (pH = 8). The solution was then transferred to a separatory funnel. 
The round bottom flask was then rinsed several times with EtOAc (100 mL total) and 
added to the separatory funnel. The organics were separated, and then the organics were 
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extracted from the aqueous layer using EtOAc (2 x 75 mL). The combined organics were 
washed with saturated brine, dried over MgSO4, filtered over a fritted funnel and 
concentrated to afford a light-yellow solid. 5 mL of hexanes was added and the solid was 
heated until completely dissolved. After precipitation, the solid was then triturated in 
hexanes and filtered over a coarse fritted funnel. The residual solid was washed with cold 
hexanes and a white powder was isolated (2.4 g). The mother liquor was concentrated 
and a second round of trituration was performed in a similar manner, also yielding a white 
powder (1.4 g, 3.8 g total yield, 75%). If trituration was not successful, then the standard 
purification by chromatography was performed. 
1H-NMR   (800 MHz, CDCl3) δ = 7.88  (d, J = 8.4 Hz, 1H), 6.35 (br, 1H), 4.30 (td, J = 8.7, 
6.2 Hz, 1H), 3.74 (dd, J = 9.2, 5.3 Hz, 1H), 3.25-3.21 (m, 1H) 3.18-3.14 (m, 1H), 3.00 (dt, 
J = 10.2, 6.8 Hz, 1H), 2.90 (dt, J = 10.2, 6.3 Hz 1H), 2.15-2.10 (m, 1H) 1.98 (br, 1H), 1.86 
(sext, J = 6.6 Hz, 1H), 1.76-1.72 (m, 1H), 1.69-1.67 (m, 2H), 1.64-1.60 (m, 1H), 1.57-1.53 
(m, 1H), 1.45 (p, J = 6.9 Hz, 2H), 1.25 (br, 26H), 0.93 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.6 
Hz, 3H), 0.87 (t, J = 7.2 Hz, 3H)  
13C-NMR (100 MHz, CDCl3) δ = 175.8, 172.0, 60.6, 51.5, 47.4, 40.2, 39.6, 32.1, 31.0, 
29.9 (3C, large peak), 29.8 (2C), 29.6, 29.5, 27.1, 26.3, 25.1, 23.1, 22.9, 22.3, 14.3  
FT-IR: (KBr pellet) ν = 3288 (m), 3095 (w), 2957 (m), 2920 (s), 2850 (m), 1641 (s), 1542 
(m), 1458 (m), 1384 (m), 1230 (w), 857 (w), 706 (w) cm-1 
MP: 58 – 60 °C 
MALDI:  expected m/z: [M + H]+, 474.40 and observed 474.39 
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H2N-Leu-C18 
This intermediate was synthesized following protocol A to yield a white 
solid (0.2 g, 24% overall yield).  
1H-NMR   (400 MHz, CDCl3)  δ = 7.29 (t, J = 5.6 Hz, 1H), 3.47 (dd, J = 9.4, 3.7 Hz, 1H), 
3.27-3.18 (m, 2H), 2.63 (br, 2H), 1.77-1.66 (m, 2H), 1.49 (p, J = 7.0 Hz, 2H), 1.41-1.36 
(m, 1H), 1.25 (br, 30H), 0.96 (d, J = 6.2 Hz, 3H), 0.93 (d, J = 6.0 Hz, 3H), 0.88 (t, J = 6.5 
Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 174.6, 53.6, 43.8, 39.4, 32.1, 29.9 (2C, large peak), 29.8 
(3C), 29.6, 29.5, 27.2, 25.1, 23.5, 22.9, 21.7, 14.3 
FT-IR: (KBr pellet) ν = 3352 (m), 3307 (m), 2957 (m), 2919 (s), 2849 (s), 1625 (m), 1526 
(m), 1470 (m), 1382 (w), 1242 (w), 1142 (w), 720 (m) cm-1 
MP:  57–60 °C 
LC-MS (ESI): expected m/z: [M + H]+, 383.40 and observed 383.35 
 
 DPL-C18  
This peptide was synthesized following general protocol B, and 
purification was performed using neutral alumina to yield a white 
solid (0.25 g, 29% overall yield). 
1H-NMR   (400 MHz, CDCl3) δ = 8.06 (d, J = 8.4 Hz, 1H), 6.61 (t, J = 5.0 Hz, 1H), 4.34 
(td, J = 8.5, 5.9 Hz, 1H), 3.89 (dd, J = 8.9, 5.5 Hz, 1H), 3.67 (br, 1H), 3.22-3.14 (m, 2H) 
3.10-2.96 (m, 2H), 2.23-2.14 (m, 1H), 1.88 (sext, J = 6.5 Hz, 1H), 1.79-1.68 (m, 3H), 1.66-
1.52 (m, 2H), 1.45 (p, J = 6.5 Hz, 2H), 1.24 (br, 30H), 0.92 (d, J = 6.3 Hz, 3H), 0.89 (d, J 
= 6.4 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H)  
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13C-NMR (100 MHz, CDCl3) δ = 174.6, 172.0, 60.5, 51.7, 47.3, 40.5, 39.7, 32.1, 31.0, 
29.9 (2C, large peak), 29.8 (2C), 29.7, 29.6, 29.5, 27.1, 26.0, 25.1, 23.1, 22.9, 22.3, 14.3 
FT-IR: (KBr pellet) ν = 3290 (s), 3095 (w), 2956 (m), 2919 (s), 2850 (s), 1641 (s), 1559 
(m), 1542 (m), 1467 (m), 1386 (m), 1229 (m), 838 (m), 719 (m), 702 (m) cm-1 
MP: 83 – 85 °C 
MALDI:  expected m/z: [M + Na]+, 502.43 and observed 502.52 
 
 PL-C16  
This peptide was synthesized following protocol B with minor 
modifications, H2N-Leu-C16 (460 mg, 1.3 mmol), HBTU (516.5 mg, 
1.36 mmol), Boc-L-Pro-OH (293.2 mg, 1.36 mmol), DMF (10 mL) and DIPEA (0.45 mL, 
2.6 mmol) were added. Purification using silica gel afforded a pale-yellow solid (207 mg, 
35%). 
1H-NMR   (400 MHz, CDCl3) δ = 7.96  (d, J = 8.6 Hz, 1H), 6.48 (t, J = 5.4 Hz, 1H), 4.35-
4.29 (m, 1H), 3.72 (dd, J = 9.2, 5.1 Hz, 1H), 3.26-3.10 (m, 2H) 3.03-2.98 (m, 1H), 2.91-
2.85 (m, 1H), 2.16-2.07 (m, 2H) 1.88 (sext, J = 6.6 Hz, 1H), 1.74-1.64 (m, 3H), 1.62-1.51 
(m, 2H), 1.47 (p, J = 6.9 Hz, 2H), 1.24 (br, 26H), 0.92 (d, J = 6.3 Hz, 3H), 0.89 (d, J = 6.3 
Hz, 3H), 0.86 (t, J = 7.0 Hz, 3H)  
13C-NMR (100 MHz, CDCl3) δ = 175.7, 172.0, 60.6, 51.4, 47.5, 40.6, 39.7, 32.1, 31.0, 
29.9 (large peak), 29.8 (2C), 29.7, 29.6, 29.5 (2C), 27.1, 26.4, 25.1, 23.1, 22.9, 22.2, 14.3 
FT-IR: (KBr pellet) ν = 3297 (m), 3097 (w), 2956 (m), 2918 (s), 2850 (m), 1641 (s), 1554 
(m), 1538 (m), 1466 (m), 1226 (m), 721 (m) cm-1 
MP: 67 – 69 °C 
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H2N-DLeu-C16 
Following general protocol A, Boc-L-Leucine (1.0 mmol, 252 mg), 
hexadecylamine (1.1 mmol, 280 mg), HBTU (1.1 mmol, 421.4 mg) were 
dissolved in 5 mL of DMF followed by addition of DIPEA (2.0 mmol, 0.35 mL). Purification 
using silica gel afforded a white solid (324 mg, 91 % overall yield). 
1H-NMR   (400 MHz, CDCl3)   δ = 7.32 (br, 1H), 3.44 (br, 1H), 3.25-3.17 (m, 2H), 2.53 (br, 
2H), 1.76-1.66 (m, 2H) 1.48 (p, J = 6.9 Hz, 3H), 1.41-1.34 (m, 1H), 1.24 (br, 26H), 0.95 
(d, J = 6.2 Hz, 3H), 0.92 (d, J = 6.0 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 174.9, 53.6, 43.9, 39.4, 32.1, 29.9 (2C, large peak), 29.8 
(2C), 29.6, 29.5, 27.1, 25.0, 23.5, 22.9, 21.7, 14.3 
FT-IR: (KBr pellet) ν = 3352 (m), 2957 (m), 2922 (s), 2851 (m), 1648 (s), 1526 (m), 1469 
(m), 1203 (w), 1141 (w), 720 (w) cm-1 
MP: 49 – 51 °C 
LC-MS (ESI): expected m/z: [M + H]+, 355.37 and observed 355.80 
 
 PDL-C16  
Following general protocol B with minor modifications, H2N-DLeu-
C16 (177.3 mg, 0.5 mmol), HBTU (210.7 mg, 0.55 mmol), and Boc-
L-Pro-OH (119.6 mg, 0.55 mmol), were dissolved in DMF (5 mL) followed by addition of 
DIPEA (0.17 mL, 1.0 mmol). Purification using silica gel yielded a white solid (175 mg, 
77% overall yield). 
1H-NMR   (400 MHz, CDCl3) δ = 7.95  (d, J = 8.4 Hz, 1H), 6.50 (t, J = 5.2 Hz, 1H), 4.32 
(td, J = 8.7, 6.2 Hz, 1H), 3.77 (dd, J = 9.0, 5.3 Hz, 1H), 3.25-3.11 (m, 2H) 3.04-2.98 (m, 
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1H), 2.95-2.89 (m, 1H), 2.86 (br, 1H), 2.18-2.09 (m, 1H) 1.86 (sext, J = 6.8 Hz, 1H), 1.76-
1.50 (m, 5H), 1.44 (t, J = 6.7 Hz, 2H), 1.24 (br, 26H), 0.92 (d, J = 6.4 Hz, 3H), 0.89 (d, J 
= 6.4 Hz, 3H), 0.86 (t, J = 7.0 Hz, 3H)  
13C-NMR (100 MHz, CDCl3) δ = 175.5, 172.0, 60.5, 51.5, 47.4, 40.3, 39.6, 32.1, 31.0, 
29.9 (2C, large peak), 29.8 (2C), 29.7 (2C), 29.5 (2C), 27.1, 26.2, 25.1, 23.1, 22.9, 22.3, 
14.3 
FT-IR: (KBr pellet) ν = 3289 (s), 3095 (w), 2957 (m), 2920 (s), 2850 (s), 1641 (s), 1560 
(m), 1542 (m), 1467 (m), 1386 (m), 1229 (m), 720 (m), 699 (m) cm-1 
MP: 80-82 °C 
LC-MS (ESI): expected m/z: [M + H]+, 452.42 and observed 452.30 
 
 H2N-Phe-C12  
This intermediate was synthesized similarly to protocol A using Boc-L-
phenylalanine (6.0 mmol, 1.59 g), dodecylamine (5.0 mmol, 0.92 g), and 
HCTU (6.0 mmol, 2.48 g) in 25 mL of DMF and DIPEA (8.0 mmol, 1.34 mL). Purification 
yielded a white solid (1.28 g, 65% overall yield).  
1H-NMR   (400 MHz, CDCl3) δ = 7.31 (t, J = 6.9 Hz, 2H), 7.24-7.21 (m, 4H), 3.60 (dd, J = 
8.8, 3.4 Hz, 1H), 3.29-3.21 (m, 3H), 2.69 (dd, J = 13.7, 9.3 Hz, 1H), 1.47 (p, J = 6.8 Hz, 
2H), 1.35 (br, 2H), 1.26 (br, 18H), 0.88 (t, J = 6.6 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 174.2, 138.2, 129.5, 128.8, 126.9, 56.7, 41.3, 39.2, 32.1, 
29.8 (3C, large peak), 29.7, 29.5 (2C), 27.1, 22.9, 14.3 
FT-IR: (neat) ν = 3286 (m), 2955 (m), 2916 (s), 2849 (s), 1631 (s), 1549 (m), 1523 (m), 
848 (m), 741 (s), 718 (s) cm-1 
H2N N
H
O
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MP: 56-58 °C 
LC-MS (ESI): expected m/z: [M + H]+, 333.29 and observed 333.25 
 
 DPF-C12 
This peptide was synthesized following protocol B to yield a 
colorless solid (0.33 g, 47% overall yield).  
1H-NMR   (400 MHz, CDCl3) δ = 8.14 (d, J = 8.2 Hz, 1H), 7.29-7.19 (m, 5H), 6.21 (br, 1H), 
4.52 (q, J = 7.6, 1H), 3.72 (dd, J = 9.1, 5.3 Hz, 1H), 3.16-3.10 (m, 3H), 3.06-2.86 (m, 3H), 
2.15-2.05 (m, 1H), 1.81 (sext, J = 5.9 Hz, 1H), 1.73-1.59 (m, 2H), 1.38-1.18 (m, 21H), 
0.88 (t, J = 6.6 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 175.3, 171.0, 137.4, 129.5, 128.7, 127.0, 60.5, 54.8, 
47.3, 39.6, 38.0, 32.1, 30.9, 29.8 (3C), 29.7, 29.5 (3C), 27.0, 26.1, 22.9, 14.3  
FT-IR: (neat) ν = 3279 (m), 3088 (w), 2919 (m), 2850 (m), 1642 (s), 1540 (m), 1380 (w), 
1230 (m), 915 (m), 699 (s) cm-1 
MP: 105-107 °C 
LC-MS (ESI): expected m/z: [M + H]+, 430.34 and observed 430.30 
H
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Characterization Of Transfer Hydrogenation Products  
1-phenylethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and acetophenone (59.5 µL, 0.5 mmol) were added to the microtube via 
micropipette. After 3 hours, the biphasic mixture is then passed through a short silica plug 
and eluted with MTBE. The solvent was then removed by rotavap to give a colorless to 
pale-yellow oil and the yield of the reaction was determined by 1H NMR (76% conversion), 
ee = 93% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 mL/min flow rate, λ= 
254 nm, retention (min): (R) = 7.9, (S) = 9.8). 
1H-NMR   (400 MHz, CDCl3) δ =  7.40-7.34 (m, 4H), 7.30-7.26 (m, 1H), 4.90 (q, J =  6.5 
Hz, 1H), 1.82 (brs, 1H),  1.51 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 146.0, 128.7, 127.7, 125.6, 70.6, 25.4  
 
1-(4-methoxyphenyl)ethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 4’-methoxyacetophenone (75.8 mg, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a pale-yellow oil and the yield of the reaction was determined by 1H NMR (35% 
conversion), ee = 91% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 mL/min 
flow rate, λ= 254 nm, retention (min): (R) = 10.3, (S) = 11.5). 
1H-NMR   (400 MHz, CDCl3) δ = 7.30 (dt, J = 8.6, 2.9 Hz, 2H), 6.89 (dt, J = 8.8, 2.9 Hz, 
2H), 4.85 (q, J = 6.4 Hz, 1H), 3.80 (s, 3H), 1.79 (brs, 1H), 1.48 (d, J = 6.4 Hz, 3H)  
OH
MeO
OH
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13C-NMR (100 MHz, CDCl3) δ = 159.2, 138.2, 126.9, 114.1, 70.2, 55.5, 25.2  
1-(4-bromophenyl)ethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 4’-bromoacetophenone (100.5 mg, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a colorless to pale-yellow oil and the yield of the reaction was determined by 1H NMR 
(88% conversion), ee = 90% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 
mL/min flow rate, λ= 254 nm, retention (min): (R) = 8.9, (S) = 8.3). 
1H-NMR   (400 MHz, CDCl3) δ = 7.46 (dt, J = 8.4, 2.4 Hz, 2H), 7.23 (dt, J = 8.4, 2.3 Hz, 
2H), 4.84 (q, J = 6.4 Hz, 1H), 2.03 (brs, 1H), 1.45 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 145.0, 131.7, 127.3, 121.3, 69.9, 25.4  
 
1-(4-fluorophenyl)ethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 4’-fluoroacetophenone (61.1 µL, 0.5 mmol) were added to the microtube via 
micropipette. After 3 hours, the biphasic mixture is then passed through a short silica plug 
and eluted with MTBE. The solvent was then removed by rotavap to give a colorless to 
pale-yellow oil and the yield of the reaction was determined by 1H NMR (77% conversion), 
ee = 92% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 mm x 0.25 µm), T = 135 °C, 
P = 1.1 mL/min (8.07 psi) He, detector = FID 230 °C, injection = 230 °C, retention (min): 
(R) = 14.8, (S) = 15.3). 
OH
Br
OH
F
 
 249 
1H-NMR   (400 MHz, CDCl3) δ = 7.34-7.31 (m, 2H), 7.04-7.00 (m, 2H), 4.87 (dq, J = 6.4, 
3.4 Hz, 1H), 2.06 (d, J = 3.4 Hz, 1H), 1.46 (d, J = 6.4 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 162.3 (d, J = 243.7 Hz), 141.7 (d, J = 3.2 Hz), 127.2 (d, 
J = 8.0 Hz), 115.4 (d, J = 21.2 Hz), 69.9, 25.5  
 
1-[(4-trifluoromethyl)phenyl]ethanol8 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 4’-trifluoromethylacetophenone (96.0 mg, 0.5 mmol) were added to 
the microtube via micropipette. After 3 hours, the biphasic mixture is then passed through 
a short silica plug and eluted with MTBE. The solvent was then removed by rotavap to 
give a white solid and the yield of the reaction was determined by 1H NMR (99% 
conversion, 92 mg, (97% isolated yield)), ee = 93% (S) by GC: (Agilent J&W Cyclodex-B 
(30 m x 0.25 mm x 0.25 µm), T = 135 °C, P = 1.1 mL/min (8.07 psi) He, detector = FID 
230 °C, injection = 230 °C, retention (min): (R) = 18.1, (S) = 19.0). 
1H-NMR   (300 MHz, CDCl3) δ = 7.60 (d, J = 8.2 Hz, 2H), 7.48 (d, J = 8.1 Hz, 2H), 4.95 
(dq, J = 6.5, 3.8  Hz, 1H), 2.10 (d, J = 3.6 Hz, 1H), 1.49 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 149.9 (d, J = 1.1 Hz), 129.8 (q, J = 32.2 Hz), 125.9, 125.6 
(q, J = 3.7 Hz), 124.4 (q, J = 270.4 Hz), 70.0, 25.6 
 
1-(3-methoxyphenyl)ethanol8 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 3’-methoxyacetophenone (70.8 µL, 0.5 mmol) were added to 
the microtube via micropipette. After 3 hours, the biphasic mixture is then passed through 
OMe
OH
OH
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a short silica plug and eluted with MTBE. The solvent was then removed by rotavap to 
give a white solid and the yield of the reaction was determined by 1H NMR (92% 
conversion), ee = 91% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 mL/min 
flow rate, λ= 254 nm, retention (min): (R) = 10.9, (S) = 14.0). 
1H-NMR   (400 MHz, CDCl3) δ = 7.29-7.25 (m, 1H), 6.95 (dd, J = 4.0, 1.7 Hz, 2H), 6.82 
(ddd, J = 8.2, 2.5, 0.8 Hz, 2H), 4.88 (q, J = 6.4 Hz, 1H), 3.82 (s, 3H), 1.81 (brs, 1H), 1.50 
(d, J = 6.4 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 160.0, 147.8, 129.8, 117.9, 113.1, 111.1, 70.6, 55.4, 25.4 
 
1-(3-nitrophenyl)ethanol9 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 3’-nitroacetophenone (85.1 mg, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a light yellow solid and the yield of the reaction was determined by 1H NMR (98% 
conversion, 76 mg (91% isolated yield)), ee = 83% (S) by HPLC (Lux Cellulose-1, 
EtOH:Hexanes = 2:98, 1.0 mL/min flow rate, λ= 254 nm, retention (min): (R) = 28.5, (S) 
= 29.9). 
1H-NMR   (400 MHz, CDCl3) δ = 8.25 (t, J = 1.6 Hz, 1H), 8.13 (ddd, J = 8.1, 2.0, 0.8 Hz, 
2H), 7.73-7.71 (m, 1H), 7.52 (t, J = 8.0 Hz, 1H), 5.02 (q, J = 6.4 Hz, 1H), 2.03 (brs, 1H), 
1.54 (d, J = 6.4 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 148.6, 148.1, 131.8, 129.7, 122.6, 120.7, 69.6, 25.7  
 
NO2
OH
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1-[(3,5-bistrifluoromethyl)phenyl]ethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 3’,5’-bis(trifluoromethyl)acetophenone (91.9 µL, 0.5 
mmol) were added to the microtube via micropipette. After 3 hours, the biphasic mixture 
is then passed through a short silica plug and eluted with MTBE. The solvent was then 
removed by rotavap to give a white solid and the yield of the reaction was determined by 
1H NMR (97% conversion), ee = 94% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 
mm x 0.25 µm), T = 135 °C, P = 1.1 mL/min (8.07 psi) He, detector = FID 230 °C, injection 
= 230 °C, retention (min): (R) = 13.4, (S) = 12.9). 
1H-NMR   (300 MHz, CDCl3) δ = 7.84 (s, 2H) 7.79 (s, 1H), 5.04 (q, J = 6.4 Hz, 1H), 2.10 
(s, 1H), 1.54 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 148.4, 132.0 (q, J = 33.2 Hz), 125.9 (d, J = 2.5 Hz), 123.6 
(q, J = 271.1 Hz) 121.5 (sept, J = 3.6 Hz), 69.5, 25.8 
 
1-(2-methoxyphenyl)ethanol6 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 2’-methoxyacetophenone (68.9 µL, 0.5 mmol) were added to 
the microtube via micropipette. After 3 hours, the biphasic mixture is then passed through 
a short silica plug and eluted with MTBE. The solvent was then removed by rotavap to 
give a colorless to pale-yellow oil and the yield of the reaction was determined by 1H NMR 
(68% conversion), ee = 73% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 
mL/min flow rate, λ= 254 nm, retention (min): (R) = 9.5, (S) = 8.8). 
OH
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1H-NMR   (400 MHz, CDCl3) δ = 7.34 (dd, J = 7.5, 1.6 Hz, 1H), 7.25 (td, J = 8.0, 1.8 Hz, 
1H), 6.97 (td, J = 7.5, 1.0 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H), 5.10 (q, J = 6.5 Hz, 1H), 3.87 
(s, 3H), 2.62 (brs, 1H), 1.51 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 156.8, 133.6, 128.5, 126.3, 121.0, 110.6, 66.8, 55.5, 23.0 
 
1-(2-hydroxyphenyl)ethanol10 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 2’-hydroxyacetophenone (61.5 µL, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a colorless to pale-yellow oil and the yield of the reaction was determined by 1H NMR 
(96% conversion, 68 mg (98% isolated yield)), ee = 90% (S) by HPLC (Lux Cellulose-1, 
EtOH:Hexanes = 3:97, 1.0 mL/min flow rate, λ= 254 nm, retention (min): (R) = 19.8, (S) 
= 18.9). 
1H-NMR   (400 MHz, CDCl3) δ = 8.10 (brs, 1H), 7.16 (td, J = 7.8, 1.6 Hz, 1H), 6.98 (dd, J 
= 7.9, 1.2 Hz, 1H), 6.86-6.82 (m, 2H), 5.03 (q, J = 6.6 Hz, 1H), 3.19 (brs, 1H), 1.56 (d, J 
= 6.6 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 155.3, 129.0, 128.7, 126.7, 120.2, 117.1, 71.5, 23.5 
 
1-(2-methylphenyl)ethanol5 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 2’-methylacetophenone (66.7 µL, 0.5 mmol) were added to the microtube 
via micropipette. After 3 hours, the biphasic mixture is then passed through a short silica 
OH
Me
OH
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plug and eluted with MTBE. The solvent was then removed by rotavap to give a colorless 
to pale-yellow oil and the yield of the reaction was determined by 1H NMR (27% 
conversion), ee = 78%  (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 mL/min 
flow rate, λ= 254 nm, retention (min): (R) = 7.7, (S) = 7.2). 
1H-NMR   (400 MHz, CDCl3) δ = 7.52 (dd, J = 7.8, 1H), 7.24 (td, J = 7.8, 1.2 Hz, 1H), 
7.20-7.13 (m, 2H), 5.14 (q, J = 6.4 Hz, 1H), 2.35 (s, 3H), 1.75 (brs, 1H), 1.47 (d, J = 6.4 
Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 144.0, 134.4, 130.5, 127.3, 126.5, 124.7, 67.0, 24.1, 19.1 
 
1-(2-chlorophenyl)ethanol9  
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 2’-chloroacetophenone (67.7 µL, 0.5 mmol) were added to the microtube via 
micropipette. After 3 hours, the biphasic mixture is then passed through a short silica plug 
and eluted with MTBE. The solvent was then removed by rotavap to give a pale to light 
yellow oil and the yield of the reaction was determined by 1H NMR (99% conversion, 72 
mg (92% isolated yield)), ee  = 83% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 
mm x 0.25 µm), T = 135 °C, P = 1.2 mL/min (9.10 psi) He, detector = FID 230 °C, injection 
= 230 °C, retention (min): (R) = 16.5, (S) = 17.6). 
1H-NMR (400 MHz, CDCl3) δ = 7.59 (dd, J = 7.8, 1.3 Hz, 1H), 7.33-7.28 (m, 2H), 7.21-
7.12 (m, 2H), 7.20 (td, J = 7.6, 1.6 Hz, 1H), 5.29 (q, J = 6.4 Hz, 1H), 2.12 (brs, 1H), 1.49 
(d, J = 6.4 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 143.2, 131.9, 129.6, 128.6, 127.4, 126.6, 67.2, 23.7 
 
OH
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2-hydroxy-1-phenylethanol9 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 2-hydroxyacetophenone (68.8 µL, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a colorless to pale-yellow solid and the yield of the reaction was determined by 1H NMR 
(92% conversion), ee = 79% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 
mL/min flow rate, λ= 254 nm, retention (min): (R) = 16.6, (S) = 15.1). 
1H-NMR   (400 MHz, CDCl3) δ = 7.38-7.29 (m, 5H), 4.84 (dt, J = 8.1, 3.2 Hz, 1H), 3.80-
3.75 (m, 1H), 3.71-3.65 (m, 1H), 2.50 (brs, 1H), 2.04 (br, 1H)  
13C-NMR (100 MHz, CDCl3) δ = 140.7, 128.8, 128.3, 126.3, 74.9, 68.3 
 
2-chloro-1-phenylethanol9 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 2-chloroacetophenone (78.9 mg, 0.5 mmol) were added to the 
microtube via micropipette. After 3 hours, the biphasic mixture is then passed through a 
short silica plug and eluted with MTBE. The solvent was then removed by rotavap to give 
a pale to light yellow oil and the yield of the reaction was determined by 1H NMR (99% 
conversion, 73 mg (93% isolated yield)), ee = 92% (S) by HPLC (Lux Cellulose-1, 
EtOH:Hexanes = 5:95, 1.0 mL/min flow rate, λ= 254 nm, retention (min): (R) = 10.2, (S) 
= 12.6). 
1H-NMR   (400 MHz, CDCl3) δ = 7.41-7.31 (m, 5H), 4.91 (dd, J = 8.8, 3.4 Hz, 1H), 3.75 
(dd, J = 11.2, 3.4 Hz, 1H), 3.65 (dd, J = 11.2, 8.8 Hz, 1H), 2.63 (brs, 1H) 
OH
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13C-NMR (100 MHz, CDCl3) δ = 140.1, 128.9, 128.7, 126.3, 74.3, 51.2  
 
1-(2-naphthyl)ethanol6 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 2-acetonapthone (86.0 mg, 0.5 mmol) were added to the microtube 
via micropipette. After 3 hours, the biphasic mixture is then passed through a short silica 
plug and eluted with MTBE. The solvent was then removed by rotavap to give a colorless 
to pale-yellow solid and the yield of the reaction was determined by 1H NMR (85% 
conversion), ee = 91%  (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 mm x 0.25 µm), 
T = 160 °C, P = 2.5 mL/min (16.5 psi) He, detector = FID 230 °C, injection = 230 °C, 
retention (min): (R) = 32.6, (S) = 33.1). 
1H-NMR   (400 MHz, CDCl3) δ = 7.86-7.82 (m, 4H), 7.53-7.44 (m, 3H), 5.08 (q, J = 6.4 
Hz, 1H), 1.89 (s, 1H), 1.59 (d, J = 6.4 Hz, 1H) 
13C-NMR (100 MHz, CDCl3) δ = 143.4, 133.6, 133.1, 128.5, 128.2, 127.9, 126.4, 126.0, 
124.0, 70.8, 25.4  
 
1-indanol6 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 1-indanone (66.1 mg, 0.5 mmol) were added to the microtube via 
micropipette. After 3 hours, the biphasic mixture is then passed through a short silica plug 
and eluted with MTBE. The solvent was then removed by rotavap to give a colorless to 
pale-yellow solid and the yield of the reaction was determined by 1H NMR (69% 
OH
OH
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conversion), ee = 95% (S) by HPLC (Lux Cellulose-1, EtOH:Hexanes = 5:95, 1.0 mL/min 
flow rate, λ= 254 nm, retention (min): (R) = 8.9, (S) = 8.1). 
1H-NMR   (300 MHz, CDCl3) δ = 7.44-7.40 (m, 1H), 7.28-7.21 (m, 3H), 5.24 (q, J = 6.8 
Hz, 1H), 3.05 (ddd, J = 15.9, 8.6, 4.8 Hz, 1H), 2.88-2.77 (m, 1H), 2.55-2.44 (m, 1H), 2.00-
1.89 (m, 1H), 1.84 (d, J = 7.1 Hz, 1H) 
13C-NMR (100 MHz, CDCl3) δ = 145.2, 143.5, 128.5, 126.9, 125.1, 124.4, 76.6, 36.1, 30.0 
 
1-(4-pyridyl)ethanol8 
Following ATH Method 1, 0.8 mL of a 3.125 M sodium formate solution in 
water and 4-acetylpyridine (57.0 µL, 0.5 mmol) were added to the microtube via 
micropipette. The biphasic mixture is then transferred to a separatory funnel and the 
organics are extracted twice with either MTBE or DCM. The solvent was then removed 
by rotavap to give an orange oil and the yield of the reaction was determined by 1H NMR 
(37% conversion), ee = 91% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 mm x 
0.25 µm), T = 135 °C, P = 1.1 mL/min (8.07 psi) He, detector = FID 230 °C, injection = 
230 °C, retention (min): (R) = 32.4, (S) = 33.2). 
1H-NMR   (300 MHz, CDCl3) δ = 8.43 (dd, J = 4.5, 1.6 Hz, 2H), 7.28 (ddd, J = 4.5, 1.6, 
0.5 Hz, 2H), 4.87 (q, J = 6.5 Hz, 1H), 3.86 (br, 1H), 1.47 (d, J = 6.6 Hz, 2H) 
13C-NMR (100 MHz, CDCl3) δ = 155.6, 149.6, 120.7, 68.8, 25.3 
 
1-(3-pyridyl)ethanol8 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 3-acetylpyridine (56.7 µL, 0.5 mmol) were added to the microtube via 
N
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micropipette. The biphasic mixture is then transferred to a separatory funnel and the 
organics are extracted twice with either MTBE or DCM. The solvent was then removed 
by rotavap to give an orange-colored oil, and the yield of the reaction was determined by 
1H NMR (37% conversion), ee = 90% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 
mm x 0.25 µm), T = 135 °C, P = 1.1 mL/min (8.07 psi) He, detector = FID 230 °C, injection 
= 230 °C, retention (R) = 29.0, (S) = 29.9). 
1H-NMR   (400 MHz, CDCl3) δ = 8.44 (d, J = 2.1 Hz, 1H), 8.36 (dd, J = 4.8, 1.6 Hz, 1H), 
7.71 (dt, J = 7.9, 1.7 Hz, 1H), 7.23 (dd, J = 7.8, 4.8 Hz, 1H), 4.89 (dq, J = 6.4, 4.1 Hz, 1H), 
4.12 (d, J = 3.7 Hz, 1H), 1.48 (d, J = 6.5 Hz, 2H) 
13C-NMR (100 MHz, CDCl3) δ = 148.4, 147.3, 141.7, 133.6, 123.7, 67.8, 25.4 
 
1-(thiophen-3-yl)ethanol8 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate solution 
in water and 3-acetylthiophene (64.4 mg, 0.5 mmol) were added to the microtube via 
micropipette. After 3 hours, the biphasic mixture is then passed through a short silica plug 
and eluted with MTBE. The solvent was then removed by rotavap to give a colorless to 
give a pale to light yellow oil and the yield of the reaction was determined by 1H NMR 
(77% conversion), ee = 92% (S) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 mm x 
0.25 µm), T = 115 °C, P = 1.0 mL/min (6.95 psi) He, detector = FID 230 °C, injection = 
230 °C, retention (min): (R) = 35.7, (S) = 37.0). 
1H-NMR   (400 MHz, CDCl3) δ = 7.30 (dd, J = 5.0, 3.0 Hz, 1H), 7.19 (d, J = 2.6 Hz, 1H), 
7.10 (dd, J = 5.0, 1.1 Hz, 1H), 4.98 (d, J = 6.4 Hz, 1H), 1.83 (brs, 1H), 1.53 (d, J = 6.5 Hz, 
3H) 
OH
S
 
 258 
13C-NMR (100 MHz, CDCl3) δ = 147.5, 126.4, 125.8, 120.4, 66.8, 24.7 
 
 2-heptanol 
Following ATH Method 1 or 2, 0.8 mL of a 3.125 M sodium formate 
solution in water and 2-heptanone (72.1 µL, 0.5 mmol) were added to the microtube via 
micropipette. After 24 hours, the biphasic mixture is then transferred to a separatory 
funnel and diluted with Et2O (25 mL). The organics were washed with saturated brine (2 
x 10 mL), dried over MgSO4, filtered, and the ether was removed using a warm water 
bath to give a yellow liquid and the yield of the reaction was determined by 1H NMR (77% 
conversion). The crude alcohol is then converted to the corresponding acetate using 
acetic anhydride (200 µL) and a catalytic amount of DMAP (5-10 mg) and left to stir 
overnight at room temperature. The reaction mixture was transferred to a separatory 
funnel, washed with water (10 mL) and the organics were extracted with DCM (2 x 20 
mL). The combined organics were washed with saturated brine (10 mL), dried over 
MgSO4, filtered, and the DCM was removed using a warm water bath to give a yellow oil, 
ee = 17% (R) by GC: (Agilent J&W Cyclodex-B (30 m x 0.25 mm x 0.25 µm), T = 80 °C, 
P = 1.1 mL/min (6.59 psi) He, detector = FID 230 °C, injection = 230 °C, retention (min): 
(R) = 35.4, (S) = 40.8). 
1H-NMR   (400 MHz, CDCl3) δ = 3.83-3.75 (m, 1H), 1.50-1.26 (m, 9H), 1.18 (d, J = 6.2, 
3H), 0.89 (t, J = 6.9 Hz, 1H), 7.10 (dd, J = 5.0, 1.1 Hz, 1H), 4.98 (d, J = 6.4 Hz, 1H), 1.83 
(brs, 1H), 1.53 (d, J = 6.5 Hz, 3H) 
13C-NMR (100 MHz, CDCl3) δ = 68.4, 39.6, 32.1, 25.7, 23.7, 22.8, 14.2 
 
OH
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GC and HPLC Chromatograms  
Note: Absolute configurations in all cases were determined based on results obtained 
from ATH reactions using Cp*Ir(TsDPEN). Note: During the course of this work, the GC 
chiral column was replaced and noticeable shifts in retention time may be apparent.  
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Figure SI 2.1. HPLC chromatogram of the reaction mixture produced by NaBH4  reduction of 
acetophenone. 
 
 
 
 
Figure SI 2.2. HPLC chromatogram of the reaction mixture produced by ATH of acetophenone 
catalyzed by Cp*Ir(DPL-C16). 
OH
OH
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Figure SI 2.3. HPLC chromatogram of the reaction mixture produced by NaBH4  reduction of 4’-
methoxyacetophenone. 
 
 
 
 
Figure SI 2.4. HPLC chromatogram of the reaction mixture produced by ATH of 4’-
methoxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
OH
MeO
OH
MeO
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Figure SI 2.5. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 4’-
bromoacetophenone. 
 
 
 
 
Figure SI 2.6. HPLC chromatogram of the reaction mixture produced by ATH of 4’-
bromoacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Br
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Br
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Figure SI 2.7. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 4’-
fluoroacetophenone. 
 
 
 
Figure SI 2.8. HPLC chromatogram of the reaction mixture produced by ATH of 4’-
fluoroacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Time (min) 
# Time Area Width Height Area % 
1 14.857 187.9783173 18.93641663 0.165446937 2.710 
2 15.385 188.8506622 16.80952454 0.187245682 2.713 
# Time Area Width Height Area % 
1 9.984 37.60312653 5.605824947 0.106258452 0.463 
2 14.669 6.31103754 0.66513133 0.150698096 0.078 
3 15.155 136.2010956 12.80424786 0.164100438 1.678 
OH
F
OH
F
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# Time Area Width Height Area % 
1 10.05 6.36864996 0.932122767 0.107711516 0.069 
2 18.39 182.4779968 16.27620125 0.174798951 1.978 
3 19.41 182.5619507 14.71863461 0.188706994 1.979 
 
Figure SI 2.9. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 4’-
(trifluoromethyl)acetophenone. 
 
 
# Time Area Width Height Area % 
1 9.70 11.49587631 1.047384381 0.168050945 0.029 
2 17.78 280.267334 20.20506668 0.197829977 0.117 
3 18.65 11.49587631 1.047384381 0.168050945 2.843 
 
Figure SI 2.10. HPLC chromatogram of the reaction mixture produced by ATH of 4’-
(trifluoromethyl)acetophenone catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.11. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 3’-
methoxyacetophenone. 
 
 
 
 
Figure SI 2.12. HPLC chromatogram of the reaction mixture produced by ATH of 3’-
methoxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
OMe
OH
OMe
OH
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Figure SI 2.13. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 3’-
nitroacetophenone. 
 
 
 
 
Figure SI 2.14. HPLC chromatogram of the reaction mixture produced by ATH of 3’-
nitroacetophenone catalyzed by Cp*Ir(DPL-C16). 
NO2
OH
NO2
OH
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# Time Area Width Height Area % 
1 13.166 58.52039337 8.063076019 0.112674631 0.644 
2 13.631 58.59947205 7.796162605 0.11569193 0.645 
Figure SI 2.15. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 
3’,5’-bis(trifluoromethyl)acetophenone. 
 
 
# Time Area Width Height Area % 
1 12.698 258.4162903 33.24071121 0.118697718 2.655 
2 13.159 9.677905083 1.103026271 0.134362832 0.099 
Figure SI 2.16. HPLC chromatogram of the reaction mixture produced by ATH of 3’,5’-
bis(trifluoromethyl)acetophenone catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.17. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2’-
methoxyacetophenone. 
 
 
 
 
Figure SI 2.18. HPLC chromatogram of the reaction mixture produced by ATH of 2’-
methoxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.19. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2’-
hydroxyacetophenone.  
 
 
 
Figure SI 2.20. HPLC chromatogram of the reaction mixture produced by ATH of 2’-
hydroxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.21. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2’-
methoxyacetophenone. 
 
 
 
Figure SI 2.22. HPLC chromatogram of the reaction mixture produced by ATH of 2’-
methoxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Me
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# Time Area Width Height Area % 
1 10.755 2.057193995 0.277422041 0.114512943 0.020 
2 16.084 8.395582199 0.944023013 0.139756441 0.083 
3 16.504 296.9397888 28.43065262 0.153850794 2.953 
4 17.703 295.664856 24.62488365 0.176078752 2.940 
Figure SI 2.23. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2’-
chloroacetophenone. 
 
 
# Time Area Width Height Area % 
1 10.617 4.437592983 0.617087007 0.115897268 0.039 
2 15.953 5.667846203 0.634238601 0.14025867 0.050 
3 16.464 40.98591995 4.179521084 0.154407606 0.363 
4 17.572 289.5748901 24.33002472 0.190856144 2.566 
Figure SI 2.24. HPLC chromatogram of the reaction mixture produced by ATH of 2’-
chloroacetophenone catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.25. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2-
hydroxyacetophenone. 
 
 
 
Figure SI 2.26. HPLC chromatogram of the reaction mixture produced by ATH of 2-
hydroxyacetophenone catalyzed by Cp*Ir(DPL-C16). 
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OH
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Figure SI 2.27. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2-
chloroacetophenone. 
 
 
 
 
Figure SI 2.28. HPLC chromatogram of the reaction mixture produced by ATH of 2-
chloroacetophenone catalyzed by Cp*Ir(DPL-C16). 
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# Time Area Width Height Area % 
1 26.418 14.9824295 1.130485892 0.2208848 0.181 
2 32.524 153.3234253 10.65937138 0.239731804 1.856 
3 33.098 153.7670441 10.12266731 0.253172785 1.861 
 
Figure SI 2.29. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2-
acetylnaphthalene.  
 
 
# Time Area Width Height Area % 
1 26.496 71.74198914 5.734248161 0.208519012 0.584 
2 32.621 21.57542419 1.660766602 0.216520727 0.176 
3 33.111 465.0305786 30.13682938 0.257177323 3.787 
 
Figure SI 2.30. HPLC chromatogram of the reaction mixture produced by ATH of 2-
acetylnaphthalene catalyzed by Cp*Ir(DPL-C16). 
0	
2	
4	
6	
8	
10	
12	
14	
25	 26	 27	 28	 29	 30	 31	 32	 33	 34	 35	
Si
gn
al
 (m
V)
 
Time (min) 
0	
5	
10	
15	
20	
25	
30	
35	
25	 26	 27	 28	 29	 30	 31	 32	 33	 34	 35	
Si
gn
al
 (m
V)
 
Time (min) 
OH
OH
 
 275 
 
 
 
Figure SI 2.31. HPLC chromatogram of the reaction mixture produced by NaBH4  reduction of 1-
indanone. 
 
 
 
 
Figure SI 2.32. HPLC chromatogram of the reaction mixture produced by ATH of 1-indanone 
catalyzed by Cp*Ir(DPL-C16). 
OH
OH
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# Time Area Width Height Area % 
1 33.063 112.4168091 5.213475704 0.359378934 1.587 
2 33.936 115.3927612 4.66753912 0.412039995 1.629 
 
Figure SI 2.33. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 4-
acetylpyridine. 
 
 
# Time Area Width Height Area % 
1 31.802 3.954531908 0.224936903 0.293010443 0.041 
2 32.527 84.02703857 3.637865543 0.384964913 0.864 
 
Figure SI 2.34. HPLC chromatogram of the reaction mixture produced by ATH of 4-acetylpyridine 
catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.35. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 3-
acetylpyridine. 
 
 
 
Figure SI 2.36. HPLC chromatogram of the reaction mixture produced by ATH of 3-acetylpyridine 
catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.37. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 3-
acetylthiophene.  
 
 
Figure SI 2.38. HPLC chromatogram of the reaction mixture produced by ATH of 3-
acetylthiophene catalyzed by Cp*Ir(DPL-C16). 
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Figure SI 2.39. HPLC chromatogram of the reaction mixture produced by NaBH4 reduction of 2-
heptanone and subsequent acetylation.  
 
 
Figure SI 2.40. HPLC chromatogram of the reaction mixture produced by ATH of 2-heptanone 
catalyzed by Cp*Ir(DPL-C16) and subsequent acetylation. 
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Table 2.2. Crystallographic parameters for DPF-C12 
 
  
formula   C26H43N3O2  
formula weight (Mr) 429.63  
Crystal system, space 
group 
Monoclinic, 
P21 
 
a, Å 9.056 (5)  
b, Å 4.839 (5)  
c, Å 28.594(5)  
a, ° 90  
b, ° 97.735(5)  
g, ° 90  
V, Å3 1241.6(15)  
Z 2  
ρ calcd (g cm-3) 1.149  
absorp. coeff. μ (mm-1) 0.072  
temp, K 100  
total no. data 4041  
no. unique data 2292  
R, % 0.046  
wR2, % 0.1167  
no. of parameters 292  
max/min peaks, e/Ǻ 0.21/-0.26  
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OH
Br
 
 383 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
4
2
6
9
.
9
5
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
2
1
.
3
4
1
2
7
.
3
4
1
3
1
.
7
3
1
4
4
.
9
6
1-(4-bromophenyl)ethanol
OH
Br
 
 384 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
5
6
1
.
4
7
2
1
.
7
5
3
2
.
0
5
5
2
.
0
6
3
4
.
8
3
9
4
.
8
4
8
4
.
8
5
5
4
.
8
6
3
4
.
8
7
1
4
.
8
7
9
4
.
8
8
6
4
.
8
9
5
6
.
9
9
8
7
.
0
0
2
7
.
0
1
9
7
.
0
3
6
7
.
0
4
1
7
.
2
6
0
7
.
3
0
8
7
.
3
1
2
7
.
3
2
1
7
.
3
2
9
7
.
3
3
8
7
.
3
4
3
3.
08
0.
99
1.
00
1.
91
1.
93
1-(4-fluorophenyl)ethanol
OH
F
 
 385 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
4
6
6
9
.
9
4
7
6
.
9
1
7
7
.
2
3
7
7
.
5
4
1
1
5
.
3
2
1
1
5
.
5
4
1
2
7
.
1
9
1
2
7
.
2
7
1
4
1
.
7
0
1
4
1
.
7
3
1
6
1
.
0
8
1
6
3
.
5
2
1-(4-fluorophenyl)ethanol
OH
F
 
 386 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
8
5
1
.
5
0
6
2
.
0
9
4
2
.
1
0
6
4
.
9
1
1
4
.
9
2
4
4
.
9
3
2
4
.
9
4
4
4
.
9
5
4
4
.
9
6
6
4
.
9
7
4
4
.
9
8
7
7
.
2
6
0
7
.
4
6
3
7
.
4
8
9
7
.
5
8
7
7
.
6
1
4
3.
03
0.
99
1.
00
1.
99
-0
.0
0
1-[(4-trifluoromethyl)phenyl]ethanol
OH
F3C
 
 387 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
5
6
7
0
.
0
2
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
0
.
3
2
1
2
3
.
0
2
1
2
5
.
5
9
1
2
5
.
6
3
1
2
5
.
6
6
1
2
5
.
7
0
1
2
5
.
7
2
1
2
5
.
8
5
1
2
8
.
4
3
1
2
9
.
3
5
1
2
9
.
6
7
1
2
9
.
9
9
1
3
0
.
3
2
1
4
9
.
8
9
1
4
9
.
9
0
1-[(4-trifluoromethyl)phenyl]ethanol
OH
F3C
 
 388 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
8
7
1
.
5
0
3
1
.
8
1
0
3
.
8
2
1
4
.
8
5
9
4
.
8
7
5
4
.
8
9
1
4
.
9
0
7
6
.
8
0
2
6
.
8
0
5
6
.
8
0
8
6
.
8
1
1
6
.
8
2
3
6
.
8
2
5
6
.
8
2
9
6
.
8
3
1
6
.
9
4
3
6
.
9
4
8
6
.
9
5
4
6
.
9
5
8
7
.
2
4
8
7
.
2
6
0
7
.
2
6
8
7
.
2
7
8
7
.
2
8
8
3.
12
0.
90
3.
11
1.
00
0.
98
1.
96
1.
57
1-(3-methoxyphenyl)ethanol
OMe
OH
 
 389 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
3
6
5
5
.
4
5
7
0
.
5
8
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
1
1
.
1
1
1
1
3
.
1
2
1
1
7
.
8
8
1
2
9
.
7
6
1
4
7
.
8
0
1
6
0
.
0
3
1-(3-methoxyphenyl)ethanol
OMe
OH
 
 390 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
3
1
1
.
5
4
7
2
.
0
3
4
5
.
0
0
0
5
.
0
1
6
5
.
0
3
2
5
.
0
4
8
7
.
2
6
0
7
.
5
0
0
7
.
5
2
0
7
.
5
4
0
7
.
7
0
5
7
.
7
0
6
7
.
7
2
4
7
.
7
2
6
8
.
1
0
8
8
.
1
1
1
8
.
1
1
4
8
.
1
1
6
8
.
1
2
9
8
.
1
3
1
8
.
1
3
4
8
.
1
3
6
8
.
2
4
7
8
.
2
5
1
3.
17
0.
99
1.
00
1.
01
1.
00
0.
98
0.
97
1-(3-nitrophenyl)ethanol
NO2
OH
 
 391 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
7
0
6
9
.
6
2
7
6
.
9
1
7
7
.
2
3
7
7
.
5
4
1
2
0
.
6
5
1
2
2
.
5
8
1
2
9
.
6
5
1
3
1
.
7
7
1
4
8
.
0
6
1
4
8
.
6
1
1-(3-nitrophenyl)ethanol
NO2
OH
 
 392 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
3
3
1
.
5
5
4
2
.
0
9
5
5
.
0
0
7
5
.
0
2
8
5
.
0
5
0
5
.
0
7
1
7
.
2
6
0
7
.
7
8
6
7
.
8
4
0
3.
03
0.
98
1.
00
1.
00
-0
.0
0
1-[(3,5-bistrifluoromethyl)phenyl]ethanol
OH
CF3
F3C
 
 393 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
7
7
6
9
.
5
0
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
1
.
4
1
1
2
1
.
4
5
1
2
1
.
4
9
1
2
1
.
5
3
1
2
1
.
5
6
1
2
1
.
6
0
1
2
1
.
6
4
1
2
2
.
2
2
1
2
4
.
9
3
1
2
5
.
8
5
1
2
5
.
8
8
1
2
7
.
6
4
1
3
1
.
4
8
1
3
1
.
8
1
1
3
2
.
1
4
1
3
2
.
4
7
1
4
8
.
4
4
1-[(3,5-bistrifluoromethyl)phenyl]ethanol
OH
CF3
F3C
 
 394 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
0
4
1
.
5
2
0
2
.
6
1
8
3
.
8
6
9
5
.
0
7
4
5
.
0
9
0
5
.
1
0
7
5
.
1
2
3
6
.
8
7
8
6
.
8
9
8
6
.
9
4
7
6
.
9
5
0
6
.
9
6
6
6
.
9
6
8
6
.
9
8
5
6
.
9
8
7
7
.
2
3
0
7
.
2
3
4
7
.
2
5
0
7
.
2
5
3
7
.
2
6
0
7
.
2
6
9
7
.
2
7
3
7
.
3
3
2
7
.
3
3
6
7
.
3
5
1
7
.
3
5
5
3.
19
0.
97
3.
07
1.
00
1.
00
1.
00
1.
18
1.
00
1-(2-methoxyphenyl)ethanol
OH
OMe
 
 395 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
3
.
0
5
5
5
.
4
6
6
6
.
7
7
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
1
0
.
6
4
1
2
1
.
0
0
1
2
6
.
3
0
1
2
8
.
5
0
1
3
3
.
6
3
1
5
6
.
7
7
1-(2-methoxyphenyl)ethanol
OH
OMe
 
 396 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
5
0
1
.
5
6
7
3
.
1
8
8
5
.
0
0
6
5
.
0
2
3
5
.
0
3
9
5
.
0
5
5
6
.
8
2
4
6
.
8
2
7
6
.
8
4
3
6
.
8
6
2
6
.
9
7
1
6
.
9
7
4
6
.
9
9
1
6
.
9
9
4
7
.
1
4
2
7
.
1
4
6
7
.
1
6
2
7
.
1
6
5
7
.
1
8
0
7
.
1
8
4
7
.
2
6
0
8
.
1
0
3
3.
05
0.
81
1.
00
1.
99
1.
01
1.
01
0.
88
1-(2-hydroxyphenyl)ethanol
OH
OH
 
 397 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
3
.
5
2
7
1
.
4
6
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
1
7
.
1
1
1
2
0
.
1
5
1
2
6
.
6
6
1
2
8
.
7
4
1
2
9
.
0
4
1
5
5
.
3
1
1-(2-hydroxyphenyl)ethanol
OH
OH
 
 398 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
6
5
1
.
4
8
1
1
.
7
5
3
2
.
3
5
2
5
.
1
1
4
5
.
1
3
0
5
.
1
4
6
5
.
1
6
2
7
.
1
2
9
7
.
1
4
7
7
.
1
5
8
7
.
1
6
1
7
.
1
7
6
7
.
1
7
9
7
.
1
9
4
7
.
1
9
8
7
.
2
2
4
7
.
2
2
7
7
.
2
4
3
7
.
2
4
4
7
.
2
6
0
7
.
5
1
0
7
.
5
2
9
3.
08
0.
97
3.
02
1.
00
1.
98
1.
17
0.
98
1-(2-methylphenyl)ethanol
OH
Me
 
 399 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
1
9
.
0
8
2
4
.
1
0
6
6
.
9
7
7
6
.
9
1
7
7
.
2
3
7
7
.
5
4
1
2
4
.
6
5
1
2
6
.
5
4
1
2
7
.
3
3
1
3
0
.
5
4
1
3
4
.
4
0
1
4
4
.
0
3
1-(2-methylphenyl)ethanol
OH
Me
 
 400 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
7
9
1
.
4
9
5
2
.
1
1
8
5
.
2
6
3
5
.
2
7
9
5
.
2
9
5
5
.
3
1
1
7
.
1
7
6
7
.
1
8
0
7
.
1
9
5
7
.
1
9
9
7
.
2
1
4
7
.
2
1
8
7
.
2
6
0
7
.
2
7
6
7
.
2
9
5
7
.
3
1
1
7
.
3
3
1
7
.
3
3
4
7
.
5
7
6
7
.
5
7
9
7
.
5
9
5
7
.
5
9
8
3.
16
1.
01
1.
00
1.
01
1.
99
0.
99
1-(2-chlorophenyl)ethanol
OH
Cl
 
 401 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
3
.
7
2
6
7
.
1
9
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
2
6
.
6
1
1
2
7
.
4
2
1
2
8
.
6
1
1
2
9
.
6
1
1
3
1
.
8
6
1
4
3
.
2
5
1-(2-chlorophenyl)ethanol
OH
Cl
 
 402 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
2
.
0
3
8
2
.
0
4
9
2
.
4
9
6
3
.
6
4
7
3
.
6
5
8
3
.
6
6
8
3
.
6
7
6
3
.
6
8
6
3
.
6
9
6
3
.
7
0
6
3
.
7
5
0
3
.
7
5
9
3
.
7
6
8
3
.
7
7
7
3
.
7
8
7
3
.
7
9
6
3
.
8
0
5
4
.
8
1
9
4
.
8
2
7
4
.
8
3
7
4
.
8
4
7
4
.
8
5
5
7
.
2
6
0
7
.
2
8
8
7
.
2
9
9
7
.
3
0
4
7
.
3
0
9
7
.
3
1
6
7
.
3
2
0
7
.
3
3
1
7
.
3
4
1
7
.
3
4
7
7
.
3
4
9
7
.
3
5
4
7
.
3
6
9
7
.
3
8
0
1.
00
0.
99
1.
03
1.
03
1.
00
4.
94
2-hydroxy-1-phenylethanol
OH
OH
 
 403 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
6
8
.
3
2
7
4
.
9
0
7
6
.
9
1
7
7
.
2
2
7
7
.
5
4
1
2
6
.
2
7
1
2
8
.
2
7
1
2
8
.
7
8
1
4
0
.
6
9
2-hydroxy-1-phenylethanol
OH
OH
 
 404 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
2
.
6
3
3
3
.
6
3
0
3
.
6
5
2
3
.
6
5
8
3
.
6
8
0
3
.
7
3
6
3
.
7
4
5
3
.
7
6
4
3
.
7
7
3
4
.
8
9
5
4
.
9
0
4
4
.
9
1
7
4
.
9
2
6
7
.
2
6
0
7
.
3
1
2
7
.
3
1
8
7
.
3
2
2
7
.
3
2
6
7
.
3
3
3
7
.
3
3
9
7
.
3
4
4
7
.
3
4
7
7
.
3
5
5
7
.
3
6
3
7
.
3
6
5
7
.
3
7
0
7
.
3
8
4
7
.
3
8
8
7
.
3
9
6
7
.
4
0
8
0.
93
1.
04
1.
04
1.
00
5.
01
2-chloro-1-phenylethanol
OH
Cl
 
 405 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
5
1
.
1
7
7
4
.
2
9
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
6
.
2
6
1
2
8
.
7
0
1
2
8
.
9
0
1
4
0
.
0
8
2-chloro-1-phenylethanol
OH
Cl
 
 406 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
8
2
1
.
5
9
8
1
.
8
9
4
5
.
0
5
5
5
.
0
7
1
5
.
0
8
8
5
.
1
0
4
7
.
2
6
0
7
.
4
4
4
7
.
4
4
9
7
.
4
6
2
7
.
4
6
8
7
.
4
7
6
7
.
4
8
5
7
.
4
9
2
7
.
5
0
1
7
.
5
0
5
7
.
5
2
2
7
.
5
2
7
7
.
8
2
3
7
.
8
2
8
7
.
8
3
4
7
.
8
4
2
7
.
8
4
7
7
.
8
5
6
3.
11
0.
94
1.
00
2.
98
3.
99
1-(2-naphthyl)ethanol
OH
 
 407 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
3
7
7
0
.
7
7
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
4
.
0
3
1
2
6
.
0
2
1
2
6
.
3
7
1
2
7
.
8
9
1
2
8
.
1
5
1
2
8
.
5
4
1
3
3
.
1
5
1
3
3
.
5
5
1
4
3
.
4
0
1-(2-naphthyl)ethanol
OH
 
 408 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
8
3
0
1
.
8
5
4
1
.
8
9
3
1
.
9
1
0
1
.
9
1
5
1
.
9
2
1
1
.
9
3
2
1
.
9
3
7
1
.
9
3
9
1
.
9
4
3
1
.
9
5
4
1
.
9
5
9
1
.
9
6
0
1
.
9
6
5
1
.
9
7
6
1
.
9
8
3
1
.
9
8
7
2
.
0
0
5
2
.
4
3
8
2
.
4
5
4
2
.
4
6
1
2
.
4
6
5
2
.
4
7
7
2
.
4
8
2
2
.
4
8
8
2
.
4
9
8
2
.
5
0
4
2
.
5
0
9
2
.
5
2
1
2
.
5
2
6
2
.
5
3
2
2
.
5
4
8
2
.
7
7
4
2
.
7
9
6
2
.
8
2
6
2
.
8
5
0
2
.
8
5
4
2
.
8
7
6
3
.
0
1
8
3
.
0
3
4
3
.
0
4
6
3
.
0
6
3
3
.
0
7
1
5
.
2
1
4
5
.
2
3
7
5
.
2
5
6
5
.
2
7
8
7
.
2
3
1
7
.
2
4
4
7
.
2
4
7
7
.
2
5
8
7
.
2
6
0
7
.
2
6
4
7
.
2
7
6
7
.
4
0
4
7
.
4
1
6
7
.
4
3
0
7
.
4
3
5
1.
00
1.
03
1.
02
1.
03
1.
03
1.
00
3.
11
-0
.0
0
1-indanol
OH
 
 409 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
9
.
9
8
3
6
.
1
4
7
6
.
6
4
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
4
.
3
8
1
2
5
.
1
0
1
2
6
.
9
0
1
2
8
.
5
2
1
4
3
.
5
1
1
4
5
.
1
9
1-indanol
OH
 
 410 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
5
9
1
.
4
7
6
3
.
8
5
8
4
.
8
4
8
4
.
8
6
4
4
.
8
8
0
4
.
8
9
7
7
.
2
6
0
7
.
2
7
2
7
.
2
7
3
7
.
2
7
5
7
.
2
7
7
7
.
2
8
3
7
.
2
8
4
7
.
2
8
7
7
.
2
8
8
8
.
4
2
2
8
.
4
2
6
8
.
4
3
3
8
.
4
3
7
3.
03
0.
88
1.
00
1.
96
1.
98
1-(4-pyridyl)ethanol
N
OH
 
 411 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
2
7
6
8
.
7
6
7
6
.
9
1
7
7
.
2
3
7
7
.
5
5
1
2
0
.
7
3
1
4
9
.
6
2
1
5
5
.
6
0
1-(4-pyridyl)ethanol
N
OH
 
 412 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
4
6
5
1
.
4
6
9
1
.
4
7
4
1
.
4
8
0
1
.
4
8
6
1
.
4
9
0
3
.
6
9
6
3
.
8
0
2
3
.
9
0
0
4
.
8
8
9
4
.
8
9
6
7
.
2
2
2
7
.
2
3
2
7
.
2
4
2
7
.
2
5
0
7
.
6
9
8
7
.
7
0
1
7
.
7
1
7
7
.
7
2
0
8
.
3
7
4
8
.
3
8
2
8
.
4
5
0
8
.
4
5
6
3.
09
1.
00
1.
00
1.
09
0.
98
1.
96
1-(3-pyridyl)ethanol
N
OH
 
 413 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
2
5
.
3
7
6
7
.
8
4
7
6
.
9
1
7
7
.
2
3
7
7
.
5
4
1
2
3
.
7
1
1
3
3
.
6
0
1
4
1
.
7
5
1
4
7
.
3
4
1
4
8
.
4
2
1-(3-pyridyl)ethanol
N
OH
 
 414 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1
.
5
2
0
1
.
5
3
7
1
.
8
3
2
4
.
9
5
2
4
.
9
6
8
4
.
9
8
4
5
.
0
0
0
7
.
0
9
7
7
.
1
0
0
7
.
1
0
9
7
.
1
1
2
7
.
1
9
2
7
.
1
9
8
7
.
2
6
0
7
.
2
9
4
7
.
3
0
1
7
.
3
0
6
7
.
3
1
4
3.
19
1.
00
1.
00
0.
98
0.
97
0.
98
1-(thiophen-3-yl)ethanol
OH
S
 
 415 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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Chapter 3 Observations With Unique Peptides and Self-Assembling 
Strategies 
 
 
 
 
 
 
Abstract.  
As an extension of the work conducted in chapter 2 of this thesis, this third chapter 
will describe the observations of a few notable peptides that directly or indirectly exhibited 
self-assembly. Various principles of ligand design were explored during our quest to find 
a robust self-assembling peptide ligand capable of enantioselective catalysis. Data 
relating to peptide self-assembly was predominantly inferred from experimental results 
obtained from ATH reactions except in cases where irrefutable microscopy images could 
be collected. Peptide ligands that formed interesting self-assemblies or possessed self-
assembly potential include (N-tosyl)-TFF-CONH2 which, by AFM imaging showed 
formation of fibrils, Cp*Ir(Cl)(DPLVFF-CONH2) formed a metallogel in TFE at a 125 µM 
concentration, and mixing oppositely charged peptides (DP)LDFDF and (DP)LKFKF in 
different ratios showed improved enantioselectivity over the individually tested peptide. 
Excellent ATH results were also obtained with the non-assembled peptide catalyst DPLF-
CONH2. 
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3.1. Introduction 
 
3.1.1 Brief background on self-assembly 
 
Since the late 1980s, the rise and development in nanotechnology and the ability 
to view and control molecules on a nanomolecular level has allowed for exploration of 
self-assembly.1 Currently, self-assembly can enable formation of incredibly diverse 
supramolecular structures from simple building blocks, providing access to a number of 
practically important materials with applications ranging from photovoltaic devices and 
molecular wires to antimicrobial pharmaceuticals and self-replicators.2-8 The process of 
self-assembly is driven by non-covalent intermolecular interactions such as Van der 
Waals forces, hydrogen bonding, electrostatic, and stacking interactions.9 With peptides 
however, additional physiochemical features allow for different modes of self-assembly 
to occur, such as by hydrophobicity, charge, and size of the peptides. Early rational 
designs of peptide self-assembly included alpha-helical peptides that formed coiled-
coiled bundles and amphiphilic amyloid peptides10-12 that can also form hydrogels under 
aqueous conditions, and other methods have since been documented.13-15 Formation of 
peptide-hydrogels however is still an ongoing area of great research interest and there 
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are many great reviews detailing the various conditions that have been used to control or 
influence hydrogelation.16-18  
 
Figure 3.1. Common groups used to drive self-assembly 
Synthetic modifications beyond the naturally available amino acids (e.g. installing 
alkyl tails, or aromatic groups capable of pi-stacking (Figure 3.1) provide additional 
opportunities to create a large variety of supramolecular architectures including sheets, 
twisted or linear fibers, spheres, tapes, and tubes.19 Among these choices of 
modifications, bulky Fmoc protecting groups20-21 in addition to long alkyl chains19,22 are 
commonly used to drive hydrophobic interactions. While an argument can certainly be 
made concerning how “natural” the self-assembly of the molecule is, this line of argument 
runs counter-productive to actually identifying the absolute minimum changes necessary 
to make a molecule self-assemble. This is why the most effective self-assembly methods 
invokes easily accessible modifications to increase the likelihood of molecules to 
aggregate in some known or unspecified manner. Moreover, increasing the diversity and 
ways in which peptides can form different tertiary structures provides new opportunities 
for short peptide self-assembly. 
Brad Nilsson, Rein Ulijn, and Ehud Gazit are big proponents in the investigation of 
self-assembly with peptides through unnatural modifications. Their labs have extensively 
O
Pyrene Fmoc
n
alkyl tail Bolaamphiphile
n
NHO
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found ways to induce hydrogel formation using the Fmoc-protecting group as well as 
phenylalanine amino acids. Fmoc is a common protecting group to find when looking to 
purchase amino acids as Fmoc-amino acids are useful in solid-phase peptide syntheses.  
 
Scheme 3.1. Comparison of self-assembly behavior of Fmoc-Phe and its peptoid derivative 
Reprinted with permission from ref 23. Copyright 2018 American Chemical Society." 
A recent paper from Nilsson examined the difference in fibril morphology between 
the already well-characterized Fmoc-Phe and its peptoid derivative Fmoc-Nphe (Scheme 
3.1).23 Nilsson and co-workers had created four derivatives for each Fmoc molecule and 
monitored self-assembly formation by diluting the DMSO stock solutions of each 
compound to a known concentrations in water. Accordingly, all four Fmoc-Phe derivatives 
formed defined 1-dimensional fibrils at a low 200 µM concentration of compound and then 
formed hydrogel fibrils at a higher concentration of 4.9 mM. Conversely, Fmoc-Nphe 
peptoids formed 2-dimensional microsheets at both low and high concentrations of 
compound in solution. Formation of 2D nanosheets was suspected to occur due to the 
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lack of interstrand hydrogen bonds which is commonly accessed with regular amino acid 
polypeptides. Not surprisingly, the ability of π-π stacking interactions of small molecules 
can lead to stabilizing ordered arrangements. 
3.2. Results and discussion 
3.2.1. Self-Assembling Peptides via FF motif 
In our original peptide design for chapter 2, we wanted to take advantage of a known 
phenylalanine-phenylalanine (FF) dipeptide motif to induce self-assembly from a short 
peptide sequence.7 This FF motif has been shown to favor hydrophobic interactions 
between the aromatic side chains in neighboring peptide ß-sheets via Van der Waal 
forces and π-π stacking to strongly promote assembly into fibrils. We began our 
investigations by examining single amino acids in the ATH reaction that were homologous 
to the TsDPEN structure (Scheme 3.2).  
 
Scheme 3.2. Early ligand screening of amino acids similar to TsDPEN. Lines in red show 
structural backbone similarity and lines in blue show induction of chirality from the ligand. 
Notably, we observed early on in preliminary experiments that N-tosyl-threonine 
amino acids (R = Me, X = O) gave promising results compared to other tested amino 
acids synthetically modified with a tosyl group. In the reduction of the model substrate 
acetophenone with N-tosyl threonine, we observed a moderate 20% yield by 1H NMR. To 
investigate our hypothesis regarding whether the incorporation of FF motif would promote 
self-assembly, we synthesized the peptide (N-tosyl)-threonine-phenylalanine-
H2N HN S
O
O
TsDPEN
HNX
R
O
OH
amino acids
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phenylanine-CONH2 (referred to as (N-tosyl)-TFF-CONH2). Excitingly, in our first reaction 
using this tripeptide in water, we observed full conversion with a 90% yield by 1H NMR. 
This stark difference in reactivity between a single amino acid and (N-tosyl)-TFF-CONH2 
very much supported our hypothesis. To our dismay however, we found that all reactions 
with the use of N-tosyl-threonine as a singular amino acid or as the N-terminus residue in 
a peptide yielded alcohol products that were obtained as a racemic mixture. Despite this 
tripeptide not serving as an effective enantioselective ligand, we sent a sample of the 
peptide (N-tosyl)-TFF-CONH2 to be viewed under Atomic Force Microscopy (AFM). The 
following AFM image revealed that this peptide does in fact form fibrils (Figure 3.2). While 
gratifying to have a hypothesis of peptide design be confirmed through experimentation, 
we knew that this ligand would not be valuable to us without the crucial aspect of 
promoting high enantioselective reductions. 
 
Figure 3.2. AFM image of (N-tosyl)-TFF tripeptide. Peptide concentration of 200 µM in pH 8 Tris 
buffer. 
 
3.2.2 Continuation with Research Related to FF Motif 
With the success of the FF motif seen in our first application of a short peptide 
ligand, we sought to capture the same phenomenon utilizing other peptide sequences 
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that could promote asymmetric induction. During our continued efforts, we realized that 
the chirality of the alcohol product was determined primarily from the N-terminus and 
second residue of the peptide sequence. In conjunction with the dipeptide screen from 
chapter 2, we found that the short dipeptide proline-leucine-CONH2 (PL-CONH2) could 
effectively promote enantioselective reduction of acetophenone. Not wanting to abandon 
the potential of peptide self-assembly occurring via the FF motif, certain tri and tetra-
peptides were synthesized and subsequently tested in ATH reactions with acetophenone. 
We quickly noticed that for some of the longer peptides tested (especially noticeable with 
PLFF) a visible solid material would remain after the work-up/extraction process that was 
insoluble to most organic solvents. Analysis of this mysterious solid by NMR in d6-DMSO 
confirmed our suspicions that it was indeed peptide that presumably aggregated due to 
its poor solubility in water. Therefore, aggregation of the peptide directly led to less 
peptide catalyst in the reaction and thus low yields were observed. To overcome this 
solubility issue with the peptides, use of an organic co-solvent was imperative. We 
reasoned that use of a minimal amount of organic co-solvent could assist in preventing 
aggregation while also preserving the potential for self-assembly to be hydrophobically 
driven in the presence of water.  
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Table 3.1. Investigation of TFE as a Co-Solvent 
 
Entry Ligand Solvent Conditions Yield (%) ee (%) 
1 PL 100% H2O (1) 44 48.3 (R) 
2 PL 20% TFE–H2O (2) 100 54.7 (R) 
3 DPL  100% H2O (1) 28 74.9 (S) 
4a DPL 20% TFE–H2O (2) 31 83.3 (S) 
A 3.125 M solution of sodium formate (171 mg) in H2O (0.8 mL) was added to the reactions. a Reaction was 
stirred for 30 mins in the pre-catalyst formation step and then only stirred for 3 hours in the reduction of 
acetophenone.  
1) MD-2-033; 2) MD-2-056; 3) MD-2-050; 4) MD-2-061 
 
The use of 2,2,2-trifluoroethanol (TFE) as the co-solvent in a 1:4 ratio of organic 
solvent:water was beneficial as both yields and enantiomeric excess (ee) values had 
improved (Table 3.1). These results exemplified the significance of solubility with peptide 
ligands in our catalysis. Thus, we created the standard reaction conditions involving a 
two-step process of forming the peptide metal complex in organic solvent first, followed 
thereafter by addition of a sodium formate solution in water and then substrate for the 
reduction. With this successful implementation of TFE, all new short peptides we pursued 
had followed the new conditions using 20% of co-solvent by volume. 
 
N
H
N
H
O
NH2
O
PL DPL
N
H
N
H
O
NH2
O
then sodium formate–H2O 
(0.8 mL), substrate, 40 °C, 6 h
5 mol % ligand
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O
(S)
OH
(R)
OH
+
then sodium formate (5 eq.),
substrate, 40 °C, 6 h
5 mol % ligand
2.5 mol % [IrCp*Cl2]2
H2O, 40 °C, 1 h
Solvent Conditions 1
Solvent Conditions 2
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Table 3.2. Screened FF Peptides 
 
Entry Peptide Ligand Crude Yield (%) ee (%) 
1 PFFF-CONH2 66 24.0 (R) 
2 PLFF-CONH2 76 55.9 (R) 
3 PDLFF-CONH2 49 80.4 (R) 
4 DPLFF-CONH2 61 87.9 (S) 
5 PLVFF-CONH2 55 53.5 (R) 
6 DPLVFF-CONH2 59 86.2 (S) 
A 3.125 M solution of sodium formate (171 mg) in H2O (0.8 mL) were added to the reactions. 
1) MD-2-066; 2) MD-2-060; 3) MD-2-072; 4) MD-2-064; 5) MD-2-092; 6) MD-2-093 
 
After re-examining some new and old peptides with the FF motif under the new 
reaction conditions, we could not infer any type of self-assembly occurring from our 
results (Table 3.2). With PFFF (entry 1), it was thought that additional phenylalanine 
residues would better promote fibrillation through π-π stacking, but this approach 
decisively failed. Definitively, the only peptide comprised of natural amino acids that has 
provided the best results has been PLFF, but the observed 55.9% ee was unsatisfactory 
(entry 2). We understood that residues near or involved with metal complexation can 
drastically influence the chiral environment by which the substrate approaches the active 
site. We posited that introducing unnatural amino acids involved with the coordination site 
at the N-terminus or second residue would lead to higher enantioselective results. 
Substituting the L-leucine to a D-leucine to give PDLFF significantly improved the 
observed ee to 80.4% (R) (entry 3). Likewise, substituting L-proline for D-proline to give 
DPLFF also gave encouraging results with an ee of 87.9% (S) (entry 4).  
Our attention then shifted to the implementation of the LVFF amyloid ß-fibrillating 
sequence to our approach with self-assembly. The LVFF sequence is well regarded for 
sodium formate (5 eq),
H2O (0.8 mL)
acetophenone (0.5 mmol)
40 °C, 3 h
1)
2) +
OH OH
(R) (S)
O
peptide (0.05 eq.)
[IrCp*Cl2]2 (0.025 eq.)
TFE (0.2 mL), 40 °C, 0.5 h
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its hydrophobicity and there does exist literature precedent of the LVFF sequence used 
in peptides to form a hydrogel self-assembly.24 However, this FF sequence also yielded 
similar results obtained with DPLFF. Through conclusive experimental evidence, we found 
that the FF sequence is not as robust of a self-assembling motif as we had originally 
speculated.  
 
Figure 3.3. Photograph of metallogel Cp*Ir(Cl)(DPLVFF) in TFE 
Notably, while we did not observe improved enantioselectivity with the LVFF 
peptide design, we serendipitously witnessed a hydrogel formation with the DPLVFF 
peptide during the peptide-metal complex step. Within a few short minutes of stirring the 
reagents together in TFE, a gel-like substance formed that caused the stir bar to become 
stuck. Thus, when the amyloidogenic peptide reacts completely with the metal dimer 
[IrCp*Cl2]2, it forms Cp*Ir(Cl)(DPLVFF) as a metallogel in the organic solvent TFE at the 
tested 125 µM concentration (Fig 3.3). Interestingly, this gel-like assembly could only form 
with this diastereomer of the peptide with D-proline at the N-terminus. TEM and SEM 
imaging of the metallogel have thus far yielded inconclusive results. We are still interested 
in exploring this metallogel formation in the future. 
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Table 3.3. Screened amphiphilic peptides 
 
Entry Ligand Crude Yield (%) ee (%) 
1 DPLFEF-CONH2 34 
81.1 
(S) 
2 DPLEFEF-CONH2 29 
67.3 
(S) 
3 DPLDFDF-CONH2 25 65.8 (S) 
4 DPLKFKF-CONH2 52 
61.3 
(S) 
5 DPLDFKF-CONH2 47 
86.0 
(S) 
6 DPLKFDF-CONH2 39 84.0 (S) 
7 
DPLDFKF-CONH2  & DPLKFDF-
CONH2 
(1:1 ratio) 
52 84.0 (S) 
8 
DPLKFKF-CONH2  & DPLDFDF-
CONH2 
(1:1 ratio) 
35 84.0 (S) 
9 
DPLKFKF-CONH2  &  Ac-EFEF-
CONH2 
(1:1 ratio) 
33 67.0 (S) 
10 
DPLKFKF-CONH2  &  Ac-EFEF-
CONH2 
(2:1 ratio) 
48 79.1 (S) 
11 
DPLKFKF-CONH2  &  Ac-EFEF-
CONH2 
(1:2 ratio) 
40 75.1 (S) 
12 Ac-EFEF-CONH2 4 0.1 (S) 
Yields (as determined by NMR) and enantiomeric excesses (as determined by HPLC) in transfer 
hydrogenation of ketones were catalyzed Cp*Ir(Ligand) at 5 mol % of catalyst. A 3.125 M solution of 
sodium formate was used (5 equivalents of formate relative to substrate). 
1) MD-2-156; 2) MD-3-002; 3) PB-1-103; 4) PB-1-103; 5) PB-1-089; 6) PB-1-089; 7) PB-1-103; 8) PB-1-
089; 9) OZ-3-040; 10) OZ-3-062; 11) OZ-3-062; 12) OZ-3-062 
 
Meanwhile, other attempts to rationally design self-assembling peptide sequences 
included amphiphilic sequences, a well-known pattern in peptide chemistry of alternating 
between hydrophilic and hydrophobic residues (Table 3.3). We limited our efforts to polar 
residues such as the positively charged amino acid lysine (K), or negatively charged 
amino acids aspartic acid (D) and glutamic acid (E) as there is some established 
precedence for self-assembly to occur with these residues.22,25 Our preliminary results 
sodium formate (5 eq),
H2O (0.8 mL)
acetophenone (0.5 mmol)
40 °C, 3 h
1)
2) +
OH OH
(R) (S)
O
peptide (0.05 eq.)
[IrCp*Cl2]2 (0.025 eq.)
TFE (0.2 mL), 40 °C, 0.5 h
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from these amphiphilic peptides did not meet our expectations. However, we were 
definitely intrigued with the results obtained from stoichiometric mixing of two 
complimentary charged peptides DPLDFDF and DPLKFKF (entry 7). When tested 
individually, the peptides showed good enantioselectivity between 61-66% ee (entries 3-
4), yet mixing the two peptides together afforded the alcohol with an 84% ee (entry 8). 
We believe the oppositely charged amphiphilic peptides were able to interact with one 
another, which we surmise is through formation of some type of assembly, thus explaining 
the higher observed selectivity upon mixing. When the sequence of each peptide was of 
neutral overall charge (e.g. DPLKFDF or DPLDFKF) there was no difference in the 
observed enantioselectivity when compared to the individual peptides or when mixed 
together. In an attempt to capitalize on a co-assembly strategy occurring via charged 
interactions, the complimentary peptide sequence DPLEFEF was deconstructed to the 
shorter Ac-EFEF-CONH2 tetrapeptide. Mixing DPLKFKF-CONH2 with Ac-EFEF-CONH2 in 
a 1:1 ratio (0.1 equivalents total) provided no tangible benefits to enantioselectivity (entry 
8). Adjusting the stoichiometry of the peptides (while maintaining a total of 2:1 ratio of 
peptide:metal in these follow-up reactions) directly led to higher yields and 
enantioselectivity (entries 9-11). We find this idea of mixing negatively and positively 
charged peptides somewhat fascinating in its potential to aid in catalysis and achieve self-
assembly. 
3.2.3 Short Non-Self Assembling Peptides with Good Results 
While we did not want to deviate far from the original scope of the project, namely 
with creating peptide catalysts that self-assemble, we found good success with the 
tripeptide DPLF. The initial results from this tripeptide surpassed our expectations when 
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compared to the longer DPLFF tetrapeptide tested earlier. These observations further 
confirmed our assumption that the FF motif would not work within this peptide design. In 
our attempts to visualize DPLF under TEM, we conclusively established it did not self-
assemble. Despite the lack of self-assembly, we found this peptide sequence combination 
to be interesting enough to pursue additional experimentation. Thus, as a side-project 
related to the development of the DPL-C16 chiral ligand and nano-assembly, we also 
tested the aptitude of DPL and DPLF peptides with the same substrate scope.  
Our results with the DPL dipeptide were fairly remarkable, considering this was the 
simplest optimized dipeptide identified from the dipeptide screen. Conversion across all 
tested substrates was overall lackluster but excitingly, good enantioselectivities were 
achieved for several examples. In comparison to the positive control (S,S)-TsDPEN 
ligand under identical reaction conditions, this dipeptide was clearly not as effective 
(Table 3.4). Thus, these results with DPL were regarded as the baseline level for activity 
and selectivity in our continuing efforts to develop a better peptide catalyst. 
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Table 3.4. Transfer hydrogenation of ketones catalyzed by Cp*Ir(DPL-CONH2) and 
Cp*Ir(TsDPEN)  
 
 
Yields (as determined by NMR) and enantiomeric excesses (as determined by HPLC or GC) in transfer 
hydrogenation of ketones were catalyzed Cp*Ir(DPL-NH2) and Cp*Ir(TsDPEN) at 5 mol % of catalyst. A 
3.125 M solution of sodium formate was used (5 equivalents of formate relative to substrate). 
 
1) MD-2-061, MD-4-007, PB-4-144, PB-2-142; 2) MD-4-020, MD-4-009, PB-4-144, PB-2-106; 3) MD-4-019, MD-4-136, PB-3-103, 
PB-3-133; 4) MD-4-039, MD-6-028, PB-3-113, PB-2-104; 5) MD-4-040, MD-6-028, PB-3-123, PB-3-133; 6) MD-5-150, MD-5-014, 
PB-4-104; 7) MD-4-031, MD-6-029, PB-3-106, PB-2-026; 8) MD-4-041, MD-6-028, PB-3-113, PB-2-126; 9) MD-4-021, MD-3-154, 
PB-4-144, PB-3-091; 10) MD-5-052, MD-5-038, PB-4-147, PB-4-112; 11) MD-4-022, MD-3-155, PB-4-144, PB-3-133; 12) MD-5-
118, MD-5-020, PB-4-104; 13) MD-5-151, MD-5-011, PB-4-144, PB-3-133; 14) MD-4-029, MD-6-029, PB-3-150; 15) MD-5-117, MD-
5-045, PB-4-144, PB-4-112; 16) MD-4-032, MD-4-012, PB-3-115, PB-3-130; 17) MD-4-043, MD-6-028, PB-4-92, PB-2-082; 18) MD-
4-042, MD-6-028, PB-4-144, PB-2-083; 19) MD-5-116, MD-5-016, PB-4-104 
 
Introduction of a phenylalanine residue to the DPL peptide sequence to give DPLF, 
surprisingly gave the best initial results in the reduction of acetophenone compared to all 
the other short peptides we had designed up until that point with a high 93% ee value. 
We thought to replace the phenylalanine with tryptophan, as the bulkier side-chain could 
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2.5 mol % [IrCp*Cl2]2
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serve to improve the selectivity further. This assumption perplexedly did not hold up well, 
as the observed ee reduced drastically to 63 % (S) with the DPLW tripeptide. Thus, we 
decided to screen the potential of DPLF with the substrate scope (Table 3.5). A 
considerable improvement could be seen with both enantioselectivity and yield from the 
various substrates that were on par with results obtained with the positive control (S,S)-
TsDPEN ligand. 
Table 3.5. Transfer hydrogenation of ketones catalyzed by Cp*Ir(DPLF-CONH2) and 
Cp*Ir(TsDPEN)  
 
Yields (as determined by NMR) and enantiomeric excesses (as determined by HPLC or GC) in transfer 
hydrogenation of ketones were catalyzed Cp*Ir(DPLF) and Cp*Ir(TsDPEN) at 5 mol % of catalyst. A 3.125 
M solution of sodium formate was used (5 equivalents of formate relative to substrate). 
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40 °C, 3 h
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1) MD-2-065, MD-4-007, PB-3-89, PB-2-142; 2) MD-2-120, MD-4-009, PB-4-64, PB-2-106; 3) MD-2-119, MD-4-136, PB-2-149, PB-
3-133; 4) MD-4-105, MD-6-028, PB-2-101, PB-2-104; 5) MD-3-001, MD-6-028, PB-4-92, PB-3-133; 6) MD-5-047, MD-5-014, PB-4-
108, PB-4-104; 7) MD-4-099, MD-6-029, PB-2-66, PB-2-026; 8) MD-4-106, MD-6-028, PB-2-122, PB-2-126; 9) MD-4-156, MD-3-
154, PB-4-139, PB-3-091; 10) MD-5-151, MD-5-038, PB-4-147, PB-4-112; 11) MD-4-103, MD-3-155, PB-2-67, PB-3-133; 12) MD-5-
049, MD-5-020, PB-4-108, PB-4-104; 13) MD-4-102, MD-5-011, PB-4-64, PB-3-133; 14) MD-2-128, MD-6-029, PB-2-150, PB-3-
150; 15) MD-5-051, MD-5-045, PB-4-114, PB-4-112; 16) MD-4-101, MD-4-012, PB-2-68, PB-3-130; 17) MD-5-001, MD-6-028, PB-
2-92, PB-2-082; 18) MD-5-002, MD-6-028, PB-2-91, PB-2-083; 19) MD-5-048, MD-5-016, PB-4-108, PB-4-104 
 
Unequivocally, it became clear that the self-assembled DPL-C16 peptide catalyst 
outperformed the non-assembled DPL and DPLF peptide catalysts in terms of yield and 
enantioselectivity, even with catalyst loading considered. However, we were pleased to 
find that DPLF had drastically improved yield and enantioselective values over the DPL 
dipeptide and had enantioselective values that were consistent but overall slightly to 
moderately lower than our assembled DPL-C16 peptide across all the substrates 
examined.  
 
3.3. Conclusions and future work 
 
The most challenging aspect to chiral ligand design for peptides is certainly 
attempting to approach data from a rational perspective in hopes of establishing a trend. 
Trends are well appreciated as they are predictable and can be expected to behave in a 
certain way. With peptides however, ideologies from organic chemistry that could be 
applied, for example substituting a residue for a bulkier one to improve selectivity, often 
does not seemingly translate well over into the world of peptides. The difficulty with this 
concept is compounded further when the ability of self-assembly of the peptide has to be 
considered. How do we know if a short peptide will self-assemble? The pragmatic answer 
is that it is challenging and you cannot easily predict what will or will not assemble. To 
some extent, the results from the dipeptide screen were extremely profound as the quick 
combinatorial approach successfully guided our ligand design to its current optimized 
state. 
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To summarize, our research endeavors to create a self-assembled peptide catalyst 
that performs asymmetric catalysis have been met and allowed us to make some 
interesting discoveries along the way. The FF motif found mild success in the self-
assembly of just two short peptides. Tripeptide (N-tosyl)-TFF-CONH2 indeed formed 
fibrils and could effectively perform catalysis at the cost of the reduction not being 
enantioselective. Use of amyloid-ß fragment (LVFF) in the peptide sequence DPLVFF 
resulted in its ability to form a gel once mixed with the metal dimer [IrCp*Cl2]2 in the 
organic solvent TFE. Our other ventures with stochiometric mixing of oppositely charged 
peptides may hint at a new strategy to co-assemble short peptides. The non-assembling 
(DP)LF was another peptide of considerable interest that displayed excellent activity and 
selectivity, and showed that rational design (i.e. FF motif) does not always go according 
to plan. Through determination we have been able to meet most of our goals to show how 
effective and novel the ligand design is via our substrate scope and characterization data. 
Furthermore, we have shown that simple designed short peptides can be considered 
equally capable for enantioselective transformations. 
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3.4. Experimental 
1H and 13C NMR. All spectra were recorded on a Bruker Avance DPX-300 (300 MHz) 
spectrometer, a Bruker Avance DPX-400 (400 MHz) spectrometer, or a Bruker Avance 
III HD (800 MHz) spectrometer. Chemical shifts are reported in parts per million (ppm) 
and are calibrated using residual undeuterated solvent as an internal reference (CDCl3: 
7.26 ppm; DMSO-d6: 2.50 ppm). Data are reported as follows: chemical shift, multiplicity, 
coupling constants (Hz), and integration. The following abbreviations or combinations 
thereof were used to note signal multiplicities: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sext = sextet, m = multiplet, dd = doublet of doublets, ddd =doublet of 
doublet of doublets, br = broad. 13C NMR spectra were recorded on a Bruker Avance 
DPX-300 (75 MHz) spectrometer or a Bruker Avance DPX-400 (100 MHz) spectrometer 
with complete proton decoupling. Chemical shifts are reported in ppm and are calibrated 
using residual undeuterated solvent as an internal reference (CDCl3: δ 77.23 ppm; 
DMSO-d6: 39.52 ppm).  
 
HPLC. Enantiomeric excess was determined by chiral HPLC using a (250 x 4.6 mm) 
Phenomenex Lux-Cellulose 1 on a Shimadzu Prominence UFLC instrument. The 
enantiomeric selectivity was estimated by integration of signals at 254 nm. All solvents 
used in our normal-phase system contained 0.1% TFA.  The conditions for separation of 
alcohol enantiomers can be found in the compound characterization of transfer 
hydrogenation products.  
 
GC. Enantiomeric excess was also determined by chiral GC using a (30 m x 0.25 mm x 
0.25 µm) Agilent J&W Cyclodex-B column on an Agilent 7820A instrument. The 
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conditions for separation of alcohol enantiomers can be found in the compound 
characterization of transfer hydrogenation products. 
Atomic Force Microscopy (AFM). AFM measurements were performed on an 
Omicron VT-AFM/STM instrument operated in an ultrahigh vacuum (UHV) environment 
with a base pressure of < 1E-10 mbar and 55-400 K at Argonne National Laboratory. 
 
Solid-Phase Peptide Synthesis 
Dipeptides were synthesized by manual fluorenylmethyloxycarbonyl (Fmoc) solid phase 
peptide synthesis strategy as described before.67 Deprotection of the side chains and 
cleavage of the peptides from the rink-amide MBHA resin was achieved by subjecting the 
peptides to a mixture of TFA/H2O/TIS (95:2.5:2.5, v/v), or TFA/H2O/TIS/EDT 
(93:2.5:2.5:2, v/v for oxidation sensitive functionalities) for 2 hours at room temperature. 
The solution was then filtered through a pipette plugged with glass wool and the solution 
concentrated to remove excess TFA using a stream of nitrogen. Purification of short 
dipeptides with C-terminal amides can easily be done by dissolving it in a minimum 
amount of TFA and transferring the solution into dry-ice cooled diethyl ether to facilitate 
precipitation. The precipitated peptide was then spun down using a centrifuge, the ether 
discarded, and then dried under a vacuum pump. If the peptides were not easily crashed 
out with diethyl ether, the concentrated solution was diluted with water or alternatively a 
mixture of solvent A (99.9:0.1 H2O/TFA) and solvent B (90.9.9:0.1 MeCN:H2O:TFA) to ca. 
5 mL total volume. The homogeneous solutions were then subjected to lyophilization. 
This cycle was repeated until lyophilization afforded peptide trifluoroacetates as white 
fluffy solids. 
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ATH Method: 
To an oven-dried tapered glass microtube, peptide ligand (25 µmol), [IrCp*Cl2]2 (10.0 mg, 
12. 5 µmol), and 0.2 mL trifluoroethanol (TFE) were added. The tube was sealed with a 
14/20 rubber septum and a short needle was then inserted through the rubber septum 
into the head space. The microtube was agitated (1000-1200 rpm) for 30 minutes at 40 
°C in a Thermo-Mixer shaker (Fisher Scientific). After formation of the pre-
catalyst/peptide-metal complex, 0.8 mL of a prepared 3.125 M sodium formate stock 
solution in water was added followed by addition of substrate (0.5 mmol). The tube is 
resealed with the rubber septum and needle, and is placed back in the Thermo-Mixer and 
is agitated (1000 – 1200 rpm) for 3 hours at 40 °C.  
 
Work Up Method  
The crude reaction mixture was transferred to a separatory funnel, the reaction tube was 
rinsed with either dichloromethane (DCM) or methyl-tert-butyl ether (MTBE), and washes 
were combined with the reaction mixture. The organics were extracted from the aqueous 
layer with either DCM or MTBE (2 x 5 mL). The combined organics were washed with 
saturated brine (5 mL), dried over Na2SO4 or MgSO4, filtered through a fritted funnel, and 
the solvent removed under reduced pressure on a rotavap to afford the alcohol product. 
Yields were determined by 1H NMR with the addition of mesitylene as an internal 
standard (~6.8 ppm, 1H and ~2.3 ppm, 3H) in CDCl3. Enantiomeric excess was then 
determined either by HPLC or GC. 
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